Show UniProt / TrEMBL protein name		View in Fasta format (DNA)		View as list

# Vibrio fischeri ES114, ES114

>VF1105 transporter
MLIKLAWRNLWRQKRRTILTASALALALLLSLLMRSIQEGSYTANIENAA
RLSTGLIQLQNPEFKETQSIDDLLPMSDDFIAPTKQQPNIQFTLPRIETF
SLAAAKDKSKGVLVVGVDPQPENTYSSLADKVVQGAYFTATDKSVLLSEG
LARYFQLNVGDEIVLYGQGYRGQTAAGLYVIKGIVHFPMPDLNNQLIYLP
IQEAVQLFSTENQVTSWVLHTRDFSLLPQTVDNLQKGYGQVVSVRPWNDL
SPEMEQQIQIDRVSGIIMMYILYGIVGFGLFATLLMMTLERQREFGVMLA
TGMVRFRLLKLLVIESFFIGLLGILLGLVIAIPVLGYLYINPITLTGETA
KAMLEMGYDPVIPVLISGWLFINQMLIVTGLLLLCLLYPLWRVYHLDIVT
ALKGGSHAA
>VF0131 phosphoglycerol transferase MdoB and related proteins, alkaline phosphatase superfamily
MNFQQNYKQLSRAIWLSVFIAVIILSVGRLVFLANIVDTAELAQREGDLW
RALFTGFRFDLKVVVIGFAPLLLIGLSVAAFPKMYRIFSKVFPWYSGLIF
FLVTGFSIGNYYYYLTYGSYIDVFIFGLADDDTKAVLANAWADYPIFLSF
ISSLIVACCCAAFIRTIIKKMQQWEWKTPHKITTSVSVFMMILTVFFFAR
GTLGSHPLKRYHAQVSDYKVLNSITPNGIIALEWANSDYKKQNKFHTVSK
AELEDQFTKVVGNTTGEFTTSKNTYLANNKPHVVMALMEGMGTNVLVEDD
YPQNDLLGALRPAFESDFVFKRFLAETPATINSLVNMLGQSNVPTISHSS
AQKVEVAAAAARPYKNAGYKTLFITATNGMWRNVANYLPAQGFDEILDEN
AILKAFPEAEAFRGEWGLSDEYAFKLAEKELNEATQPLMIYILTITNHTP
YEVPKNYDVKPLKVSKQLVERMQKGEEEAMRLLETYQYANNALGEFIANV
KQSPLGDSTLIAAAGDHKLRGFTMKYPDDIAIMNAVPFYLYVPEKIQQYV
PYLYDEKRVGSHKDIFPTLYAFSLSEAAYYSLGGENMLSTTDTSRFGYNP
EMTVVEQGMYLNSQPEKLYQWRSELETSLEPTSNDKPNVDKDYHTLQTLY
INGQVKGVH
>VF2207 division specific D,D-transpeptidase
MKLPNRKKNNKRITKAPPTFIQWRFGVIVFFVFLALAILIARAAYIQVIE
PDNLVKQGDMRSIRVKSLPSARGIISDRNDEQLAVSVPVDAVWADPVTIY
KEGGLAEIERWYALADVLGLKRKELISKIEKNKKRRFIYLQRQISPAVAA
YIKKLKLAGIGLKAESRRYYPTGEISAHVIGVTGIDSHGLEGVERSYDGW
LTGEPGRRTVRKDRYGRVVENISLKEKQEGKPLTLSIDQRLQAIAYRAIK
QAVSDFRAMSGSVVMIDIKTGEVLAMVNAPSYNPNNREQLQSFRMRNRVI
TDTLEPGSTVKPFVVLAALDGGTANLDTIIDTGNGIMRIGGSRVRDSSKV
GKADLTTILKKSSNIGVAHLALGMPLQELLAEYAAVGLADPSGLNLIGEA
TGIFPDRRRWSDFEIATLAFGYGLSVTPIQLAHAYATLGAYGEYRPLSIL
KTTGPTPGKQVVNRQHAKAVLEMMETVTQPGGTATRAAVPGYRVAAKTGT
SRKAVRGGYSDEYMTVTAGVAPVSNPRIALVTIVNQPQGDEYYAGQVAAP
IFGQVMKDALQILNVAPDESTVKHIDVLN
>VFA1004 galactosamine-6-phosphate deaminase (isomerizing)
MNHYLGYSESELETLSGFWTAKEITQQPESWRRTDLIIQDNIAEISSFID
KWNTNSERRIILTGAGTSAFAGQAVAPALSKVLHQRVEAISTTDLVSNPA
EYFAEDIPTLLVSFARSGNSPESVAAVDLANQCLTNCHHLILTCNGEGAL
FSQFQHQDNALVLLMPEETNDKSFAMTSSFSSMTLACFSVLTHKNNNSKE
IESICKCSEELIKEINSNVRDTASHDFSRVIYLGSGGLKGLAQESALKLL
ELTAGKVVACFDSPLGFRHGPKSIVNNETMIVVFISNDPYTRQYDLDLLA
ELRRDNIAKKVIAITAQLNDVVADENVIRVPMMENASDVELLFPYMLFAQ
AYAFHRSVALGNTPDNPCPTGEVNRVVQGVNIHTFNNKD
>VF0475 OmpU, outer membrane protein
MMNKKVLALAVAAITSAGAVNAAELYKDEAQSIEMGGRAEARLAMKDGDA
ADNTRIRLNFKGTTQISDGLYGVGFWEGEFTTNDAVNPNGNLENRYTYAG
IGGNFGEVTYGKNDGALGVITDFTDIMAYHGNSAAYKLAVADREDNAIAY
KGQFGDFAFKANYRFDDAAANQESNDGFSTSGIYAFGDSGFKLGAGYADQ
GTDNEAMVAGSMTMGDFYFAGTFTTGEVVDLDYTGFEVAGAYTMGKTVFT
ATYNNADHDTNALTVANNENADNFAVDATYFFNANFRTYISYNLNLLDDD
ASKGITKAMTEDEVALGMRYDF
>VFA0984 amino-acid ABC transporter binding protein
MEIIPNTKKIKKVHFSQQINNKSNFMLKLTNLFAFLLLTLVITTISQFIF
VPEIIYLSSTNNKSNKNTLEKIKKRGFLLVATKLDGVGCYYKRGQLRGIE
CELLQEYANYLDVELNILFFPDLHSLFTALDNKRVDIIASDLTPNNERKK
KFLFSNALFHTEEWLIQRKDNAISNLKQLNGKTISIRKGTTYKDVILTLQ
QEMNINIKIELLPETLSTLEIIKGVANSIWSYTLADQHIAQNQHAQYPQL
SPPLTIGQPREISLALFKDDKELLLHLNSWLANKKAKDILNKKNRTDIKK
QYLITPWDNIFKKNASQPFDWLWLTSQAFAESSFDPNAISSSGAKGLMQL
MPETAKDMGVTQLFDPNENIKGGAKYNKWLYKTYWNYLPEKEALAFTFAS
YNAGVGHIIDAQRLALRNGDDPNVWFNSVENHIIKLEKKSIFTLPYIKYG
YCRGSETKSYVRKIFFQKRIYSNNKALLNKQHLNN
>VF0558 soluble lytic murein transglycosylase
MKYTQYKLGMMTALCIGMNVQVVDASPVDTWRAQYQEAKTLLNEKKYDEY
KKVRAELDGYSLAPYLDYRELRMDLSSKTPDDIRLFKHNHQSLPIGNSLS
YQYLVILGLNERWAEFIDYFPNEPSSKNLQCYYYQAKNKLGDKATAWKGA
EQLWLTGSSVTYECDDLFQDWAEAGKLSDDLIIERMLLVYKARNNNLFSY
LEKMLKADAAKEKAQHIVTLFNDPDLLESFSKSNKKTEFSKQLTLISMER
EARKNPKKAIEILPDIAKKQLFTQEELVQVKRRIVSSIMSTESAELAQWR
DKELAANPEDSFIERRIRVAIRAADWDDVSNWIEYLTPTAKNSLRWQFWT
AQIESKEGEQDKADARLKKLLGQRNFYSVAAANILGEPIQYPMNTAPRNI
KPIKDKYSVELARIKELIAIDEIPTAKSEWEYLLNRASKTEVKELASYAA
QHRWHHFTVLATIKGRMWGYLSLRFPIAHQWWFNHYSKELGLDKVTLMSL
SRQESALYAEAQSPVGARGLMQIMPATAKYTAKKIDYDKYEGVDSLNDVD
VNIHIGSNYLKGLLDDYDGNRIFALAGYNAGPHRVKRWRAVSDEKLDAYA
FIEAIPFKETRGYVQNILMFETYYRSLLGEKGAFLSEKELNLKY
>VF2206 UDP-N-acetylmuramoylalanyl-D-glutamate--2, 6-diaminopimelate ligase
MMQLSELLLPWCDLNQSVAISSMTLDSRQVSPGCLFVAIKGHAVDGRQFI
SSAIEQGAVAVIADADKENIAGTVKVIDNAIVVYIDSLYTQLSAIAGAFY
QADKRNMQLVGITGTNGKTTISQIIAQWTTLLEQPAAVMGTTGNGLLSDL
KPALNTTGSPIEIQQTLTELENIGAKLTALEVSSHGLVQGRVNALSFDAA
VFTNLSRDHLDYHGDMANYAEAKKLLFTSHRPKNSIINGDDQVGCQWLKE
MPHAVAVSLNEENISFHSGKKVFATSVVYSTEGIKLSISSDWGNVAFSVP
LIGAFNASNILVAFAALLSLGYDIQALAQTASQLNAVIGRMELFATDNKA
KVVVDYAHTPDALDKALQALRVHCEGKLWCIFGCGGDRDTGKRPIMASIV
EQQADAIILSDDNPRSEEPSLITDDMLVGLKNAESAHVIHDRFEACQFAL
SQANENDIILLAGKGHEDYQVLADKTVHYSDRETAQTLLGLQS
>VF0651 amino-acid abc transporter binding protein
MSRIRHHRFIQSCLVISTLLITLTGCQVESEPKTKLEQIRERGILRVSTL
NNQLSYYIGSNGPTGLDYDLAKAFAEKLEVKLEITPAYTYSGLFPALERN
EVDIIAANMTITPERLQKFRPGPVYYYVSQQVVYKKGSWRPRNIKNLTQL
DENLTIVKDSSFEGTLIKLKEKYPNLDWNTAADTDVSELLKKVATGEIHY
TLADSVELSLTQRIHPDLAVAFEVTEDQPVAWFLQQTEDDSLQALLIEFF
GELKESGKLALLEEKYFGHVESFDYVDTRAFIRALESKLPKWEPLFKKYA
GDFDWRFLAALSYQESHWNPLAKSPTGVRGMMMLTLPTAQSVGVKNRLNP
EQVFVVVQNIYVE
>VF0352 undecaprenyl-phosphatebeta-glucosephosphotransferase
MPRSDMKQQNIKMISDSYRTLTKAFDFIAINLLLTSILSFHGLEETAVDL
SAGLLFSTIFLLISEYSGLYTINTKVELKKYLLRLTFSLLLTVSVFFILK
LRLASLEGMQISNLNSHIYLLWYVCVWGGLSLSRTLCTLSYTYIVIPRLK
INKIAIIGLTPAGLSIEQALISKYKNQKISIEFYDDRSSSRFSYVNKSGY
AGKVSELIEKVKNDEIQSVYIALPMVAKDRIKDIIHQLSNSTVNAYIVPD
LYTYKLSVSQIKRIGNVHTFSIFSSPFEGLGAVIKRIEDIVIGSLITLLI
LPVLCIVALGVKLSSPGPILFKQDRYGLGGKKIKVWKFRSMKVMENSEVV
TQATKNDPRVTRFGSFIRRTSLDELPQFINVLQGSMSIVGPRPHAVAHNE
EYRVLVDNYMVRHKIKPGITGLAQINGYRGETDTLDKMEKRVEYDIKYLQ
NWSLSMDLKIIFLTVFKGFVSDTAY
>VF2133 periplasmic component of efflux system
MGKYTSAFLSYLIHRPWIISFLLFLSLFLWVMSGPSQAEESSGIKETSTF
SIPLANVVIEQFESTPTHKTISLYGRTSPDKQAILGAQVAAQIEELLVKK
GARVTKGQPIARLDMADLDLQLSQAKAIYSVRMKEFNAAKELKRKGLQGE
VAFSQSQASLAEAKARVRNAELILENTTITAPFDGIVEHLFIEVGDFVSR
GDPVAKVVVLDPLVIDVNVSERHISQITKQQKAEVSFINDVSIEGYVRYI
SKISSLSTNTFSVEIEILNIGGKIPAGISSEVEINLALQSAIKVTPAMLA
LNESGDLGVKTAIEAEGHSETNYKVKFVPIQLVKAEDDGVWLTGLGNEVD
IITVGQGFVRDGDFIHVQRK
>VF1710 outer membrane protein Slp precursor
MKQVIYFLSVLLLVGCSSLPQELKSTQATTLVEYNAFSDAANAGEKAEVR
LGGVIARLDNLSDQTRIEIVNLPISSVGKPDISEEPNGRFVVYVNGFIDP
VTYAKGRLITVIGQADGIEQANVGEFVYPFPVIQASAIHLWQIQEYVVTN
DLDMDYMPCAGARCFHQRSHLETRRGKVVQEVK
>VF0147 acylneuraminate cytidylyltransferase
MKNFAFIFARGGSKGLPGKNIKPLAGKPLLQYSVDTAIASPSIDKVFVST
DDSDIAKVAVESGAILIERPAELATDISPEWLSWRHAIEWAEEYHGQFDG
FVSLPATSPLRGVEDVEAAIEKRSKVGADICISITPASRSPFFNMVKETQ
DGLVELVNKPESNVTRRQDAPEVFDITTVVYVTTPDFVLNNYGLFTGKVT
SIEVPKVRAVDIDDIYDFRMAEAILQDAK
>VF1141 beta-glucosidase
MDKQFKGFGLTISHVSALSGGLTNACLKVEAKEGSFVWRPISLQAKILGA
DRAKEHEILQALSDESFSPNVYGENEEGILVEWLEGEVIALDKAQDVAVD
LLCSVHQISLDKLSEQIKNKPMSLKDRIIDYWNSITPENQTPEMEAYFEY
FSQQDEQAFFSHCLCHYDIGAYNIVVKEDGYGLIDWEYASMGDPSQDLTS
MIIANQFDMDDVISLYCQKRRLNIDEWKRAVIHWTPWVTFMGALWFSLGY
QLLKNTCYQELAEREMCKLIKLLPSIHK
>VF2574 methyltransferase GidB
MTDLSQQFDRLIAQTDLNVSELQKEQLLGYVALLHKWNKAYNLTSVRNPS
EMVIKHILDSIVVSPKLSGERFIDVGTGPGLPGIPLAIMNPEKSFTLLDS
LGKRIRFIKQVIHELKITNVTPIQSRVEEFQPEEKFDAVLSRAFASMTDM
VNWCHHLPKEEDGVFLALKGIYSEEEANDLPEWCSVKNVATLIVPELEGE
RHLVTLAGKK
>VF0196 undecaprenyl-phosphatebeta-N-acetyl-D-fucosaminephosphotransferase
MIRILDFLAAFFGLLFLWPVLLIVTIIGLFDTGSPVFIQERVGRNKKPFN
LIKFRTMSVETKSVASHLASNASITKLGAFLRKTKIDELPQLINVMKGEM
SLVGPRPNLFNQEELIKERDALGVYDVLPGVTGLAQVQNIDMSTPALLAK
TDRKMIDTLTVKSYFQYILMTATGSGSGDAVK
>VF2089 GTP-binding protein LepA
MKHIRNFSIIAHIDHGKSTLSDRLIQVCGGLSDREMAAQVLDSMDLERER
GITIKAQSVTLDYTAKDGETYQLNFIDTPGHVDFSYEVSRSLAACEGALL
VVDAGQGVEAQTLANCYTAIEMDLEVVPILNKIDLPAADPDRVAEEIEEI
VGIDATDATRCSAKTGLGVDEVLETIVKSIPAPEGDPEAPTQALIIDSWF
DNYLGVVSLVRIKNGSLKKNDKIKVMSTGQVWGIDRIGIFTPKQIDTDVL
NTGEVGWVVCGIKDILGAPVGDTLTHAKGGCEERLPGFQKVKPQVYAGLF
PVSSDDYENFRDALGKLSLNDASLFYEPESSAALGFGFRCGFLGMLHMEI
IQERLEREYDLDLITTAPTVVYEVAKTDGEILYVDSPAKLPAVNDIDEIR
EPIARCNILVPSDYLGNVITLCVEKRGVQVDMQYHGNQVAVTYDVPMAEV
VLDFFDRLKSTSRGYASLDYNFQRYEASSMVRVDVLLNGDKVDALAIITH
KDNSQSRGRLLVEKMKEFIPRQMFDIAIQAAIGNHIIARSTVKQLRKNVI
AKCYGGDVSRKKKLLKKQKEGKKRMKQIGNVELPQEAFLAILHVGKD
>VF0350 putative capsule polysaccharide export protein precursor
MKPLFISFCLFLSFVSNALASEAQETPSDTQEKAKTEQSQQKEDLGYILG
AGDTIQISVFKEPEMTTRLKIHRGGYVNFPYLGEIKLSGRTPTQIEEDIE
ARLADGYILQPMVTVSIEAFRKFFISGEVANPNGYEFQPGLTVEQAIAMA
GGFTDRSDRDSINVRSAATNELIEDVAPTYPVGPGDVVIIEQSFF
>VF0722 putative lipoprotein
MKKVIIALSALFLAACSAPSDPQLDIQPKASSNAHQIVDGIKLTLDSSDL
RTAQYVAVIDNGRQNVQPIHAKQNLRVTLEDALSSQLKTQGFVITVDSDN
TLRLDIIEALVSVQHSLMSNEIKTQVKLQITAETPKGKFVKTYNGVSEKT
GSMSADNQDIEQVLNDLLNAVLDKIAVDEELQTYIKGNF
>VF1950 acyl-[acyl-carrier-protein]--UDP-N- acetylglucosamine O-acyltransferase
MIHETAKIHPSAVIEGNVTIEANVSVGPFTYISGNVTIGEGTEVMSHVVI
KGDTTIGKDNRIFAFAIIGEESQDKKYGGEATTVVIGDRNVIRESVQIHR
GTVQDRGVTTVGSDNLLCVNVHIAHDCVVGDNIIMGNNATLAGHVTVEDF
AIVSALSPVHQFCTVGAHSFIGGASVVVQDVPPFVMAQGNHCKPFGINIE
GLKRRGFEKAEIHAIRRAYKALYRNGNTLEEAKVEINKEIEAFPVLQGFL
DLFEKSTRGIIR
>VFA0714 serine protease
MIILIWMVIMRHVFRLNLWFVFLATFLFTPYLYAEPIKEPSRPKIALVLA
GGGAKGAAHIGVLKALEELNIPIDIITGTSMGAYVGGLYATGKSASEIEA
YLHTVDWYSGYQDEVGREEKNSRDKKYEDRFAINPSLGIRKEGVKSPKSA
IQGQNMLKILRETSGNPVSVASFDDFPIRYRSVATDIVSMEEVVIDHGLL
VDAMMASMSVPGALPPYEFEDKLLIDGGVTNNMPVELAKEMGADIVIAVD
ISSNYMTKEQIGSLFDVASQLTNFMVKRSTQEQAEFLTDKDILLQPRVGD
IETTDFSSMPRAYQEGYDTVMTLKSRLQSLAVAPNEYAQYQNKIKQQSAN
VRLAQGAIIDKVEVENRSHYESDKLERFIQFEQGTLLSSDYIEDKIHALY
ATNRFETITYLVEEDNNENVLKVTAKEKEWGPNYLNFRFFLEEDFDTHSQ
YGLGASINFTDLNDYGAELRTNVELGTDKIFDATIHYPFYLNHHFFVQSN
MMYSDKKRSISTSSLEDKEPNSSMSFYPVNLRDFTVDALFGVEATKDQQL
KTGILYARGSHELTGLSAYGRTEYERLGATLEYNFDSLDSISLPTHGSLI
NARYLYAFDKVNSRDVEGSDHSEQYIDEFTAEALFARSIARHTFISSAEY
GITNSDDYLVPVNPIELGGFNHLSGLPRNSLIGANKIYGRLTYRYRWFEN
DLGMFKTAVYLGASAEYGGLWSMKSTDISSAPLIFSGSLFGGIDTPIGPI
ILSYGRAENGLDSVYLIVGNVE
>VFA1168 type I secretion adaptor protein (HlyD family)
MSKKGFNKLDKHELDFVDDKTAALLLNTPTNAKILLWVIVVFFGIAIGWA
SWAEIDKVTVGQGKVIPSSQLQVVQNLEGGLVKEMLVKEGDQVEKGQQLL
LIDDTRFRSDFRERKKQLINLTASAQQLAASMDSILIQDINNRKRWKESV
IVYTDKLKFDEAFVKENPIVTRRQLAEYKADMNNLKNRIFVFDQQVSQKQ
QDLVEIKARVRNLKASYNLARKELDITKPLADEGVVPRIELLKLQRQVND
TKRELTSTELKIPVLTSAIQETVLNRIDAALKFRSEQQEKLNTTQDKLSA
LTESQVGLKDRVNRTVVLSPVTGTIKKIYINTVGGVIQPGMDLIEIVPTE
DTLLIEAKIAPQDIAFLRPGLSAIVKFSAYDFTRYGGLKGTLEHISADTI
QDEEGNSFYLVRVRTSQEDLEEKTQFNIIPGMTTTVDIITGKRSILDYLV
KPIVQAKGSALRE
>VF2131 cell wall endopeptidase, family M23/M37
MILSKLTRIPVIHRILIGLCSAGIVVTIATIPDTVAPDSGFYKLTVGQTY
PIEIRKEALISHEKNSLNQQLSWETHTVKSGESASVLFSRIGLGYSQLLK
LTSSDKEIENQLTRLRPGDKLKFGFNQGQEIVQLIRPISKFETYRISKAG
DGYIGLFEKQDIETQLNYTKATITSNFWNASIGAGLNPNQIMELAGIFGW
DIDFALDIREGDNFKVLYEEKYVEGEYAGKGNIIAASFTNRGDTFTAIRN
DKNGNFYEPNGRAMKKAFLRSPINFRYVSSNFNPRRLHPVTGQRKAHRGT
DYVAPVGTPIWAAGDGVVDKAGYNQFNGNYVFIRHSNTYITKYLHMTKRY
VRAGQRVKQGDTIGTLGGTGRVTGPHLHYEFLVNGVHKDARTVSLPQSKS
LTGKDKKEFEVVAKERLKQLEQYGQFIVGNHPVINHE
>VF0151 O-antigen ligase
MINNYCQKILSSISKYWVLAIVYIPILWTLSFNFTLPNGRSIASKLLVIS
AIFSFIYFRKRVFLFKEKPKTFKILITSLFIIILFRSILFLYHGEQTSSI
RAFGIIFLYIYSFPYWLVKKEHIKNLTFISLFLFGLDAFIHVINNGFTRY
GGNTNPNPYGLYAALIFIFVYIYNLINTKTHILYKTIPLIIIGFLPIMIS
QSRGVWVSTILTLIIIHIARIKFNIKNISIYILTILAIAFSLYSTPTVKN
RIEATKIEIKNIEHHNLSSSLGVRIQVWKDSIPLIKEYPFFGLGNKLKEI
NNTRFENKKISQYSYYYSRNHLHSQYFEFITKQGFIGFFIIIGAIIFPLI
IMRKDNDIFVKFCSISFLCVLLINFITEVPFNWINFTYTYLILILCLTLQ
SYHSTKDIRS
>VF1952 UDP-3-O-[3-hydroxymyristoyl] glucosamine N-acyltransferase
MSRITLAELAEKLDATVHGDGTVVVHSIASMSKAKEGDITFLSDAKYRKH
LVECQASAVIVKEADVEFCQSNVLIMRDPYLGFALAAQALDTTPAPASDI
APSAYIADDAIIGEGVAIGHNAVIESKAVIADGAMIGAGCFIGKEAKIGK
NTKLWANVSVYHRVEIGEACLVQSGTVIGSDGFGYANDRGTWVKIPQLGS
VIIGDNVEIGANTTIDRGAIDDTVIESNVIIDNQIQIAHNVQIGSGSAMA
GGTIVAGSTKIGKHCIIGGGSVINGHIEITDGVTITGMGMVMRAIDEKGM
YSSGIPLQTNKEWRKTAARVHKIDEMNKRLKAVEKKLVD
>VFA0427 3-deoxy-manno-octulosonate cytidylyltransferase
MSFTVIIPARYQSTRLPGKPLADICGKPMIQWVYEQASKAGADRVIIATD
DSRIEAVVKGFGGDVCMTSPNHESGTERLAEVIEKCGISADEIVVNVQGD
EPLIPPSIIQQVAQNLSDSVAPMATLAVTIDEEDDVFNPNAVKVVTDAEG
YALYFSRASIPWDRDAFAQGETLTANPLLRHIGIYAYRAGFINTYINWQP
SVLEKIECLEQLRVLWYGEKIHVAVAKEAPAAGVDTPEDLEKVRAILSK
>VFA1033 glycosyltransferase
MKPDLIVFGEDWGGLPSSTQHLIKQLALTRKVVWINSIGLRQPRFSIHDM
KRVWRKLTQKSAVQAHNENEAPFTTVNIKTIPAPKGTFARWVAKKLIINQ
LKPILQKEKLNQPILWTSLPTVADVCGELGEKSVVYYCGDDFGALAGVDH
NTVIQHEQKLIDKADLILAASKELLIKFPKGKTQLLTHGVDFTLFNQPVP
RAKDLPNDGRPIAGFYGSLSDWLDYDLLNKVIAENPLWHFVFIGKNELTY
NPFKNHPNLHLLGPKMHYHLPRYSQHWQANLLPFVDNEQIKACNPLKLLE
YLATGTPIISTSFPALVPYIAEIHTVNSTQDFTTHLNNIHSNWLNSSVNN
KNTQQAALTKKHTWQAKAQQLDVWLEAL
>VF0300 conserved hypothetical protein
MLKKGLLTGLIAISASVHASEIDIEDADTSSSSPNSIEIDYGNDRSLSQN
CSLESVYTSGTNSHVDEEKYYLSKDDCEAGTKELTLEKKPSINPVISQLE
AEMEEPDTTPPSPWKSQIEFGYQSSKGNDDSQSLNGRLEASYTAGQHRHT
GEVKYYLAKDDGETDKDQLSLNLQSDYKISPDYYLYANFKGLNTKYSAYF
NDYTFSGGLG
>VFA0110 multidrug resistance protein A
MRKILLGLACIVTLQACSPDKGDEALGTLERDRVTFSATSNEIIRALPVK
EGSEVKVGDVLVQLDTKNQEAILAHAIANTAKAQAYLLRLTNGERPEDIA
SAQARVDQAKAQLIDAEKTYRRMVELVKKNLASQSNKDAALASRDSARAA
LNSANEEFSKLTAGARPEDIEPARAELDAMKAEAILQQQKLDELTIVATR
DGILDNLPYNLGERVPVNGFVAVIQANRVPYARVYVPASYRVGFVPGKKF
SVKVDGIDTPFEGTVRWVATDPLFTPYYALTEEDRSHLVYLAEVDLPESA
ALLPSGVPAQVELSKD
>VF1280 carboxy-terminal processing protease precursor
MNCRFRVSLIAAGVMLAASAHALEAKVLDAKFSETDLPVLAAETQHATAS
KRVTSRFTRSHYKHFSLDDDFSVAIYERYLDMLDYNRNVFIQADLASFAP
LSTQLDDQLKVGDTKAAFDIYNLSLKRRFERYVYALSLLDKEFDYTVDES
IELDRSEAAWPKDEAELNELWRKRVKYDALNLSMAGKDWPEIQEMLGKRY
NNALKRLTQSHNEDAFQLYINAFAREVDPHTSYLSPRNAEQFQSEMNLSL
EGIGAVLQATDDYTVIRSLVAGGPALTSKKLSEGDRIIGVGQEGEKIVDV
IGWRLDDVVQLIKGPKGTKVKLEILPEGKDSKSHTVTIVRDKIRLEDRAV
KSEVIEQNGKKIGVLEVPSFYVGLAEDTKKEIAELKEKDISGIIVDLRNN
GGGALTEATALSGLFITAGPVVQVRDSYGRVNVNADTDGEISYTGPMTVL
VNRYSASASEIFAAAMQDYGRAVILGENSFGKGTVQQHRSLNHIYDLFDK
PLGHVQYTIQKFYRINGGSTQNLGVVPDIAFPTAIDPKDTGESVEDNALP
WDSIKAADYAKTNQIAETIEPLAKKHVERIKTDEEFGFIQEDIARYKAEK
DITSISLNKKVREKESDDADARRLTRVNERQKLLGKEEFKTLDDIPKDYE
VPDAYLDEAVSITIDLALMNQKK
>VF1121 BCCT family transporter
MKKHFELIDKPTFFGAILLLCAVVVPLLVFPAEGAEWIAVAKTFMTDKLG
FAYLGLGLAAFFFMIYIVFSDIGQIKLGDPDEKPEFALASWAAMLFCGGI
GASILYWGTIEWAYYYQNPPFQLEAGSEEAVRWAATYGLFHWGPIAWCIY
MIPAIPIAYFFYVRKQPVLKVSAALMPVIGEANSFGKLGKVIDVLFIFGL
LGGAATTLGLAAPLINEGISYLFGIPATTGSQILVLMVCTAIFAYSSYMG
MDKGIKILSNINFWGALGLLLFVLVCGPTIFMLETGLDSIGRMLSNFFVM
ATWAEPFGGMGTFADTHFPQDWTIFYWAWWLVFAPSMGLFVARISRGRTI
KQMVSGAVFFGSLGCAMYFIILGNYGLSLQLSGELDVVGILNSEGATRAI
FSVLEQLPFSTFVIAVFTLLCVIFTATTFDSISYILASVVQTNVTEDPMR
WNRLFWAFTLSFMPSALMFMGGLATLQTAAIVGGLPLLVIAIMLMISGVK
AAMLDLSHQDNYVDPVINISDLPDVDPWSKEGQALARFEQLRDNAIEAAD
LEREANDAIWMLKKQLRKEALARGESSVDLGDAPDEIIEKLRQLTDDSTN
AKEAKLAASELAQEARVAFDALMRQKVEEETLQANEEAKLAIKTRLNTPS
>VF1582 periplasmic component of efflux system
MNKTKSIALVVLLACTLSTPSYAKKTRGNQSVAVLSEEVATHEISQSLSL
IGKLKASESVVISPEVAGKIERIAVKANQNVRKGQLVVQLNDDKAIAAIK
EARAYLNDEKRKLTEFQRLAKKNAITQTEIDGQKASVDIAQARLDAANAD
LSDLHISAPFAGTVGFIDFSRGKMVSAGTELLTLDNLSVMQLDLQVPERY
LSMLSVGMNVEATSQAWKNSVFSGKLIGVDSRINAETLNLRVRIEFPNKD
LKMKPGMLMAATLDFPAINAPIIPVQALEYSGTKRYVYVVGEDNKAIRTE
VTLGARVENRVVIASGLNVGDEIVVQGLVNMRDGVTVKQLEQNKTEVQ
>VF1556 phospholipase A1
MKKWMLLIALAIPSLSFAKELNRIHAYEDSYILGSYISDLNKQTYIDGGF
EDADGLHDVEVKFKFSFAVPLFPVSQSSSIMFAYTQKSLWQLGNSDISSP
FRETNYKPQFFLMHQSNMLIFNNAEFGYMHESNGQTASLSRSWDRIYGAL
ERIDGPVQYGVRAWYVIADEENNEDITDYLGNYDVWASVGNDIGTLSTRF
HYNFETDKGGAELGYTLNVNKFVGLYVQAWKGYGETLIDYNHDQTRIGLG
IKLMPPN
>VFA1034 chain length regulator (capsular polysaccharide biosynthesis)
MITLSQRIFIILESAWRRRYLIVLPIILMPFIGLTVAKLAPKHYDSHTSM
LIQETAKMNPFLEDLAVSTMLKERLSALQTLLHSRHILGSVAEERGYIHE
SMSPQAIDNEINKLSANLSVSMAGKDLIRIDYRANNPDGMKDTLEAVSRH
FTEQLLAPERSSMKDSSKFLSDNIEFRRQELDAAEEKLAEFKSQENTVLP
EMQITSLDRLTKLKQRLYERQAELAGAKKRLGSIDLQLSKTNPVIGKIEE
QIIRIRGELTLLQAKYTPQHSKVQGKLRNLNRLEEERSRLLSQTQPGLSS
EQLWDIASSNSVEDLAKAPPILLSQLEELQQATSKVDALTEETRVLESMI
KDIELQASTFGQNEKVLYQLQRDLALKRELYNDLVERFEMAKLTRSLGVF
EQEKRVKIIDRPYTPSGPSNLPTILYAIAGVIGGIGFGIGMAIIAELCDT
SIRRKDEIATLSTSPVLSRIPPQPVKCFNLSEDTHSTTNNLLSSMSKAN
>VF0831 cell wall endopeptidase, family M23/M37
MKYKEVLAARINSLSKRHKLVLMSLSLFTVVVFIWEPTHSISQSLSEPSR
STVTLSSENLQTLADQNSEPVETIFDPNDPEFNAPKDELDKHINAEDIVH
SHTVDAGETLGAIFNQYALSISDMYALLDVNKSAANMRVGVDLEWQQDED
GKLTELKIHRNIKDTDVYAWNGEKYTFTQIEEKGEIKPVFLSGRVTSNFY
NSARSAGLTPGQIQTLAKQLQWKFDFGKEARKGDRFAVEIDKEFIDGKAV
SSGDVKAVLYKNAGRDITLIKHTDGHYYDVQGRSLNRALERFPTHQRYRI
SSPFNPYRKHPITGRISPHNGTDFATPVGTSVYATGDGVVVRALHHPLAG
NYIIIKHGREYMTRYLHLSKILVKKGQKVSMGDKIALSGNTGRSTGPHLH
YELIKNGRAVNAMKVPLPQASPVKSDERARFKQQAKLTIEALQEQV
>VFA0376 hypothetical protein
MTLLKISTAVLLSCYALSISAKEEPQSWVDTFLEELGSSEDIDVSQGVDW
AVLPGPFANPEQGFGLGIAAVGLYSPLENKDSAPLSTVSITGYGSSSGSY
GIGINNRTYFENDEIRFLVQAKASHTPEYYWGIGKEQAENEGNKTLVEAE
IFGFTPKIAYQFYPNTYLLAGFDLESHRKQTTDSLLLHSKDLEDTLLTAA
TISLEYDSRDFELNAYSGTLLSINWNEYSKSLGSDYEFNKATFNYRQYYR
VTSDTVLAWEAYSETVQGDVPWFALSSLGSDKRMRGYYSGQYRDNTQASA
QIEVRHQFNHRHGMVAWVGGGNVADSYQQLFDSKWLLTYGVGYRFAFKPR
VNVRLDYGIGKDSQAVYFQINEAF
>VF2198 cell division protein FtsQ
MALTERLSWQVVLDNGIRLELGRDSREERVERFIALYKQLESKKDSIDYI
DLRYDTGAAVGWKSDDVENKEEN
>VF1166 hypothetical protein
MFNFVEPPNAFYDFENILTQDEWQKKQGWFKDKITELNSDVIGFQEVFSP
NALKALVDELGYAYFCTVDEPKSEDGYVFNSPVVAFASRYPILNAQPVIA
EQTQLERFGIEFEFNRIPVHASIELPHLGITDCYVVHFKSQRPKEPEVNN
EIDEESLSSLNQLHNEQLGSWLSTAQRGLEANILHNHIIQQRKKTNQAIV
VMGDFNKPLFHDEFKGLLSHELRFDKFSSDYLAQFQLKDSWNLYGKLKGI
DLLEERTYTHYYGAKGSVLDYILLSNEFDSSFSGNILEVVDYTVTDKHIV
NPTFDIDQFSTDHALVSITARIRQA
>VFA0842 outer membrane lipoprotein Blc
MFKSISKVGFGAVILMMLNGCLGMPKGVEPVTGFELNRYLGTWYEIARLD
HSFEDGLSQVSAEYSINEDDSVKVINRGFSDQDQQWSEALGKAKFVDGSD
EGYLKVSFFGPFYGSYVVFELDKENYQYAFVSGPDLDYLWLLSRTKKVDQ
EVIERFVSTAQSLGFKTNELIFVEQK
>VF2405 curli production assembly/transport component CsgG precursor
MKYSIYYLFILLLAGCSNSIDIPETSESPTLMQRGANYIDLISLPKPQGK
IFVSVYDFRDQTGQYKPQPNSNFSTAVPQGGTALLTMALLDSEWFYPLER
QGLQNLLTERKIIRAAQKKQESISNHGSTLPSLLSANVMIEGGIVAYDSN
IKTGGAGARYLGIGGSGQYRADQVTVNIRAVDVRSGKILTSVTTSKTILS
YEVSAGAFRFVDYKELLEVELGYTNNEPVNIALMSAIDSAVIHLIVKGVQ
QGLWRPANLDTRNNPIFKKYASETNQIL
>VF0752 rare lipoprotein B precursor
MTSACGFHLRGDYLLPDEVHEISLTSFDQYSSLTRDVQKQLRMNGIRQVA
PTTVTPSLDLISESLNERTLSLYQNSRAAEKELTYNVSYSVLIPGHDLKT
YTTTVNRNYLDNPLTALAKSVERDMIEEEMRAQAAEQILRQMARLKADDA
PVETSDVITHDDETESKVTTKEVIKSMSTTAETTQ
>VF0302 alanine racemase
MSYMKAATAQIDMSALAHNLQKIKQQAPSSKLLAVVKANGYGHGLLNIAK
GAQGADAFGVARIEEALQLRAGGIVKPILLLEGFYSAGDLPILVTNNIQT
AIHCKEQLEALESTDLEFPVVAWLKVDSGMHRLGIRPEEFQEYVDRLHAC
KNVAKPLRYMSHFGCADELDSSTTTEQIDTFMSLTKGCQGERSLAASAGL
LAWPDSRLDWVRPGIIMYGVSPFAEQSAQELGYLPTMTLTSHLIAVRDVK
AGESVGYGAIWTSERDTKIGVIAIGYGDGYPRTAPNGTPVLVNGRKVPIA
GRVSMDMLTVDLGPDAQDKVGDEAILWGRDLPSEEVAEHIGTIAYELVTK
LTSRVQMQYT
>VF0140 UDP-N-acetylglucosamine 4,6-dehydratase
MNSILSLIGRDTELFHQDINANEKELQSVVSQSRFLVLGGAGSIGQAVTK
EIFKRNPQKLHVVDISENNMVELVRDIRSSFGYINGDFQTFALDIGSIEY
DAFIKADGQYDYVLNLSALKHVRSEKDPFTLMRMIDVNVFNTDKTIQQSI
DAGAKKYFCVSTDKAANPVNMMGASKRIMEMFLMRKSEEIAISTARFANV
AFSDGSLLHGFNQRIQKNQPIVAPNDIKRYFVTPQESGELCLMSCIFGEN
RDIFFPKLSEALHLISFADIAVKYLKQLGYEPHLCESEDEARELAKTLPA
QGKWPCLFTSSDTTGEKDFEEFFTDKETLDMARFDNLGIIKNDSLYQQEL
LELFEQKIGQMKTDRQWTKEEIVQLFFIMIPDFGHKETGKYLDSKM
>VF2433 glutamate racemase
MPKHILIFDSGIGGLSVYKEIKYQLPLAKYIYAFDNAAFPYGELTESVLI
ERTTHIISKLCSKFPIDIVVIACNTASTVVLPSLREKLDIPVVGVVPAIK
PAALVSNKIGLLATPATVKRSYTYDLIKSFAPISDVQLLGSTRLVEMAEE
KMIGIDVDITELKEILSPWQNKVDTIVLGCTHFPFLKNEIKKALGNKILL
IDSGEAIARRVKQLLNGDEVESAVLFEGEVFCSAPSIKEEALNHTFKELN
FSSLQCLGYPKF
>VF2200 UDP-N-acetylmuramate--alanine ligase
MTKEQKLQLAEIRTMIPEMRRVECIHFVGIGGAGMSGIAEVLLNEGYHIS
GSDMAENTVTVRLAQKGAEIFFGHQASNVAKASVVVVSTAIDPSNPEIVA
AKENRIPVIRRAEMLAELMRYRHGIAVAGTHGKTTTTALTTQIYSEAGLD
PTFVNGGLVKNAGTNARLGSSRFLIAEADESDASFLHLQPMVSIVTNIEA
DHMDTYGGDFETLKQTFIDFLHNLPFYGQAVMCVDDPVVRELLPQVSRQV
ITYGFSDDADVRLINYRQVGQQSFFTVQRKDRTDLDIVLNIPGKHNALNA
TAAIAVATEEDVEDEAILTALLNFEGAGRRFDQLGEFETGNGSAMLVDDY
GHHPTEVDVTIKAARAGWAEKRLVMIFQPHRYSRTRDLYDDFANVLDNVD
VLIMLDVYSAGETPIAGADGRALCRTIRGRGKIDPVFVPTIEALPPVLAN
IIQEGDLILTQGAGDVGKLAKQLASMELNIETMKKLG
>VF0265 UDP-N-acetylmuramate:L-alanyl-gamma-D-glutamyl- meso-diaminopimelate ligase
MHIHILGICGTFMGGAATLARQLGHKVTGCDANVYPPMSTLLESQGIEII
EGFDPSQLDPAPDLVVIGNAMSRGNPCVEYVLDKNLKYTSGPQWLQEFLL
QDRWVMAVAGTHGKTTTSSMLAWVLEECGYKPGFLVGGVLGNFGESARLG
ESMFFVVEADEYDSAFFDKRSKFVHYRPRTLVLNNLEFDHADIFDDLAAI
QRQFHHLIRTVPSTGRIFAPKQDKPLEQVLEQGCWSELEFTGEDGQWKAI
KLQKDGSQFDVYFEGENVGQVNWDLVGDHNVSNALMVVASARHVGVTPDL
ACEALGKFINTKRRLELKGEVNGVTVYDDFAHHPTAIDLTLNGLRNKVGD
KKIIAVLEPRSSTMKLGVHKDTLAASLHAADSVYLYQPDNIAWSVDDVAQ
QCTQPAHTHNNIDAFVDMIVNEAQPGDQILVMSNGGFEGIHGKLLSGLGD
AVKHIEMVD
>VFA0487 OmpU-like outer membrane protein
MKKLLLSTAIVSSFVSTPLLAATVYDQDDTQLKVGGRAEARANISDNNES
ATESSFQDKSRARINLKGKTKINEDLGAFGTYEVEIADGKNNLVNTRYLF
AGLSTAFGNFSYGQQDSAQVMLTDYTDILATFGGDAADLTDGNKDKRENN
FVYSGEFDALTVQANYIASNTKKSDSFGLSGMYALPIGLDLGLGYASGEQ
AGLDADQINLALRYTLDAFMVSGLFTTGEIDKIDAAGYELAAAYKMDKWV
FQGVYNYQEVDSKDTEINVAIEAIYKLNKSFRTYAGYKFEQIDDLDDQIQ
FGLRYDF
>VFA0230 outer membrane protein
MYKILIIVAAVLGLSFNANANANANANANANANANANANANANANANANA
NANANANEKVEDIKKSEQSVLIYCGSVNKEYQKEVNVAEGKRLSLNEGGF
YQIQHLEPIEPKGAFVNRELDSIDVESTCSEFLISNTSDALVNKNAVLAR
VYFNFDKSTLTKRSEYVLDKLYSKMGEKDIKLKVEGHTDSKGSSTYNYDL
GLKRANIVYQYLVQQGAEPNQFSVVTKGEREPIKTNKTANGREKNRRVEI
EKI
>VFA0760 cyclopropane-fatty-acyl-phospholipid synthase
MSNNQINSVSIENQQVEPVSWIDGLARKVLIDYLGKMSQASLTIYDPIGQ
VTLGNPDATLEAVVEIHNTQAYRKILFGGGIGASEAYVAGWWTSPNLTKV
IQVLGREQGVLDRVENSFSKIIQFFDLLNHKRNKNTEHGSKKNILAHYDL
GNEMYKTFLDKEMLYSSAIYPHQEANLEEAQLFKLQTICERLELKPGETL
LEIGTGWGALAIYAAQNYGVKVTTTTISDAQYEYAEQRVKQLGLEDSITL
LKQDYRTLEGQYDKLVSIEMIEAVGHEYLSTFFDVCSQHLKPEGKMLIQA
ITISDQRYDKYRKSVDFIQRYIFPGGCLPSVSVMANKVAENTDMVITSLH
DIGLDYAKTLNHWYQRFDKSAGELKEMGYGDDFIRLWKFYLCYCEGGFLE
RKISTVHLVAAKPQHGVV
>VF2562 glucosamine-1-phosphate acetyltransferase
MNFSAVILAAGKGTRMYSNKPKVLHTLAGKPMAKHVIDTCEGLGAQNIHL
VYGHGGDQMKAELGEERVQWVLQAEQLGTGHAVNQAAPEFADDEKVLVLY
GDVPLISAETVENLLDAQPTGGIALLTVVLDNPMGYGRIIRRNGPVIAIV
EQKDATEEQKLIKEINTGVMVATGGDLKRWLAALKNENAQGEYYLTDIIA
AAHDEGRAVEAVHPVSPIEVEGVNDRAQLARLERAYQAAQAQKLLEQGVM
LRDPSRFDLRGTLQCGMDIEIDANVIIEGNVTLGDNVIIGAGCVLKDCEI
DDNTVIRPYSVIEGATVGEECTVGPFTRLRPGAELCNDAHVGNFVEVKNV
RLGEGSKANHLTYLGDAEIGKRVNVGAGVITCNYDGANKFKTIIGDDVFV
GSDSQLIAPVTVANGATVGAGSTVTKDVNENELYISRAKERRIANWQRPT
KK
>VFA0502 outer membrane protein
MLRLLPLFASLLFVGCAPQGSSLLDIAPKTKEDAPFPDFENPETAPVEEM
ETSEMTRALTGPNGELKDDDMRQVAQQLTNMGIQYHKVGNDQLVISIQEK
VHFSSAKAELTPLARSLLNKLIVVMASKPELALVLDGHTDVTGDPIKNQN
LSEQRSNEVRRYLLANKLNASQLYSRGFGEYLPLCDNDTILGRKCNRRVE
ITILKIHW
>VFA0687 lipid A biosynthesis lauroyl acyltransferase
MKTVPSPKFTWALLSPKYWLVWLSFSFLAVLVNVLPFVVLKRIGNGIGCL
SKFCLKKRANVARKNLALCFPHYSQTEIERLVNENFKNTGLALIETGMAW
FWPDWRVKRHISIIGQEKMLEKEQEGKGVLVLCCHFLNLEMTARIFSLFA
PGYGVYRANSNPVYEFIQHRGRTRKGHKMIDRHDVKSMIKVLKSGNRLWY
LPDHDYGRRNSVFVPFFAVQEAATTTGSSFLIDMTKCAVMSGTSIRTDNH
YTLEIGDDISDDIPRRDAVTAANVLNREIERLIEKEPSQWMWLHKRFKTL
PEDSEEMNRYA
>VF2209 S-adenosyl-methyltransferase MraW
MSEQFQHVSVLLHESIDGLAIKPDGIYIDGTFGRGGHSRQILSQLGENGR
LYSIDRDPQAIAEAKTITDPKFTIIHGPFSGLKQYVEELDLVGKIDGVLL
DLGVSSPQLDDAERGFSFMKDGPLDMRMDPTSGIPVSQWLQEADVEDITW
VIREFGEDKHAWRIAKGIVAYLENEENEPLTRTSQLAKLISEVAPKSFKE
KKHPATRAFQAFRIYINSELDEIDTALKGALDVLAPEGRLSVISFHSLED
RMVKHFIRKESKGPQVPHGLPLTEEQIKALGSAKMKPVGKAIKPTKNEVN
ENVRSRSSVLRIAERL
>VF0143 N-acetylneuraminate synthase
MTLIIAEAGVNHNGDEHLAFQLVDAAYHAGADIVKFQTFKAKNLVTEDAA
QAEYQVTNTQKQESQLAMLSRLELSYEVHHQLVKHCESLGIEFLSTAFDS
ESLDFLVNDLGLTRLKIPSGEITNAPLVLEHARTGCDLIVSTGMATLSEI
EAVLGVIAFGYVADKTAEPSELAFQQAYASEQGQKALKQKVTILHCTTEY
PAPMPEINLKAMDTLGRAFELPAGYSDHSEGITIPIAAVARGAVLVEKHF
TLDKNMEGPDHKASLEPQELMAMITAIRQVEVALGVGVKSPTVSEVKNKA
VARKSLVVAKAIQQGEIITEDNLTIKRPGSGMSPYHYWSLLNKPASKAYQ
AGDLIFE
>VF0193 UDP-2-acetamido-2,6-dideoxy-beta-L-talose2-epime rase
MKKLKVMSVVGTRPEIIRLSRVLAKLDEHCEHILVHTGQNYDFELNEVFF
NDLGVRKPDYFLDAAGKNAAETIGQVIIKVDQALEEILPDAMLVLGDTNS
CLSAIPAKRHKVPIFHMEAGNRCFDQRVPEETNRRIVDHTADINLTYSSI
ARDYLLAEGLPADRVIKTGSPMFEVLNHYMPQIDASDVLSRLGLKQGQFF
VVSAHREENVDSPKQLAKLAESLNCVAEYYNLPVIVSTHPRTRNRIEAQG
IEFHKNIQLLKPLGFHDYNHLQKNAKVVLSDSGTINEESSIMNFPALNLR
EAHERPEGMEEASVMMVGLSVERVMQALQILESQPSGDERLLRLVYDYSM
PNVSDKMVRIIHSYTDYVKRVVWKEY
>VFA0570 D-alanine--D-alanine ligase
MTHILLLCGGGGTEHEVSLVSSKYISQQLSELDAFEITHLEIKDEGWFHI
ESGLKYELRSDKTLLSGETVSSPVDYVVPCIHGYPGETGDIQSMLDMLSI
PYLGCDAESSTNSFNKITSKLWYDALGIPNTPYLFLTENNEETHQSALAA
FKQWGGLFVKAACQGSSVGCYKVTSEAELSKAINDAFGYSQQVLVEKAVK
PRELEVAAYEIDGQLFTTAPGEVTAPDGAFYTYDEKYGSGSHSTTSLDAQ
NLTEEQVKLIDQYSRKVFTQMKLKDLSRIDFFLTDDNEIYLNEVNTFPGM
TPISMFPKLLEHNGDCFKTFLQKAVLNAIK
>VF1547 aspartate racemase
MNKKLGILGGMGPLATVEFMLKIISQTPAHNDQEHIPMVVSSVPQIPDRT
AFIMGHGQDPYPELKHSFEQLERSGAECIVIPCNTAHYWYPQLSATSHVH
TISIIDSVVQEAQNRRYKTVGLLATTATMKARMYQQKLNQYHIEVIETDD
IQQRDVMQGIYEVKAGNVEKGKALMLPVFESMLAQGAEAVILGCTEIPVA
LAEQNLKQPQQCLDSLEILAKCCVDWSYEEQAALAS
>VF0988 hypothetical protein
MSQLTATALFISSLSLLSFSSLAAEPSADDGAFSGDAKIGFIYTKTDETS
MSVNSGATLKYEEALWHHKAAFSTYYTKGNESDDGTNKNKTVYDVKYDMT
DSLFVFGNAKYEHDQFATYREQVLLVSGFGATLIDSSNSKLDVGAGPGYR
YSKRQAFDEDLPNNSEDEVIANLFIEGDSKITDGLELGGGVRMDYGESNT
TTTTHVYLKNKLMESLSLLIDAEYIYNSVVATGKEHDEIYSTISLNYDF
>VF0194 hypothetical protein
MLSVWFGKSINVKKKIVILAEYIGENHNSTAYYWSQITKHLQGEYEIVLI
APENKYSLFFASENKITTRFVKLAEHNKNNLLSRLQGQIKQTMSFLSVVK
EEVGSADLLFSGTNPIVTMASLVLLKWRYRFQWLVLVHDVFPNNLIPAKV
LSASSPFYKALIALSKKMYAAPDSMICIGRDMKVLLKQKIGNEKHIHYIP
NWASTEKIPSLNKSDNKIITDLGWQNQVVYQFFGNMGRLQGMGNLVKAIQ
QSTHQQARFLFIGCGSEADNVQKSLGQINEECGYDKTHFYGRLDLEKNHI
GLNACDISLVTLSDNMCGLGVPSKAYFSMAADKPILYVGDGDSELSILLS
EYPVGWACEPEQPTLLAQQLDAITENCLISEMPKMRPRVLLTEHFSEALA
LTKIARVVNSTIEL
>VF2298 multimodular transpeptidase-transglycosylase PBP 1A
MKFIKALLIVTLVCIILGVTTIFGFYQYVKPELPDVATLKDVQLQTPMQV
YSRDGKLIAQFGEKRRIPLKLEEMPPHLLEAVIATEDSRFYSHYGFDPIG
ITRAAFAVLASGSAKQGASTITQQLARNFFLSNEKKIMRKIKEIFIAVHI
EQLLTKQEILELYLNKIYLGYRSYGVGAAAHVYFGKEVSQLTLGEVAIIA
GLPKAPSTMNPIYSVDRATTRRNVVLARMLDEGYITKQEFDDAKAEVVIS
KYHGAEIELQAPYIAEIARAWMVNKYGEEAAYTSGMNIYTTVDSKMQAAA
NKASIDNLLAYDERHGYRGAVKTVWEPKATPLDEEAITKHLKNEPSYGEL
MPAVVTSIKGKTATVDIKNNGVATIPWDGLKWARRFKTDKRQGPAPRRAS
DILAVGEQIYVRPLSQETKDDVTTTVWKLSQVPAANTAFVAMDPRDGAIT
SLVGGFNFVHNKFNRATQSVRQVGSSIKPFIYSAALYHGKTLASLINDAP
INTWDESQGTAWRPKNSPPTYVGPARLRIGLAQSKNVMAVRVLRDVGLDE
TIDYLTRFGFKKDELPRSETIALGAGSLTPVQMAQGFAVFANNGYYVEPY
YIDHITGPFGDEVYKATPKTICQRDCSHQNDEDSPYAKKVISAQNAFLTK
QMMYSNIWGGGSWRKGTGWNGTGWRAQVLKRRDIGGKTGTTNDSVDAWYN
GYGPNVVATAWVGFDNPSHRLGYTTKNDNMTKEEMSFGGEAGGKTAIYAW
VNFMKVALEGVPEEKLQLPANIIKVKIDRETGLLTNKNDETSMWEYFAGG
TQPKEYVEQDFQDTIYSSHDADGDGMEDESLF
>VF0746 lipoprotein
MRVILLAVSLILAGCASEPPQKTTDEPNAGRYQIDNDIAPDMPISVEHIE
DAHPRYEPKSLYGNKDYTLLGKDYPIVKEPKGFTQEGISSWYGKKFHGHK
TSNGEVYDMYSMSAAHKTLPLPSYVKVTNKDNGKTAIVRVNDRGPFHEGR
IIDLSFAAAAKLDVLKTGTANVKIEYISVAKPTNPQEWHAIDPNQYHIQM
VAVKNEQSADKIAKKLEAQFNAPTNIIKSGNVYRVRLGPFIDRDRADKTL
IEAKNGQYTSAFIIQELKK
>VF1949 lipid-A-disaccharide synthase
MTKPLRIGIVAGELSGDTLGEGFIKSIKAQYPDAEFVGIGGPKMIAQGCD
SLFDMEELAVMGLVEVLGRLPRLLKVKAELVRYFTQNPPDVFIGIDAPDF
NLRLEKTLKDNGIKTVHYVSPSVWAWRPKRIFKIDAATDLVLAFLPFEKA
FYDKYNVACEFIGHTLADAIPMETDKIAARDLLGLEQEREWLAVLPGSRG
GEVALIAKPFIETCQRIHKQHPNMGFVVAAVNEKRREQFETIWKATAPEL
DFVIIQDTARNVMTAADAVLLASGTVALECMLVKRPMVVGYQVNKLTGWI
AQKLSITEFVSLPNVLAGKELVQEFIQEECHPDFLYPAMEKVLNNDNREL
IEKFTEMHQWIRKDADKQAANAVLRLINKETAE
>VFA0478 N-acetylglucosaminyltransferase
MSEFEYIFYSIIGMISEDTELIFILFPIMILIEMPLFILVASGVLRWSVN
LSELEATSCPSISFIITCYGEGEAISETIDTLVEQIYPNKIEILVVVDGA
KQNAETYQAALYGAKKHQHKQMRTVKVIAKWQRGGRVSTLNAGLSEAKND
LVINVDGDTSFDNNMAWEMAKQFSDPNVLASGGALRVRNWDANLLTRMQS
LEYMMSMQTGKTGMSNWGVLNNISGAFGAFRIEVIKRVGGWDTHTAEDLD
LTMRLKQYKGRHPNSRLAFTPHSVGHTDAPDTLKILLMQRLRWDGDLLFL
FLRKHKQGLSPSLLGWGNFVYTLVYGVIQNVVLPLLMALFSLYVCLSYPI
TFVLSMLLFIYLIYITFIVLTFSIYIGLVSERPKEDIKLSIWLPLYPIYA
FFMRLITAFSMVNEITRRSHEESSMAPWWVLKRGKRF
>VF1978 accessory colonization factor AcfA-like protein
MKKYLFLLMAATSTATIAAPYVGLEYGLTNMSHDYSTTFSNDNVSLTPDD
SSSAFGGFVGYRFNEFGLEFGYKKFESDDSRSQMLVSDKPGYTKEREWDA
DLDATQFTFKPVYFYNINEKVQLKTGLGLTYTQYKFDSSANTEYENDLTD
HEFTQDYVAGDSKSESVFGGIASVGIEYMVIPNLALGASASYQVDSIANS
TSFMLSSAYYF
>VF0183 CDP-glucose 4,6-dehydratase
MNPSFWKGKKVFVTGHSGFKGGWLSLWLQEMGAIVKGYSLPAPTLPSLFE
EAKVGSRMSNEVGDIRDFTHLRQVISEFKPEIVFHMAAQPLVRLSYDDPM
ETYSTNVMGTVYLLEAVKQVGGVKAVVNITSDKCYENREWVWGYREDEAM
GGYDPYSNSKGCAELVASSYRQSFFNKDKYAEHGCALASVRAGNVIGGGD
WADDRLIPDMLKAFSSNQAVEIRSPHAIRPWQHVLEPLSGYITIAEYLYE
YGCDFAEGWNFGPKDEDAKPVEWIVDTLTSVWGDDARWFLSEGEHPHEAH
YLKLDCSKAKMRLNWQPVWDLEYTLTKIVNWQKAWLNKQDMQQYTINEIK
EYMTARAGTK
>VF0374 rod shape-determining protein MreD
MASSHLMRGRVIIWLSFLIALTLQAAPWPGALEVLRPSWIILVTFYWVLA
LPHRVNVGTAMVLGILWDLLLGTTLGIRGMTMAILVYLVAANFKVLRNLA
LWQQAAIFSGLTLLGKVLEFMGEFLVHDVSFNAHFLWAGVLNFLLWPWLF
LLMRRVRRHWSIR
>VF0201 UDP-glucose 4-epimerase
MNILVTGGMGYIGSHTCVQMIEAGLTPIILDNRYNSKEVVLDRIEALVGV
KPKFYQGDIRDPKILETIFAENQIDSVIHFAGLKAVGESVEKPIMYYDNN
VSGTLVLVEAMRKAGVNSIVFSSSATVYGDPASTPIREDFPTSATNPYGR
SKLMVEECLTDIQKAHPEMSVTLLRYFNPVGSHKSGTMGEDPQGIPNNLM
PFISQVAVGRREFLSVFGNDYPTVDGTGVRDYIHVVDLADGHLAALKYKG
QEAGLHIYNLGTGNGNSVLQMVTAFEKASGAKVPYKIVDRRPGDIAECWA
DPAKAREELKWEAKLSLDDMTADTWRWQSNNPEGY
>VF0587 membrane-bound lytic murein transglycosylase A
MFRKLSFVCVLLGLAGCADQPTDRAQQYLDGGFSSNLNKVGEINSDKPSD
FSAFKKQSAEVLERSESMSLRYEELYVQLQKWIDESSNPAELSNYGIQFA
QMGGGDKKGNVMFTGYFSPVIEMRHTPNETFKYPVYDKPDCGSDCPTRAE
INAGALAGLGLELGYADNMIDPFIMEVQGSGFVHFGDDDKLEYFAYGGKN
NHPYVSIGRILIERGEVERKDMSLKAIKEWVAKNDEATVRELLETNPSYV
FFSPKEAHHVLGTAGIPLHAGAAVAADRTLLPMGTPILAEVPQLDKDGKW
TGKHVLKVLLALDTGGAVKENHLDQYYGMGTEAGIAAGHFKHFGRVWKLG
LQDTETENPWEMPKSE
>VF0176 2-dehydro-3-deoxyphosphooctonate aldolase
MFLIAGPCVIESEDLVLDTFAQLQEMTNKLGIEYIAKSSFTKANRSSASA
FTGPGLEEGLKILQKAKDQLGVKIITDVHEDTPLDEVASVVDVLQTPAFL
VRQTGFIQRVASMGKPVNIKKGQWMHPADMAPVVEKCRAVGNDDIWLCDR
GTSFGFGALVNYMPGLTIMKETGCKVVMDATHSVQMPGMLNGSTGGNRLH
VPAIARAAVAVGIDGLFMETHPDPDKALCDGPNMLPLKHMEELLETLLEI
DEVVHRRAFIESKLV
>VFA0372 mechanosensitive ion channel
MLEHHVRDYISDKLSALGINSDPYGVELTIVFVSVVIGIAIIGHLITHHI
IVRTIRNVLHRTNEPLSDAFSKYKVLEKLTLLVPVMVLDLLIPLALGHYT
LLSAIADKVLSISILISFIRLVFALLDALNDVATFKGITRRMPVKSFVQL
IKLFTFFVGLVVSMSILANESPVIFLSGLGVATGFVMLVFKDTILGFVAG
IQLSANRMISLNDWIEMDSFKANGSVEEISLTTVKVRNFDNTVSMIPAYA
LVQNAFVNWQGMSDSGGRRIKRAVNIDVNSIRFMTDEEIESLKDIRILRE
YLFEKSKEIKAYNDELDEIPHLGNTRQMTNLGVFRAYLAAYLRTNKDIHS
YMMFMVRQLDPTPEGLPLQIYAFTNNTDWVFYEGVQADLFDHIYSIMPLF
GLRPYQALSGHDVLGLKKN
>VFA0605 hypothetical protein
MGLFSSRSTSASLSIVAKGCRIIGNLESEQSIQIDGYVQGNIATEAEVIV
TPTGRVQGDIKAGLVLINGLVEGTCQGGEVNIQAKGKFKGTMQTQHLTID
KGGLLIGENLEVVEVENVTKISPNRDLDKEASEDSSKSA
>VF0139 ADP-heptose--LPS heptosyltransferase II
MKILIIGPSWVGDMVMSQSLYITLKQQHPKAIIDVMAPAWCKPILDRMPE
VNQAIEMPLGHGDFNLLGRRALGKELKNNNYTHAYICPNSAKSALIPWFA
GVPVRTGWKGEMRYGLLNDLRPNKKAFQYMVERYVALAHPKSEMIDSSSL
GGLENLPRPALSIDAKVQKNTLEKFSLSLDKPILGLCPGAEFGPAKQWPV
EHYAAVANEMINRGHQVWLFGSAKDKETTESIKALVDADNQAAVFNLAGD
TSLIEAVDLLAACKTVVSNDSGLMHVAAAVGCHVVGVYGSTSPKYTPPLA
EKVDIVSTDIECRPCFKRDCPLGHLKCLKELKPILVLNKLL
>VFA1164 outer membrane porin F
MKQSIYPLIIASLFLTGCVSGDKDYIETPTSDQIADLRDDDNDGVINARD
ICPGTPRGAQIDNDGCAEYVEHSDKKDLKILFANDSSEISPIFKTEIRTM
AEFLEEYPETSIQLQGFASQQGNAEYNIRLSELRAAAVRVALIEYGVDPQ
RIETIGFGDTLLTAKGDSAVSHALNRRVVATVVGFKGDVVNEWNIFTSRK
KR
>VFA0104 hypothetical protein
MFDSASIIIAGSTGLIGHYLLNFSLKNESVNRVYSLSRRSLDETSSKLVQ
MVSDDLSIDKNQLEEQTPDIGFITLGTTIKKAGSKAALKAIDTDLVVSVA
QSMREVGVRHIYVVSCIGASSSAFSHYLKCKGEMEDSIALLGFSSTTFMQ
PGPLSGDRSETRKDEVLLQGVMSIINPLMKGCLLNYKPIEGEVVAECMLD
LALQNDNAVGVHRYRSKAMFEMKS
>VF1484 murein hydrolase export regulator
MWVILTLIVFYSARWFAKRFPHPVNNPLLLSVCIVIPILMVLHVPYETYY
ADNAFLSYLLQPAVVALAYPLYEQLPHIRANWKIILLACSVGSLFSMISG
AFLAVWMGADMQLVASILPKSVTTPIAMAISSQLEGEAAIAAILVLLAGL
MGAIFAYPIYNMLGIKSSLARGLTMGNVSHALGTAQAAEENPQDAAFSSL
ALVICGIITSLVAPIIYSFMVMMK
>VF0149 glycosyltransferase
MKIALVMVHGRVHGHVGGAPRVFFDMANHLSFEGHEVLAVYNDSKEGSPY
YEVTNKVNLKNLALPIKFKGLWLYKAFREVIRSFAKLFNTDLRLNPVTKK
NQKRVGLALKSLIDDFKPDVTISYNVSDLVSLSYIEWKARNSIVMCHTDP
KRVYKGLANYERSIWQGADFIQVLLASYKDYLSKVINTNIEVIGNVVIEH
DEVNDLSAFRIIYLARIEKNKQQHLLIEAINKIPLNVRLGWQVVLYGSCN
DTEYSEFLINKINSYNLSDVIKLKGPTGKPFEELLNSSICAFPSAFEGFP
LALTEAMSLGLPCIGFQSCSGVNELLINNYNGFLVKGVEEFALQLEVLMK
SKERRSLMGSKARDSIECYSKESIYKKWKALIENKNVIV
>VF1795 Outer membrane protein C
MKKTLLALAVPALLMAGSASAATVYTAEDGSTIDVYSRLGFNITDRNDDG
DSVGNFDARIGLGGSQVVNDKVSVIGWAEYQVNAAEARGNGDWSPRYVWA
GIDASEAGKVTFGRVASGIIMLSDIGDVFAASDVVLGRQLQLVDNSSAQT
FRQDGTIQYQNSFGAFDMSVAYILGNTDSDQDGSYNAVGRYTFDLGDAGT
LAPVLAYQANSTGDNAINPDADYTFWGAGLQYKLNALTLGAMYNQDEIEG
VYSDKSTDKSYELTAVYNINDDWTARVGYRSLENSGGDEAEYKDTTFEVQ
YHLTERSSIYTSYVMRDGDNGNVTTAGPVMTDWNNAEEDYYHLGLRYEF
>VF0134 alpha-L-glycero-D-manno-heptosebeta-1,4-glucosyl transferase
MTHSSTPTLAVALIVKNEAKHLQACLETVQGWVDEIVILDSGSTDETESI
ARQFTDRFFVNTEWPGFGKQRQLAQQYVTADYVLWLDADERVTPELKEDI
LTAVKANKPNVAYKINRLSSAFGKFIKHSGWSPDWVVRLYKVNDMAYNDA
LVHESVSVPDGVQVAPLSGRLLHFTYDVLHQYNAKNVMYIKSWVDQREGK
KKGSLSGAFFHGFFCFIRMYILKRGFLDGRHGLLLAMLSASVTFNRYADL
WLRDYNKSNKE
>VF0470 4-hydroxy-3-methylbut-2-enyl diphosphate reductase
MKIVLANPRGFCAGVDRAISIVERALELYEAPIYVRHEVVHNRFVVEGLK
QRGAIFVEELHEVPDDNIVIFSAHGVSQAVRKEAKERALTVFDATCPLVT
KVHMEVARASKKNIEVVLIGHAGHPEVEGTMGQYASDSAGMYLVETPDDV
IKLNVKDPSNLHYVSQTTLSVDETADVIDELRRVFPEIQGPRKDDICYAT
QNRQDAVRDMASQVDVMIVVGSKNSSNSNRLRELSEKLGTTSYLIDCPED
LKEEWLTEQTKVGVTAGASAPEELVNQIIEQVKAFGGTAVEELTGREENM
FFEVPKELQIKTVS
>VFA0196 TonB protein
MWRLFLAMPIAISMTFGIFTFMAWMVDNGTQEKPESSETVRFDMVMAEQE
QDVQRRQRRVPEKPDTPEPPPQATPMAAQTQTSMATPQSPMPLIGLDSSI
SGLAISAPNFADFTGNQQAMPLYRVEPRYPSKAMKRGAEGFVVMSFTIDE
QGRPTDVKVTDAKPRRMFEREAVKALKKWKYQPKVIDGKTIAQVGQTVKL
EFTLAK
>VFA0462 lipoprotein releasing system transmembrane protein LolE
MFHPVSVFIGLRYLRGRSGDRFSRFISYMSTAGITIGVLSLVTVLSVMNG
FEGQLKDRILGVLPQAVISSTDNQITPLDDEREYVASLPHVTQVTPVVRG
EAIIQSARGLSAGMLVGIEPNEYDPIAYELISGNVRQLAAGEYGIFLGSK
LARELSVRYGDTVRIMVTNASQYTPLGRIPSQRNFKVVGVFNTGSDVDGQ
LMVANIQDTARLMKLKKGNITGWRLFFEDPFQVTELAKMPLEHEMTWSDW
RDQRGELFQAVKMEKNMMGLMLGLIVAIAAFNIISALIMVVMEKQAEVAI
LKTQGMTSNQVLVIFMVQGASSGVIGAIVGGTLGALFASNINVILSTLGL
SLFTVGGSLPAEVEPLQVCVVIILAILLSLLATVFPSYRAAVVQPAEALR
YE
>VF0184 CDP-4-dehydro-6-deoxy-D-glucose 3-dehydratase
MSKELIRSQIADLVDQYAALEYAPKEFVGGETVVPPSGKVLGANELKMMV
EASLDGWLTTGRFNDAFEKRLGEYLGVPYVLTTTSGSSANLLALTALTSP
KLGDRQLKPGDEVITVAAGFPTTVNPTIQNGLIPVFVDVDIPTYQIKPDM
IEAAVTEKTKAIMVAHTLGNVFDLTEARRVADKYNLWLIEDCCDALGSTY
NDQMVGTFGDISTVSFYPAHHITMGEGGAVFTKDKELRKLIESFRDWGRD
CYCAPGCDDTCKKRFDQQLGSLPQGYDHKYTYSHLGYNLKITDMQAACGL
AQMDRVEELVQARKDNYAYLKEGLASCEEFIILPEATENSTPSWFGFPIT
IKEDSGIERVDLLKFMDQFKIGTRLLFAGNLTRQPYFKDVEYRVVGELTN
TDLIMNNTFWIGVYPGLTKDHLDFVIEKFEEFFGVSF
>VF1388 dTDP-glucose 4,6-dehydratase
MTSISVLGCGWLGLPLAKHLVDTGFMVKGSIRSSNKISELEKNHIKPYLL
DIDAVEQSWSQFLTSDVLIIAIPSKNIEGFTSLIPIIEASSIKHVLFVSS
TSVYEDANRVVTEEDATIPSSALSQIERLFMQSTKFTTTVIRFSGLVGYS
RNPGRFFAKSGRSVSNPDVPVNMIHQDDCIGLITQIIKQEKWNEIFNACA
DTHPSKREFYTQATQRIGVETPTFIESNEQTFKIISNHKIKEALGYEFIH
PDVMNITYDS
>VF1183 acriflavin resistance periplasmic protein
MQRLMKLSLLSSTLLLTACNPAPTETVVEIPNVVIKDINSNGVSDRLYLP
AVATAADRSHLSFRLSGEIKELNIKAGEIVKKGQVLAVLDKTDYNIDVDN
ARARYNVANSQYKRSKPLVDKGLLAKSQFDELAAQRQIALADLELAKLRL
SFTELKAPIDGVISRVSVEQFENIQVGQQIFNINNRDAVDIIVQVPDKLY
AKQPNKEIIESIKATVRLDSGESYSARIKEYTTEPDPDSGAYLVTLTMPM
PEDQFILDGMAVEVATSESEIRLSTQAGMVIPIEAIFNEDGDTIDLAEKY
VWLVDENNTVKKQKVVTTKATSSGLRVVEGLSTGDRIVIAGVSRLRDGMS
VNVINAEEKK
>VF0195 UDP-N-acetyl-D-quinovosamine 4-epimerase
MNILLTGGFGFIGQQVVKLSPIKRKVVRMGESYSGSSVHQIDTLSTTTNW
QGAFTDINAIIHLAGLAHSNSFSEQDYQEVNVDGTLHLANEAAKSGVKRF
VFVSSIGVNGTSTYQTPFSSLSKVEPHSAYAQSKYDAEVGLQKIAEETGL
EVVIVRPTLVYGPNAPGNFGALTRLVNKVPVLPFGLVNNKRDFISVQNLA
DLLITCANDPKAAGRTFLASDGQVVSIKDFTNAIAKGLNKRVIQLPIPVW
CMRLAGKLLGKEVMIEQLVGNLEVDSSNAQEVLGWIPPYTMQQAMHSLLE
NNK
>VF0745 D-alanyl-D-alanine serine-type carboxypeptidase
MKNSAKQLKRLILSSFILGSTVAVAAPAVIPNAPQIAAKGYVLMDYHSGK
VLAEKDMNVRMNPASLTKMMTSYVIGQEIESGNISMDDDVVISKNAWAKN
FPGSSKMFIEVGSTVKVRELNKGIIIQSGNDACVAMAEHVAGSEDAFVDL
MNAWAKTLNLKNTHFANVHGLDRDDLYSTPYDMALIGQALIRDVPEEYRV
YSEKSFTYNGITQYNRNGLLWDKSMNVDGIKTGHTNGAGFNLVSSATEGK
MRLVAVVMGTKSGNARKAESKKLLNYGFRFFETVSPHKANETFVTEKVWM
GSTDEVALGVAEDTYVTLPRGQAKKMTASFVLEKTLEAPIYKGDVVGKLY
YQIDGEDIAEYPLLALNDVEEGGIFSRLIDYIVLMFKGWLS
>VF1656 hypothetical transmembrane protein
MIRLFVLCLSLMMSSTALAEDAQSIDNLQQFASLIRWSGVAASFFIILGA
WLFLRFIQSIVDGVSSQFAQRRMLMQKLQSFFQFFIYMSTAVAVFMLSFR
VDDRVLALIGGTIAVSVGFALKDLTASFIAGLTVMIDRPFQVGDRVTFEG
HYGDIIAIGLRSVRMQTLNDDIITIPNNKFLNEVTVSGNYGGLDMQVVIP
FYIGMDQDINKARDIIQEAASSSRYIHLPKPVVVLVKQTITDNYLAIQLT
CKAYVVDIKFEKLFETDITLRVMQEFRKANIIPPTIAIQSKLA
>VF1225 TonB protein
METFVLNFRYLAAAGISLAIHTALIWSVPEKKAFAMPTGSTSSQVNIQFV
APSVPTPQSVQTKKNEVTKPKEQPKQQTTVEKTVQKQVVKKKPVQSKQKP
KPKKKMVKKPTISKPIEPEKKILKEKAETKPTTKTAKKTDKPVEKESTAK
PVASKSGATEKPQLVQKPNFLKRPNAPRYPRIAQRKGIEGTALYEIWLNE
NGKQIKQELITSSGAQVLDEAALNAIRDWQFSPQVINGQAIAHRVQIPVR
FSLN
>VFA0624 aspartate racemase
MKTIGMLGGMSWESTASYYKAINEGIKDELGGLNSAKICLYSVNFDEIEK
LQHQGEWDETALILVEAAKSVEAGGADFLIICTNTMHKVAPEIESNISIP
ILHIADATANKLVINGIKKVGLLGTRFTMEQDFYKSRLAEKFGIEVVVPE
ENDRTTVHNIIYDELCRGVINSDSREKYLSIVKSLHEQGAEAVILGSTEI
ALLIQQAYTEVPLYDITEIHAAQAVQLAISGVAI
>VF1506 iron-regulated protein FrpC
MKETLIPSKVEIKNIEGDAYTLNKSGVPTKVNVGQSMNADDILFTGYDAK
VVVQIHGKLVTIDKNCISCLDETKSEELLQVKNIEGDIELDPTQSIDEND
IAAIQDAILAGEDPTEILEATAAGESGSSANSGFVTINYAYTASIATTSF
TTSNEFSYDNQDYIDSLGDGNGSNPPADPIITANNTGLTKEDEIINTDGQ
LAVTNPQSNLSYTWSINGNATSEYGTLSLNAVTGEWEYILNNSALSVQSL
ANGQIITDVFEVSVSAGGNLTSTQEVTVTIIGTNDDPVISGIAVGDLTEG
DVGDPNPTVSDTLTVVDVDATDTHTWTILEGGSGVYGVLTINNGVWEYTL
DNSRDATQALGQGDVVTETFTIEVDDGNGGTDQQEIVITINGTNDEPVIS
GTNSGRVVEDLIDSAEGQLIAVDADAGDSVTWSVTDPSLGMFGSLTIDAS
GKWVYSIDNNLSATQALSNGEVQTETFEVVADDGNGGTVTHTVTVEVTGT
NDLPEITDTSVTTGAVEHRTTESATGDLIFEDVDALDTHTWTVEANSNDD
LGTFSVDANGKWTFNLNTNSASVIALGVGETLEITYVVQVEDNHGGIDSQ
EVTITVTGSNDGPVISGTDTGAVVEDTVAEASGQLEATDADVNDTATWSV
TDDAGVYGSLTVDSTGKWTYVLDNTLTDTQAISNGEVKTETFEIVVDDGN
GGTVTHTVTVEVTGINDLPEITDTSVTTGAVEHRTTESATGDLILEDVDA
LDTHTWTVEANSNDDLGTFSVDADGKWTFNLNTNSASVIALGVGETLDIT
YVVQVEDNHGGIDSQEVTITVTGSNDGPVISGTDTGAVVEDTVAEASGQL
EATDADVNDTATWSVTDGAGVYGSLTVDSTGKWTYVLDNTLTDTQAISNG
EVKTETFEIVVDDGNGGTVTHTVTVEVTGTNDFPEITDTSVIAGAVTEET
TLTTSGDLFVDDVDTLDSHTWTLLSSNNDPYGSITVSTNPDGSGKWEYTL
NNTAAQVQALANGETYTVEYQVQVDDGQGGVTTETISIEITGTNDDPIVS
GQSTGLVKEDTATQSEVEGQLTVDDVDLIDVHSWSVDSNAGTYGSIVIDP
ATGLWTYSIDNSLPATQALTEGESVEDKFTVTVDDGQGGTDTIEIIITVV
GTNGVPIIGGDTVGEVTEDTTLTATGTLTATDEDATSSFNWNIVGSDTGT
YGKFTLDASTGVWLYTLDNDAAQSLGAGDDPIKEYYTVELSDGAGGVITE
TVEITINGTNDKPELSGQTLGSVKEDSIETTEGQLIVDDVDLTDTHTWSV
EPATGKYGSIVVDANGKWTYTIDNSLDVTQQLAEGESGEDRFVVTVDDGQ
GGTEQKEIVISLEGTNDLPSIVDSNDTGTVTEDGVQSISDTLTVEDVDLA
DTHNWFVIGASESKLGHFSIDAATGEWTFVLKNDEAQLLAKDETVVESFV
VVVGDGNNGYAQHTVEVTIVGTNDRPEITGRTTGTAVEDIIPTATGALTA
VDVDFTDTHTWLVDGGGVGKYGTMTIDVNGNWIYTLDPSNPDTQALAENQ
QEFETFTIAVDDGNGGQNAIVITVEILGTNDVPIIGGKTSQTIIEDDKAS
VSGQLTDGDVDLTDTHTWTLLTDPQGIYGSMSLDANGKWTYTIDNSSPLT
QGLLEGQTVKEKFIIQVEDQYGAIDTVEVTVKVKGTNDVPELSGDLSGVV
EEDSAITMVNGKLEPDDKDIGDTYTWTLDSKTGSYGTLTLTADGRWVYNL
DNDKASVQSLSEGERVQDTFTVTVTDGFGASTSKEIVIDIVGDNDQPSIS
GATTGSTIEGTPGKDVATGELAAVDIDTLDTHTWSVVTPNGVYGSLVVDP
NTGMWTYQLDNSRPATIGISSGQIVQDKFVVQVDDGQGGTSQIEVVIDIA
GTNSSPGIIGDTTGEIKEDAAVNVIDGDLNSGDLDTQDTLTWEIVGSTGQ
YGQFTLDQNGHWTYTLDNSNSTVNGLKEGAELVDTITVKVTDSFGEVSEK
EVEITIEGTNDAPTMTGALTGTVIEDTTTVIEGQLKSGDPDVGDVHAWNL
VDGVGQYGALTMNANGRWTYSLMNSLAAVQALGPSDILTEIFTVIVTDSQ
GESVQKDITITIEGTNDLPEITGGTTGEYIEDVSPDVVTGQLIATDVDAG
DTTTFEMRTYVGNYGTFYLEADGSWRYEINKDSAAIQSLNEGEMISETFT
AVVHDSNGGFTNEQIDFTITGTNDRPVVSGDNAATVIEDAQDFLPPGETF
NGQFTKVTGNVIADDIDLGDEVVSWQVINGSGVYGIFTVDENGQWTYLLD
NTDPDTNALNFGDVRTEVFQITATDKHGGISEPFEVTITVEGNTDPDGGG
GGSYDEVIDIDSIEEGVDGDGNAIGGGSSGTIDLPSGCEIISVDGTSSID
GGLFGSLTVDNDGNWVYDVADDKSYVDSLCEGQEVTERWAVTVQTDCGTE
TILVNVTITGSNDVPVIIADTDTGELGEVVEDDILEVSGQLEVVDPDSCD
THTWYLVDVDGNKIGTLDPSGENIVIQGVYGELTLNQSTGEWTYVLDNDS
EIVQALTPDQIEKEYVRVVVEDDKGAVSSDSTININIIGVADDAPAVAVI
EEIEFKEDGSPLTQTGVLDDVAGLTPELTWNLVTGDGTYGHLTLDNNGNW
TYVLDNDSLAVQQLNEGELVTDTFSVTVVDKFGKTVVDENGDPLEMIFKV
DVTGTNDAPEISGQLTGTISNIDSDGRISGNLNDGDVDTGDTHTWSVADN
QGDYGRLMLVNGKWTYTLDTSLDAVKLLGVGETLSDTFEVTVTDSYGETS
TETITVTIDGSNLPPEIAQDDQIVMELKEDEKITDSNTLVVTDPNGDDVT
FDAKTLTGTYGVFTVDENGVWTYELDNDAAHIQGLREGEVVSETFTVFAV
DEHGAKTAQEVTINITGTNDVPKISGMDTASVEEADGSTASGNFVTSDVD
VGDNVVVSPGTQGSYGSVSVDNNTGRWTYTVDGNDPAVNSLSKGETLTDT
ITIIATDDAGDTAEMTITITINGENDAPDLVVTVPSEVTEDTDLNADGNL
EVTGNWDDGDPDTADTHIWEVLSGDSLGTLTFDPNGDYKLVIDNSALEIQ
QLGVGESLDLTYTVKVTDEHGLSSTQDITFTVNGTNDDPEVVDTSILSVD
VEEDGIGTQTQSGQLDITDIDLNDTTFDFSVTTSPTDAYGSVTVDANGKW
TYVLNNDKAQEIGDETITETFTIQIDDGNGGVITQDVTVNITGTDDDPII
DTTIPQVTEGTVVEDGTLTATGQVSYVDPEGDVINYNVINPPSSPYGTFT
VGADGTWTYELDNALAQEIGVAGAQETYTIEVTDQTGGTIQQVITINITG
ANDDPTIDVSSVIIGSVEEDGTATAIGQLDVSDVDLTDTSFTYTVVSGPN
TAATPGDVTGLYGALTVDANGEWTYLLDNDKAQALGDTVATEIFTIEVSD
GNGGTVTQDITVSVTGHDDQPIVDAGATQETTGAVVEDGELHAEGTITYL
DPEGTLIGYTVSTTSTPLYGTFIVDPATGKWEYDLIDSLAQAIGADGAQE
SLVIDVTDATGQVTQQVITIDITGENDAPVITGTTTADVKEGVVETVSGQ
LNATDAESDPIGWQISSSSSATGVYGTLSINAAGLWTYVLTENSTLALAT
DTTDVFTVEASDGKGGITQQVITVAVAAPNVVQGVSGSDILTGTTNDELL
FGNPLDLSDAGTADTFTWTNASIGGDLARDIIKDFDVNSDRIDLTDIANI
TTVWDSATLASQIQISEVDGSTEIYINEAGSTVQTIVVDGVTLDELTGES
TASMTDEEKLTSLTNSGHLVVSDTFGNEANNTLYASGQNDILTGGGGNDI
FYFADEIAGSSASPAQTSIADFAVDGVAANNEADILDLAELLPDSIQASS
TMDDMLQHINVNIDDSNSQTVLSVTDELGNQTDITLKGVDSTTLGISDLG
SMSDQDILSTLYNDFNMFKVD
>VF1539 transporter
MLRIFIFFITLGFGSLAFAEEAQSIDNLQQFASLIRWSGVAFSFVIVFVA
WLLLRFTQSIVDGISSQFAQRRMLMQKLQSFFQFFIYMSTGMAVFMLSFR
VDERVLALIGGTIAVSVGFALKDLTASFIAGLTVMIDRPFQVGDRVTFEG
NYGDIIAIGLRSVRMQTLNDDIITIPNNKFLNEVAVSGNYGALDMQVVIP
FYIGMDQDINTARDIIQEAASSSRYIHLPKPVVVLVKQTITDNYLAIQLT
CKAYVVDIKFEKLFETDITLRVMQEFRKSDIFPPAIAVQNK
>VF0197 UDP-N-acetylglucosamine 4,6-dehydratase
MQFLQPIWSMPRPLKRLVSIVVDILFIVFAFWAAFATRLDGIEIYMQDVS
YWKLLAVLIPCTLLVFTKSGLYRAILRYLSLHAVLSICISAIISSAFIVF
ISYFNYLYMPRSIPVIYATYLVMLCGGSRLIVRVLVSDLLGKQKKKVLIY
GAGSAGLQLANMLRQGKEFHPIAFIDDDRKKHKTTMQGITIYRPKYLERL
IKKHCISTVLLAVPSASQVQKKVIIESLAKLHVEVLTIPNLDDLVNGKLS
IGQLKEVSIDDLLGRVAVTPQAELMEANIKDKVVMVTGAGGSIGSELCRQ
IILNKPTTLVLFELSEFSLYQIEHELSQIIANQQLSINVVPLLGSVQRLN
RLAATMKAFKVQTVYHAAAYKHVPLVEYNVVEGVRNNIFGTNYAAQAAIE
AKVESFVLISTDKAVRPTNVMGTTKRVAELGLQALAQVENAKPNGTRFCM
VRFGNVLGSSGSVIPLFKKQIAQGGPITLTHKDITRYFMTIPEAAQLVIQ
AGAMGKGGDVFVLDMGESVKIADLARNLIHLSGLEVRSDENPDGDIEIRC
TGLRPGEKLYEELLIGDNVGKTAHERIMTANEEFLPLNEYNQLLDDLDTA
CHNFDHATIRQLLIDAPTGFAPVDGIGDLVWKAEQ
>VF2068 lipoprotein NlpD
MRKMIINLISIRLWLMAAVVSLLLSGCSMGPHRPAPVSSVNSSSSAYNGA
ERGSYRGSYYTVEKGDTLYFISYVTNKDVKELIAYNELKAPYMIHPGQKI
KLWGPKYIAPAYGSDGHSVTPSNSSSSSTATAVAVVPVATNKPAPKPKPT
TTSAKKTSSVQKESTKKVENSKPKEYVNSNKTITSSKPKPVAKPKPTPKP
KPKPVQQKSDKVDSWLWPTKGRIIAKFSTGDQGNKGIDIAGQRGQDIIST
AKGTVVYAGNALRGYGNLIIIKHNDDYLSAYAHNEALFVKEGQNVTAGQK
IASMGSSSTSSVRLHFEIRFRGKSVNPQRYLP
>VFA1021 OmpA family protein
MKKILGLVFGLLSVSGCTSFAEPGKGGEAENYPQAAFSPVMPDQPLGPEH
GLRFDWELAARHLDILILEKAEWCFPATVHQAKQNEARIARELEGGLQLD
AANDLVIQRNLLKRLERQLDYVKRQETCQPPTDSNNGNSDIELAQKIHDL
LNRDNQFAFNSAELNPKYIVNLSEASQLLNQHKDFKLLITGHADALGEED
ANQNLALERAKQVKRYLSIFGLSQQRIHVDSVGSNDPYLSGTEPHVRLTN
RRVTIELLQLDQPLMLEKPSHNEG
>VFA0328 outer membrane protein
MKKITIALALLISLTGCQATQRQNATTGESETNSATKGVLAGALAGVAIG
LATGDNAKERRKNALIGAAAGGAVGGGVGYYFDQQEKALRNELKSSGVQV
ERVGKNELKLVMDNGIGFQSSSYQLDASIYNTLNGVARILVEYPDTALQI
DGHTDSSGNATKNQTLSEQRADSVRTYLIKQDVAAGRVNARGYGARYPVC
DNSTKQGRACNRRVEITILPLK
>VF0459 prolipoprotein diacylglyceryl transferase
MSQGYLNFPHIDPVLIEIGPLAVRWYGLMYLFGFMFALWLANKRADKPNS
GWTRDQVSDLLFAGFLGVVIGGRVGYVLFYNFGYFLDNPLYLFEVWTGGM
SFHGGLLGVISAMLWYGYKNNRSFFTIADFVAPLVPFGLGAGRLGNFMNG
ELWGRVTDVPWAMVFPTGGPFPRHPSQLYEFALEGVVLFLILNWFIRKPR
PLGTVSGLFLFGYGTFRFLVEYVRQPDAQLGLFGDWISMGQILSLPMVIG
GLLMMLWAFKRNLYPSIEQPQSTTKKK
>VF1368 membrane-bound lytic murein transglycosylase C precursor
MKNVLIPFIISLATVSCTPIFDGNFQRPNSNSCNCESDITNSNNNTTSKP
DSWKPSTSKPNQSIEEQLENLANHVHKTWGDKEFLEAGKHRYVKYLDGYR
TRAHIDFDKGKIYVSTISQYQPKETLKKAIIGTVLMPADPSHVDLFSDKS
IPLRGRPFLLGQIKDQENKDIEWPWRAGRYADYLIENKLQTKTIKNGKAY
YVEISMVDDHLEQREFQYADLIKKASKEYDISIDLIYAIIQTESSFNPYA
VSHAGAYGLMQVIPKTAGADVFKLVKNKPGIPTKEYLFNPAHNIDTGTAY
FYILKNRYLRDIKHPTNKHYSMISAYNGGSGGVFSTFDPSRTKAIDEINS
LQPNQLYWALTNKHPKAEARRYLEKVLKFQKEFNEKS
>VFA1151 hypothetical protein
MMGIDAIEGDGKGASSQVEVVLNLENGKEYKHLGKVDFIGNRIDKTTGTL
TLRALVDKP
>VFA0516 hypothetical protein
MKLKNKMLLASAISFALTACGGSDSDNNELITASLTGKAIDGYIEGATVY
LDLNFNRQLDSNEPHAITSNLGDYRLELNQAQQECAQYVPLIVDVPVGAI
DEDLGIVEKAYQMVLPPKFEPITKEDLYHVTPLTTVLWTSVEKELASNGT
LTCESVKNDYQKRETLISSLNQAIDRVVYHYNIPEDVIFDDFIAAGDADT
SLKAQEIVRGLQQSFTATEELKRQNPNALFAYVDYHKGDYRDNNNAYPTA
WYREQLISFDNEQRSELVKVRDDFSQDIRTIIYGKTATTKGNNYTYRTSY
EFESRNGDSSPYTCDIKEEISDVVSSNKTYSLVNLTNNNANTFEDCIPSD
IAQAITHRYAIIDYTGNNDRFSSQFGYDRNAGSFPFLSDWVGFESNHHQL
DLNELMTNFENLPYQYDNLTAEPDASFWVKSKTVSMEDNTQIRTSYDNNG
QYRKFTIFPNGTHKEECGTDGIVWAECTN
>VF1162 outer membrane protein TolC
MRDKFSEKMLFVFWALIASGLSSMSYALTIEDAWQATKQYDPEYLRSQLD
EKISETTIRSSKSALLPSARITATTAWNENSTYGIALEQIIWDSSKWSEL
DSSQASLLASQLKIKQSHNELAGRLISAYLDLAQSQGELRLAQQKFDEGR
KMLRIVELRYKAGKIRSVDLEDMRSNHLDEEANILANRLQVEDKKVRLIK
LISIEPTQVNEIKTNNLSQPKLIVNSKQEWLKLASNYSPDLLMAKQNIRI
SELETGKAKTGYYPTITASVGYSDNTRSDNTRSDSGLNASLNLSLPLDLN
SSIGSSVERAKLEVLRAKQDVRAVEIEIKSTISNRFNQLSLNWQRVEMAE
KQVASKELVLKSKQAIYKAGMAEASDIIEAHNSLFVSKSSLQSLLYQYWR
DRISLLKSVGRLDDETITLISQALQS
>VFA0939 hypothetical protein
MKRLLPLLLLGATASAQATDTLHQIYIQPSLANLKIDGSHGSALMTQVGY
NYHFAPMIAMDLSYYMTASMNDIAMDNDKASATGATIAAKMYFPMSYYGS
FYGKFGLNRTNVEYQYKEGNQTLKQEAVSTKPYVAVGTVMKLFPSVTFNV
EYQYMPLASDDYISSIGAGVNFMF
>VFA0241 choloylglycine hydrolase
MKIKILSMLVASCVAYSASACTGISLSTTEHDYIQARTIEWGQNDLNSKL
IISPRNHAYVSTMPDQKKGLKWNSKYGFVGISVSDDRFIADGVNEEGLTA
GLFYFKNYGSLEKYDPSDTTRTITDMDFNRWILSQFKTVDEVEQAINKIK
IVPVYIDAKGNPSPTAHWRVADKQGNNIVIEIMNNGEVNIHKNTAKVLTN
APDYQWQVTNLNNYIHLSPGSSQGQKINEVNAFSFGVGSSFLGLPGDITP
PSRFVRAAFYVNSAPVMKTEEQAVSQAFHILNNFDIPIGSEFSAKEHIPD
LPSATQWTSVIDQTNGAFFYKTMRDSTIKKVDLTKIDFNQKEEVKRPLDS
GRFHVIDVTGGL
>VF1104 hypothetical protein
MKKKIKLIIKIVLFLAFVGVVGHVFAAEPMSADKVVAKSDEQMRGKSSYS
EITMNIIRPDWTRSMSMKSWTKEQNLSLVLITGPAKDKGNASLKRDKEMW
SWIPSIERVIKIAPSMLGQSWMGSDFTNDDLINQSSIVVDYDHKFVKEET
IDGDKTWVIDAIAKPDAPVVWSKVRLWISQKTFIQRKVESYDEFDELVNT
MTTYDIQEMGNRMIATRMVMIPADKPENKTEMITHKAQFNFLINDEFFSQ
MQMKALRY
>VF1889 outer membrane porin protein precursor
MENKFFKTTLLGAAVALASAGVTAKEVGINSDFNVEVYGVAAMSTVNYNT
TGNGDGTNGYVLENESRIGFRAHKEMFENVLVTMQIESGYVDSWQGGELG
ARDTYLGLSGDWGNLRAGRVLTPLYEIIDWPFSNPGLGSVFDWGGVNAHY
DRQSNQVRYDSPNFGGLTFALSAGRDGNPSGSATRDSRFFSGNVKYTIST
VTLMGAVEGGSDFRGVDDNDNLTYLVGAEVGLPGGFSLAGAYKQESVDKF
SGKNAAGVAVSGENVDQGSFSVIGQYWLDSLGFKVGYAANLDADGIKTVG
LKEESLDSNTISGQVMYVHNGFVPYLRVAGRTVGDKDTDIVTRVGLEYGF
>VFA1031 secreted polysaccharide polymerase
MMDNNVPLQSQTRQWVTALACSLILGGLWYIFPNPSWLISVSFLILATLY
TLNRPFVIVLLFVIFSFFRIHEVFPQLYSLKIPLFLSIGSLTALIWQVGV
TRQIKLFWCKEFTLLTSFLLLVIIGVVFASNHPLAIEYFKNIYWKIILMT
FAIAILVRTPQQLAFTLKIITLAGVLVGIVAIQNKLGGIGLVEGTRVTIG
RELGSMLGDPNDLALVLMFPTSFAVGLLVTHQLPWHQRLIGFIAIPILFW
AIIATQSRGGLLGIMAVFGIYGLQRIKSKVLLISIAIIAGGFLFVVAGIS
DRASGGAAEAGVDASAMGRLYAWEAAFKMALTNPLTGVGLDNFYSNYFYY
SPHWDGLNHAVHSTWFGVLAETGFLGLSIFIALIVVLIKNANHTLQSVKA
VKDRIDPAIYTSAQAVFAGLMGTIVSGTFLTQGFNWPIYILAALVVAVGK
TAQVALNQLKE
>VFA0443 copper/silver resistance outer membrane protein
MKKLPLIRFKKAWLVSAISIVLSHQVMAEEQLTQLIEQALSSDASREQIY
AQSQAMRATGIANSTLADPTLKVGFGGLPVDSFKFDEDPMTNISVGLMQK
FGRGSSLDLQQKQMGQQADVLAMQVQVRELEVANAISQLWIELGFLQKAE
AILHENRRLLTEMESYINTNYSIGKSESQDLLQAQLQLTRLDEKVQTNKQ
SQERIYAQLSEWLPNLPQQQLDKIRPLHWDYLDQILERNAHSSTDFYELL
KTNPTIKMSELAIVATKTKVDIADESYSPQFGVEVMYAYRQANGMGGQPA
SDLVSAYVTMDIPLFTDKRQDQNYAAAQYQVGSAKSQRDVLLRQMNAKVN
ALLVDKSNLEQRLSRYNETLLPQSKERTKAVERGYENNTAQFNDVIIASN
DELSLELEKQRLMSDLDKTNSNLAFYLNGFDYHISAPQLAPSEN
>VF0169 hypothetical protein
MSKFTVFGGRGFIGSEFVKELRTQGHDVFVPEREDLSIYEDDLGTVIYSA
GYGDCQRDQFNVLTANVILLSSLLQKAKFDKLVYISSTRVYMNQNESSEY
SDVTICSKDNRRLFNLTKLTAEELCLKSERECLIIRPSNVYGLALNSNLF
LPSIIRNAIKNKHIDMYVDKNYEKDYVSVYDVVSSTLKLIKFPQEVNKII
NISSGENISANDIAQVLINKTGCSIKWKQTLNNTECFSPIDISYLKSLID
YKPRTLINDINNMVDSFIESI
>VFA0926 hypothetical membrane associated protein
MIFSVLIISFIFLLRHYAVKHIRGDIAFLTEDQRKWISRTKNGSFTVIVI
TLFILWQSEINEFALSVTAIAVAIVVASKEIILCFTGSIQRASSRSFRIG
DWIEVGSLCGEVIEHNMMATVIQEIDLHHSQYDYTGKTATLPNSMFFTYP
VKNLNFMKRYVYHNFSICVKEFVNLYPMLPDLLAKIDVHCEEFIEVARRY
NSVIEKHAGVDLPGSEPHIHITTTSMGDQKVHYMIFCPTEKASHLEQLIR
QDFMEMYEINFPQKTE
>VFA0906 acriflavin resistance periplasmic protein
MKKIIANSLIIGLLSTLLLSGCNKEETKQAVTPSLPKVKSLTLNPQPITP
HLEFIGRTSSVSSVEIIPRVGGELKAIHFKDGDFVKKGDLLYEIDPRIFH
AAVNSAKASLEKARATLKMTTSNAERAKQLIKDKSISVQQYDTAIANYES
AKADISEKQATLKSAQLDLEFSRIYAPFSGRLGFSRYKVGEQITALLPPS
STMKNSLVSLTKVNVINFDFNVDEKVYRRIRSAIDVVRNENKKLNLDIRL
TLSDGSEYAKNGKIAAVGNKIDPSTGSIHVRAIFDNTDYSLMPGEFGKIK
IGLKERTVNGLLIPKSSIQQDQAGNYVMQLTKKNIVKQQYVILGQAYGTN
KAVISGLNSGDRIVTEGLQKIRPGIQVEEITPEK
>VFA0776 TonB protein
MFRLLMALPIAVAISIALFSLMAWMVDNGNQAKPEASEQLSFTMMMVEPE
SEIQRRQRSVPEQPKPLEQPPEAKLSQSQSEVSSVMPVTPMSSSGLDTAI
NGLKISAPTFGSFKTNQQAMPLYRVEPKYPSRALKRRIEGYVIMSFSIDE
TGKPFAISVQEAKPKRLFDRDAMRALKQWKYQPKLVEGKAIIQQNQTVRL
EFKLAE
>VF0401 UDP-N-acetylglucosamine1-carboxyvinyltransferase
MYKFRIQGSDKPLSGEVTISGAKNAALPILFASLLAEEPVEVANVPKLRD
VDTTMELLKRLGAEVSRNGSVHIDASGVNDFCAPYDLVKTMRASIWALGP
LVARFGKGQVSLPGGCAIGARPVDLHIHGLEQLGATIKLEEGYVKAEVDG
RLKGAHIVMDKVSVGATITVMCAATLAEGTTVLENAAREPEIVDTANFLN
AIGAKVSGMGTDTITIEGVERLGGGYHEVVADRIETGTFLVAAAVSGGKI
VCKNTKAHLLEAVLAKLEEAGADVQTGDDWISLDMTGRELKAVNIRTAPH
PAFPTDMQAQFTLLNMMAKGSGIITETIFENRFMHIPELQRMGAHAEIEG
NTAICGDTDGLSGAQVMATDLRASASLVIAGCIAKGETIVDRIYHIARGY
DKIEDKLTALGANIERVHSDDL
>VF1918 dihydrodipicolinate synthase
MFSGSIVALVTPLDTDGEVDYNSLKSLVDYHIKAGTNGIVAVGTTGESAT
LSVEEHVKLVMKTLEFADGRIPVIAGTGANATHEAVTFSKLFHDSGVAGC
LSVTPYYNKPTQEGLFQHYKAISEATDIPQILYNVPGRTAVDLLPETVAR
LAELDNIVALKDATGDLDRVAITRELCGENFIQLSGDDATALDFVKLGGH
GVISVTSNIAAKDMATMFALAAQGKFEEAEIINQRLMPLHNDLFVEANPI
PVKWAAHRLGMITHSDIRLPLTELSLSAQPTVEQALKSAGLLK
>VF0373 rod shape-determining protein MreC
MTPIFGRGPSLQFRLFIAVMVSASLMLADSRLNTFSDIRYLLNSFVSPIH
YAANLPRTMFNGMYERFNSRNTLMLENQRLKQEMFVQNSNLLLMEQLKQE
NSRLRNLLGSPFIRDEKKMVTEVMAVDSAPYTHQVMIDKGAADGVYEGQP
VISDKGIVGQINNVGAHNSRVLLLTDANNAIPVQAVRNDIRVIASGKGHL
DTMQLEHIPTNTDLKVGDLLVTSGLGLVYPEGYPVGYISKIDNDNKRPFA
SIDIETTVEFDKLRYLLLVWPTGKAPEEISDGE
>VF1411 probable lipoprotein NlpC precursor
MLIPVKFIQNSYLHFLYRLVMFRHLFAIFTVVGLLGCSSTPPVAELSKQE
ITTQHPQLSSSDAYQDYFYQWQGVPYKYGGTSKNGVDCSAFTQNAFDVLH
RLSLPRTTEYQATSGTQIALANAKKGDLIFFKTSVKVRHVGVYIGNREFM
HASTSKGVIISSLDNPYWKKAFWQVRRVL
>VFA0591 multidrug resistance protein A
MSNSKKIISIVTLSVVIGWIGYSFWSAYQPRPELLQGQIEAEQYNISSKV
PGRIENIYVKKGDMIEKGQAVFSLYSPEIEAKLAQAKAGEAAASALAEEA
EQGARTQQVAAAKDQWRKAKAASQLLEKTYARVNNLYKDGVVAEQKKDET
YTQWQAAKYTESAAYQMYQMAKEGARTETKRAANEKVKMAMGSVAEVEAY
VADTKIDSWYQGEVSQVLLNEGEIAPQGFPVVSVIDMNEAWALFHVREDK
LKNYTKGEVLKVYLPALDRTEDFKITHVSVLGDYATWRATDNSQGFDLKT
FEIEAHPVNPISDLRVGMSAIVTVESK
>VFA0674 hypothetical protein
MYKSKLAPLALALFVSSPAFSAEEEPATRNDVTVMVGRVGFSSHDDASAN
GNGFAIGVHKEINKIVGISARYARHELLATGVTGEIGTFGAYPEFGYRFD
LNNAVSVKPYVMVGIENNILGYTDYWQRHDFSVISFAKGLGIRAEFNDKV
TLSIDIKRADIEIADDYYVDSTISSLMLGVKF
>VFA1100 outer membrane protein
MLIISNGTIASESKEEQSHVYLGGQVGVSHFLGACSSNAIECKNYVTGGG
LYGGYQFNSWFALEGSWHDYGSPKTFYGVGDGYYSNATGVDLSVKLSLPV
TDNLDLYAKGGAAYNYLSVSGNDNVHLGMFESDSSIDDIWEIGAEYALAP
NWSLRFGTSIIDGIGNAKTGKSDLYFTSLGLTYKFKAKPEPELKPETIVK
LVPEATYYPEQVTLHFEFGESRFVVESKQWHSWNELALSVKQGQGKVSIT
GYTDAKGTDSANDIESLRRATYAADMLIKAGVDEERILINSKGSADPLVN
EDLMRNESALNRRVVIQFNRRVGS
>VF0345 lipopolysaccharideN-acetylglucosaminyltransferase
MKILLVNKFFFMKGGAETVYFQERDMLLSEGVKIVEFSMQHEKNIESEYS
EFFVQNVDYYQKQTIKDKLATAINFIHNRQACEKLQALLEQEKPDLVHFH
NIYHQLTPSIIKVAKQFGCKTVLTAHDTKIACPSYTMYRNGHTCEACVHG
SVWNATKYRCQEGSLSKSVLLSLEAIYQKISKNYQYLDAIVSPSRFLGRF
IQQKLPHNRIEVIVNGIDENVSLEGIKDNGYYLYLGRLSQEKGVPTLAEA
HQLMTEKAGLKIVGDGPEFNQLKENYPTAELLGFKSGEELLTLIKEAKAV
IVPSECYENCSMSVIEAMSYGKPVIGSKIGGIPEQIKDGIDGYLFEAGNA
QALADKLDLLVKEPVKTIDMGKNARERFLSKYTLTKHKNDLLNLYQELLK
G
>VF1751 AsmA
MKKIALLISIPFIAVIGAVLVLVLLVNPNEFKPLITEQVEAQTGRQLTID
GDIEWRFFPSIGFSIGKMALSNPEGFVEPNLVSFDNAILDLNVRPLFQQE
VSIGLITLDGASFTLHTLKNGVTNLDGLVAKKETSTVENNNPTAPAEETD
VNPEASSATSTEFNGWKVSLQGIALTNAEVLIQDDKAGSKIHFSDMNLSL
SQFIPGQWAKLNFDLKGDLGKQKVALKGKTELNIAETLDDASFKNVEFNA
SYADAVNKFNDITFTIDQFSFDKWANLVLKVKGKANNLEVNSNSTFALYV
PKALDLIKIKEFTSTNNVKGKGIPNEDVTAVIGFNSSFALNKSFLKIDKL
ALSAVDTDFTGKLSVQLNDIPKVRFDLRSPSIDVDALLATLPKDESSKTV
DSTTSTKASSTPVKEVEPDLSALKTLDVAGSIIIDKFKANNAKMQNVTSV
FSVNRGVLKLTKFHSDLYSGGIDMTATLDARKSVPTYSVKQTIKGVKVAP
LLTDVMGESLVEGTGNIAINASGKSLKPTALKQNLKGKVSINFADGAVNG
INIPLLIRTTYAKIKGEKVKGSEEAEKTDFSALTADFYLANGNATTKNIK
MVSPLLRIHGEGSAHYVNETANMLIKTSIVGTLKGQGGKDIDDLKDVTIP
IRVTGSWTNPKYKLEFDDVMKQKAQKEIDRGIEKLEEKYGDKIKDEKVKD
AANKLLKGLFN
>VF1161 periplasmic component of efflux system
MKLAINKYWIYLFLFSFVVVSVGYYFVRVDSQHKKLPFVVASIGSIEKKA
VAVGHIVPAHSISIKSQIDGIVGEIYHQVGEVVAINTPLIKIRPNPTPAK
LMLANTDLMQSEAKLELAQKKLENLKQLVEQNIIPENYGGYIEAKSDVKS
NKASVQQKKQNLDLILSGESSAGNSKLNSTIVAPINGTILNLKVEIGEPI
ISTASNQAATVMMSIADMSDIIFKGSVSEHDASRLTVGTPATVILASYPD
IVVSGKLRKVAVQSEKLNLTTTNTSTNSVKSFDNGFQVEVDQIQFPKNLT
IRSGFSATAQIILQQSTNVIIIPERSLQFKGGEAEVWVIDDSEYGYSSRV
VTLGLSDGVMVEVLSGLEEGEEIVDMSMMIGELNA
>VF1915 D-alanyl-D-alanine carboxypeptidase
MTYQELTGQSFQHLSKLSPHRQLHHDCILPFKALSDAAHQAGFTLTIASS
FRDFERQLLIWNNKFLGIRPILDDNGHELDPSSLNDLEKIHAIMRWSALP
GASRHHWGTELDVYASNTLPEDVQLQLEPWEYNTGHQAEFSSWLNKNAPK
FGFFFPYKTDKKGVAIEPWHISYKQNSNAYMSQLTPEMLLKAWEGVDLAG
KETIIKHIDTLFVRYITNIDKE
>VF1246 putative omptin family serine protease
MKQLIFILTPLVLISEAMAESDKKDISLGLSLGVLNGASKELVYDDTGRK
LSQLDWRIDNVPIIKLETDWNINQRWTLTGDFWSILIDDGNAHMEDRDWF
IENQHFPTDISISPKTTLKKAYQASLHTTYWLFIQNNYEIGALGGFQYNQ
FKWEDLGGTYSYNNGTDVGTFPDVVGIDYKQEFGMFYAGLTGKYRLDNSE
FSFLLKLSPWVKAKDVDNHYLRNLTFYEKSNEYSDAVSLSINYNYNFGPN
MNLYTEYAYTRYFEANADMTKVNNKTNDSSFSENAAGLDNLYSTLSIGLK
YSF
>VF0174 beta-D-GlcNAc beta-1,3-galactosyltransferase
MNSYPLISVIMSVYKEEREWLVSSIQSILDQTVSDFEFIIILDFPNSELL
KTLKDFEKKDSRIIIYQNEKNVGLVESLNTALSFSRGKYIARMDADDISH
KNRFEKQLKYITLNNLDLVGGNVNIFHSNKGIYNTTDKVQSDYFLCKLLK
IGTIGIVHPTFFSKRNVYDTIGGYYHAECAEDLELLMRANLNGFKIGNIP
DVILDCRYSEKSITKENAYFMFCTVKYLKSLYRSSLKSGDYKFNSNYIEL
YLYDENNKLAFSEKQNLMSEARHSFNEKKYISFLINLIKSILISRTVFFS
IKVNVMSFLFRKVEVKIPKVLLACIKIKLQ
>VF1399 glycosyltransferase involved in cell wall biogenesis
MNPLSIVIITLNEENRIGRLLEDLTEQTFKNFEVIVVDSNSSDATCEVAQ
SFSASIPDLTVHKMDKQGVSLGRNTGASLAKHERLLFLDADVRLSPDFLT
KALTQLNEKGLEVAGVYMGSKGLPVAHKLGYMTFNIGLFLTQFAFPTAVG
ACIFSTRRAHKDLLGFDENITLCEDCDYVKRASRTWRFRFLPMTFEFDPR
RLEQDGFLRMGYTYLKANVRRFLFGEMRNNEMEYKFGHYSNQK
>VF2203 UDP-N-acetylmuramoylalanine--D-glutamateligase
MIDTRDTPPGHDQLPENVELHSGGWQQDWLINADLIVTNPGIALASPQLK
PAIDKGIKIVGDIELFAWAVNAPVIAITGSNGKSTVTDLTGEMAKAAGVK
TAVGGNIGFAALDLLEQDAELYVLELSSFQLETTSTLKLKAAAFLNLSED
HMDRYQGMADYRQAKLRIFEHAEVCIVNRDDKQTYPDVEKTLKSFGFDQG
DYGCIEKDGIEYLAKNTVPLLAANELGLVGKHNIANSLVAIALLDAAGIN
LDATLDTLRTYNGLTHRCQVVADNNGIRWVNDSKATNVASTLAALSGLQL
EGKLHLLVGGVGKGADFSELSPALHDLNLMMYCFGEDGDQFVSLDPRSLL
CETMNEAIATLYPTLNKGDMVMLSPACASFDQYANFMARGDAFTQLAKQY
SIES
>VFA1037 bacterial sugar transferase
MIDSYYTMNQSTIKAKRAFDVCLSIIGLMLTLPLFPFIALAIKLDSKGPV
FYRQLRVGKAMPDQIHVFEMIKFRSMVQDAEVATGATLATKGDSRVTTVG
RILRKTRLDELPQFFNVINGDMSLVGPRPERPTFYNKLEREIPYFSERTY
GVLPGITGLAQINQGYDTCIEDVRSKVGFDHSYALSLTSISGWIKSDIYI
LLMTIKVMIFARGQ
>VF0418 diacylglycerol kinase
MTDVPSGKPGNTGIKRIIKATGFSIQGLKAAFKHEAAVRQEFAMLVIATP
IALLLDVTVD
>VFA0884 cellulose synthase catalytic subunit [UDP-forming]
MFGWLSFLFQPRFVKEFRLQLNFYTQDKVATGISQLVLSLWFFICFCFLK
PTIFNVDSWKLPHYLFPQIDFSQLKFLDPLRMCIQLVWIILVVQPKKITQ
DIPLTQWISYVWRQINRIFYFPLKGLTSVVAWLENYSKYSEIRKKENVSK
RSAIVSERVINVIIGVAVCMLALLCFTIPFSLTAQAFFIFALWSLGMMFR
RMPGKFPTILLITLSVTVSCRYIWWRYTSSLNWDDPLALFLGCVLLIAET
YAWIVLILGYFQNIWPLNRQPASLPEDQSTWPTIDMMIPTYNEDLDVVRA
TVYSALGVDWPKEKLNIFILDDGKRDSFKEFAKEVGVGYIRRPTNEHAKA
GNINYALKQTSGEFVAIFDCDHIPTRAFFQLTMGWFLKDKKLGLIQTPHH
FFSPDPFERNLSNFGVVPNEGSLFYGLIQDGNDLWDASFFCGSCAVLRRE
PLEEVGGIAVETVTEDAHTSLRMHRLGYRSAYLRKPLSAGLATETLSAHI
GQRIRWARGMAQIFRVDNPLLGKGLKWQQRLCYANAMLHFLSGIPRIIFL
LAPLVFLIMHTYIIYAPALAIILYVLPHMVHASMTNSRMQGEYRYSFWGE
VYETVLSWYIARPTTVALFAPHKGTFNVTAKGGLIEETHYDWSISKPYWL
LVILNVLGIGFGLYRLGWGPDDELGSVVVNLLWVFYNLLILGGAVAVAEE
SKQVRKDHRVVVNIPMSIHLSSGHKVRCDIKDFSLGGLRVELPVSLDLPS
GHSLNIALQRGEHHFVFPTTVSYSNGKALGLQLDPLTKQQNIDYVQCTFA
RADVWSKWQKSYQSDKPLSSMLSVFKIGAKGYKNTIAYSPKTVRAIVKLI
TITSEFLLTFKPKKVNF
>VFA0285 amino-acid abc transporter binding protein
MDRLRRVFWVLLLLPQLAFAIELSPLTQTPYVGDLKELEKKGTIRVLVSA
DLGFYYIEKGQPKGIIAEFLHHFELHLRKNKIHVNVQVIPIPRDDLFTAL
ERGFGDLAVANLTITPQRLQYVDFSDPVISNSQEWLVSSPSTPPLESLED
LSGKEVWVRPSSSYFESLQRINKQLSSQGISPINVQFLEENLQDYELMEM
LNQDILPITVIDSHKSRLWTQVMKNITIYETLPIRENANIGWAMRKNSPE
LKTAVNKYIRTIRQGSFLGNVIYKKYLANTKWLKKAVDPETVKQFKSLAT
LFEQYADKYEFDWLMISAQAYQESKFNNRLVSHMGAVGIMQVLPKTAREP
YINIKNFRELENNIHAGVKYMNFVHKRYFLKPEITEENQMYFSLAAYNAG
PANVRKMRRMAVKHGYNPNIWFNNVEIMARKYVSKEPVHYVANISRYYVI
YKQIAQLQTHREQRNASNYKLF
>VF0299 outer membrane protein
MTIPFRVVWVNQVSNTEKLLLEVEFGPGFRYQNPNLDEIDDDDLILPETV
QEPIIRTNVRTSWKALSNLTLAGEVTVTAGHSNTRVDSEVSVTNNITEEI
ALKIAQSQQYLDRVPPGLSNTDSVFSINLLFSF
>VF2326 N-acetylmuramoyl-L-alanine amidase
MLIGKYFRIIWYTLFVVLSTSSFFVSANTLEGIRVWPSPDETRIVIDLNS
EANYSYFTLSSPYRLVVDLKNTNVKAKLPLNVKDSKVLTKIRKSSPPSKN
TTRLVFELKHSVMAEVFKLAPTPGGQYGHRLVMDLPHSKTSSSTPAPSKP
SKPVINSSSNHIVGNGEIIIAIDAGHGGEDPGSIGPTRKYEKHATLAISK
KVVAQINAQPGMRAVMTRSGDYFVNLNKRTEIARKNKSHLLVSIHADSFR
SPQPRGGSVFVLNTRRANTEIGRWVEKHEKQSELLGGAGDVLAKNSNDRN
VSQTLLDLQFSHSQKEGYKLAKNVLSEMGKVIRLHKKEPVNASLAVLKSP
DIPSILIETGFISNPTEEKQLFQRAHQDKIARSISKAIIRYLHDNPPQGT
LLAAQGGQTKHKVRSGESLSLIAKKYGTTMAKIKSENNLKSTSLKIGQVL
VIPSNKSVYVAPKNTASSVNTSSSQARTIITHKVRSGEYLGKIASKYKVT
TSSIRSLNKLKSDTLFVGQKLKVSIVAPVKKHTVKRGEFLGKIASKYGVS
VSSLRKANKLRSDELAIGQVLIIPTS
>VF2233 type I secretion outer membrane protein
MRKLLPLFIGMALGSFSSLAAADDLAQVYNQAKENDPQLLRAAATKDAAF
EAVNSSQSSLLPQIDLTAGYNILRSDNDTRDNDRLTAGINLSQELYQQSS
WVSLDIAEKSARQADSAYAAEQQGVILRVAQAYFDVLRANDNLEFVRAEK
AAVARQLEQTKQRFDVGLSAITDVHDAQAQYDSVLANEVLTENQLVNSYE
DLRVITGQGHTHLSVLDTKRFSASPSEQSSDSLIEEAQEKNLSLLAARIS
ADVAKDNISLASSGHMPSLTFDAGYNYTDQSGTKNGFNDDSYGDINAGIN
LYIPLYTGGNTSSLTSQAEFQYVAASQELEATYRDVTKNVRAFNNNINAS
IGALKAYEQTVISAQSALEATEAGFDVGTRTIVDVLDSTRRLYDANRNLA
NARYDYIISVLQLKQAVGTLSEQDIMDINMGLKANKTTQTK
>VF2372 glucosamine--fructose-6-phosphate aminotransferase [isomerizing]
MCGIVGAVAQRDVAEILVEGLRRLEYRGYDSAGVAVVDAEHNYTRIRRLG
KVKELADAVETAHVVGGTGIAHTRWATHGEPSEVNAHPHVSGDITLVHNG
IIENHESLRTLLQERGYIFESQTDTEVIAHLVEWELRSSGSLLEAVQKTA
TQLEGAYGTVVMDRREPERLVVARSGSPIVIGCGVGENFLASDQLALLNV
TRRFMYLEEGDVAEITRREIRVFDARGEQVERAITESNAEHDAGDKGQYR
HFMQKEVFEQPKALINTMEGRITNDSVVTESIGVNAVEILNKVEHVQIIA
CGTSYNAGMTARYWFESLAGVSCDVEIASEFRYRKFVTRPNSLLITLSQS
GETADTLAALRLAKERGYMGAMTVCNVAGSSLVRESDFAFMTRAGTEIGV
ASTKAFTTQLAALLMLVTALGKQQNRISKEKEKEIVEALHALPAQIEQAL
SFDKEIEALAPDFADKHHTLFLGRGEFYPIAVEASLKLKEISYIHAEAYA
AGELKHGPLALIDAEMPVVVVAPTNDLLEKLKSNVEEVRARGGLLYVFAD
EQAGFEADESMKIITMPHVSDITAPIYYTIPMQLLSYHVALIKGTDVDQP
RNLAKAVTVE
>VF0961 TolA protein
MKADNNYTFAIGVSVVLHLLLVIALIFGSDFSLDDKAKPNTIQAVVIDPG
TIAKQANQIRQERERAERAEQERLKKLKQQAAQLEKNRKAEEERIRRLKE
KQVQEKKAARQAEEERKKAVAEAKKEKERAVAAEAERKRKADAAAKAEAA
KQAKIKADKEKAAKEAAKKAQLEKERAAKAEADRKAKEKAAKAEAERKAK
AEAERVAKAKAAEKARKEKAARAEAERKQKEAALNDIFAGLEDETVQNSS
AKQQHIDNEVNRHAAIYTQMIQQNLLVDETYVGKSCRVKIKLASSGLLLS
VTTLGGDAQVCRAAKTAVTKVNVFPMPKDADVVAKLTNINLTVQPE
>VF0198 UDP-glucose 6-dehydrogenase
MKIAIAGTGYVGLSNAVLLAQHNEVIAVDIMAEKVELINNKKSPISDVEI
EDFLVNKKLNLTATLDKEFAYKEAEYVVIATPTDYDPVTNYFNTGSVEAV
IKEVMVINPKAVMVIKSTVPVGYTERIKQELNCENIIFSPEFLREGRALF
>VF0883 nucleoside-diphosphate-sugar epimerase
MAHRIIIVGASGYIGSQLIPLLLEQGHQVIACARNIQYLTDRVQQHPNLR
CEYLDLENKTTIEPLLFDCDIGYFLVHGMSHGHDFIDYEVSLAQNFADAA
EQSQLKRIIYLSALQPENHQSQHLLARQKTGEILRSTGITTIEIQSGIII
GAGSAALEIMTDFINHLAIILCPKWIHSQANPIAIDNLNDYLIQCLDIEV
SNSLSLEAGGPDTVTYLQLFNLLAKRLNKSIKIIPTRFISPKFAGLWLGI
ITSVPSELGRALLAGIDHDLLADNSKIQQLMPQTLTPLPEALKLANHTSA
NSLQGEIWGFDPSALRRWQPDYGYYPKQAGASFTTNASANSLWKVILQLG
GPEGYFFANGLWRTREWLDPLLGGSFPIRRKPKSDQLQLGDYIDSWKVIR
CENNEFLSLLFGMTAPGLGRLEFSIKELENNTRELDVRAWWHPKGFWGLM
YWFAMFPAHLFIFKGMVKAICKKAEKEEKG
>VF0175 glycosyltransferase
MYKDKVAVIMSVYKSDNPIDFNVAVNSIIRQTLKCDIFIYQDGPVSRELK
SAINRFRKFNNIFIFVSEENKGLAYALNYLIDSCLLNNYQYIARMDSDDI
SHKNRMSIQVNFLEDNSDIHVVGSYCKEFGADCSLAEKKLPITHNDLLNF
SITRCPFIHPSVMFRTSIFYNGLRYPVNTKYTEDMAFWFILLDLGYKFEN
IPETLIDYRMTENTVLRRRGFDKALSEVFIRFKYMIKFKKITVKNVSFII
GRFVFHLLPPNAIKYLYKKMR
>VF0199 hypothetical protein
MLFFDNLHPSRIIVGEQSERAQVFADLLVEGAIKENIEVLLTNSTEAEAV
KLFSNTYLAMRVAYFNELDSYAEAHGLDARQIIEGVGLDPRIGNHYNNPS
FGYGGYCLPKDTKQLLANYQEVPNNIIGAIVDANRTRKDFVAESIMKRNP
KVVGIYRLIMKAGSDNFRASSIQGIMKRLKAKGIEVVVYEPVLKEADFFN
SRVIEDLAEFKQVSDVIVSNRMMEELSDVESKVYTRDLFGSD
>VF2205 UDP-N-acetylmuramoylalanyl-D-glutamyl-2, 6-diaminopimelate--D-alanyl-D-alanyl ligase
MITMLLSEIAKACDGRLVGADCQISSVSTDSRHIDEEGLFVALIGERFDA
HDFIPAVQEQGATALLVSKEVDTTLPQVIVSDTQKALGLVAKHVHQVCHT
FTFALTGSCGKTTVKEMLASILTRSGEVLATAGNFNNEIGVPLTLLRSQP
SNDFAVIELGANHQNEISYTTQLAQPNVALVNNIAAAHLEGFGSIEGVAK
AKGEIFEGLQENGIAIYNLDSNGLPKWSSLFEGKQVVSFAMDDSSADFYA
SNIEVNAIGEPSFQLNTPKGNIQVSLGIIGKHNVANAVAAAALAIQAHAS
LNDIQQGLQELGSVKGRVAVETLASGLKVIDDTYNASVPAMKAAVDLLGG
FKGQRWLVLGNMAELGEESLALHREVGEYAAPYQFEQVVTFGDDTKVISE
LCNGRHFETRSDLNAYLLKELQLIKHNEVTVLVKGANSSRMSEVVSALKE
CQ
>VFA1150 acriflavin resistance periplasmic protein
MLWLINPEHTLLPGQHINVNLREKQPTEVLVVPRRAVQSDLEGDFVMVLT
EGNIAERRNVTLGKQLPEGVIISSGIKANEQVLVKGLQRVRNGVQVRLEN
TES
>VF0162 putative polysaccharide export protein YccZ precursor
MFMSKTHRSLASALLLVMLSGCTVFPGSHISTSDKNKVEEEQSEDNQNAY
SSDINVYELTPQKVADYQVKQASAQANLELEEQVASYEYRVGPGDILNVT
IWDHPELTIPAGSYRSSSESGNWVHADGTIFYPYIGTVEVEGKTVREIRT
EIAQKLRKFIESPQVDVNVAAFRSKKAYVTGEVDKPGQQAITNIPLTLLD
AVNRSGGLGEDADWRNVTLTRNGKEETLSLYALMQRGDLTQNRLLQSGDI
IHVPRNDTQKVFVMGEVKDPKLLKMDRSGMSLTEALSSVGGINELSADAT
GVFVIRSSSPDKKQESMADIYQLNIKDASALIIGTEFDLKPYDIVYVTAA
PITRWNRLIMQLMPTITGFNELTEGALRVKNWP
>VFA0373 mechanosensitive ion channel
MLDLRIRNYVTDKLNVFGFHDEPYGVELAIVVIVIVISVSIGYLITRHVI
VKIVNNILHKTNESLFLYLSSHKVGQKLTVLVPIIVFDLLFPFALGYNTQ
LAHITDKLLSILIVTIFTSMLFSLLDALNDMATSKDVTRRMPIKSLVQLI
KLFAFIICIILCLAIFIEESPVIFLSGLGVATGFVMLAFKDTILGFVAGM
QLSLNRMVGLNEWIEMDEYKANGTVEEISLTTVKIRNFDNTVSMLPAYAL
VQNAFVNWQGMSDSGGRRIKRAVNIDVNSIRFMTDDEIESLKSIRILREY
LFEKSSEINTFNEEVDDIPHVCNVRQMTNVGIFRAYLTAYLRTHRNIHSH
MLSMVRQLEPTQEGLPLQVYAFTNNPSWAFYESVQADIFDHIYAIMPWFN
LRPYQALSGHDALTLASSNPQHLS
>VF2162 multimodular transpeptidase-transglycosylase PBP 1B
MAEKKKTPTKAAPKKTAAKKKAPAKRKTSSKKKAQSSRPFWKSLMILGFK
LSLVVLAILVIAGIYLDTVVKKRFDGQLFSLPTVVYSRVLTLSPGQNISL
KTVQNELDLLKYQKVRQPQRPGEYSSSSTKIELIRRPFEFQQGPEPDRHV
MLYFNSEGLQKIENRSVMKQMGFLQIEPQFLGMLDADDDQQRLFLRREQF
PEVMVDALLATEDRDFYQHDGVSPLAIARAMVVNAKAGRTVQGGSTLTQQ
LAKNLFLSRERTLWRKVREAYLALILDYRYSKDRILEAYLNEVYLGQTGG
EAIHGFGLAAQVYFGRPIEELRIDQLAMLVGMVKGPSYYNPMRFPERVKE
RRDLVLRLMMQEEILSPHQYEMAASRPLDVKKRATIATRQPAYFQQLKWE
LKEKAGKAYQKGEGLRVFTTLDPLSQQKAEQAVERTVPQLEKRAGKGLEA
AMVIVDRQSGEIRAMIGGSRTGFDGFNRAINAKRPIGSLVKPAIYLSALE
TPDKFSLATTLDDKPIALKGSKGTTWTPRNFDRKFRGEVPLYYALSRSLN
VPTVNLGLMVGLSKVTDTLVKLGVDANEINQVPSMLLGSINLSPYQVAQM
YQTIGNGGRKAALTALKAVVDNDGNLLYENFPKSAAVVPEQATWLTVYGM
KRTVSEGTARFLNSKYSWAALAGKTGTSNDSRDSWYAGIDGREVAITWLG
RDDNKPMKLTGSSGALRVYADYLSMRSPEVLQLPWPNEVTAAGFDLQSNK
TLEPDCSGRVKLPIWDKKGQYKAECEKNKPAAWLTDIFGF
>VF0133 glycosyltransferase
MKIYHINLARGFSGGEQQTLALIKQHQKQQQEIAVIALANSPFHQAVSDL
GCEVITVRHYLLGHTISLPKDAVLHVHEGHAIYWAAIQHKVSQTPYIITR
RLDNPIKKKWLTTFAYSNAAAIVGISTCVSEVVRTRLPQQHIVTIPDSPV
IYPVNHSEVANIRERFKDKFLVIQAGNMIPHKGFDVTVNAAMRLKDPNVH
LCLLGDGKQRSELEEQASGLANISFMGRQHNMGDWFAAADLLIHPSYTEG
LGSVILEGMNAGLPAIGSHAGGIPDIIEHDKSGLLIEPGNSVELAENIEK
IANDATLKERLIEGGREKLTSFMIEHTAALYFKVYQRALQHD
>VF1955 membrane metalloprotease
MSELLWNLASFIIALGILVAVHEFGHFWVARRCGVIVEKFSIGFGKSLWS
KKGKDGTEYNISMIPLGGYVKMLDERVDDVPEEQKERAFNNRPLWQRSAI
VAAGPIANFLFAVFACWLAFMIGVTALKPVVGQVEDGSIFSKAGITAGVE
LKAISGIQTSDWEAVSMAIVSHIGDDSMTVTYSDENNIGVEVTKRLDLSQ
WNFDPEKDSPLLSLGFLPYRPALTLDVANVSSNSAAEKSGLLVGDRLVSV
NGNALTKWQEMVDVIQGNPSKAVDLVISREGQTVDLVLIPDSKEIADGKV
IGFAGVSPVYQEWPEGYRYEKQYGPIVAFEKALAKTGDIIDLTLTMTKKL
FTGDVALNNLSGPISIAKGAGTTAEYGLVSFLGFLALISVNLGIINLLPL
PVLDGGHLLFFAIEGITRKPVSERVQEIGYKVGTAMIMSLMAIALFNDFM
RL
>VF1815 lipoprotein
MKRVWISCCILLFVSACSQTPEQTEEELDTTQQIDTEYEETHVSDPLEGF
NRVMWGLNYDYLDPYLVRPVSIGYVEYTPTPIRYGIANFLANLDEPSSMI
NNLLMGNGNMAMVHFNRFWLNTTLGLVGLIDIASAADIQKPDSKSFGDAL
GHYGVGNGPYFMLPGYGPWTLREAGDFVDGLYMPLSYLNFWQGLGKWGLE
GMESRVQLISQEPMLEASPDPYVLTRDVYLQRQDFKAEIEPEVDLDAEDD
IDDYLDEIDE
>VFA0780 hypothetical protein
MMKKALLLIAITQTVVANASDLSSAQAIQNKTNTEASQSQTRINKSADNT
LSYQADIEQLEDELKNLDVYRKHLTALVDDQHRELKNINQQISDIEQTRQ
GVVPLMYKMIDGLKNTVKNDKPLRAEQRYQRIEKLETMMTIANVSDAEKY
RRILEAYQIELDYGTKLGVYQGEISFDNGKKIQANILYLGRISLIARNFN
QDKYWTWDQKAKAWVLLDSSLNSELDKAYAVANKEIAPSLLTLPVSLNIA
EKK
>VF0191 UDP-N-acetylglucosamine 4,6-dehydratase
MFKDKILLITGGTGSFGNAVLDRFLETDIKEIRIFSRDEKKQDDMRKKYN
SPKLKFYIGDVRDYNSILSASRGVDFVFHAAALKQVPSCEFHPMEAVKTN
VLGTENVLEACIANEVSRVVCLSTDKAVYPINAMGISKAMMEKVIVAKSR
NVDPNKTVISTTRYGNVMASRGSVIPLFLRQIMSGDAITITDPNMTRFMM
TLNDAVDLVLHAFIYGINGDIFVQKAPAATIDVLVQALKAITSKPEHEVN
VIGTRHGEKLYEALCSREEMFVAEDQGGYYRIPSDNRDLNYSQYVEEGEQ
DLSTIEDYNSHNTDRLDVDGMIELLHKLDFIADIEAGSLIVPEGV
>VF1085 hypothetical protein
MPPTFPSQFINENPMKKIALLLVLFSAFSNANDNISGFYLGAGLGATTFD
DGGAFDYTGASINADDSTLKFMGGYQFNRIVAVELQYTKYGDINVNHPTA
KAAGFKGIDIESTSISLAANLGYTFDSGWRPFGIVGLGSLESSTNVLGHS
LSENNTSFHYGVGVEYAPKALSGLAFRVAYEGDMFIEENVYQDYGYYSYS
DDYAMNIGTFYAGATYKF
>VF2159 serine protease
MRFKPFIFSSVFLYLFSSTAVASDESRPKIGLVLAGGGAKGAAHIGVLKA
LEEMHIPVDYITGTSMGAYVGGLYASGMSADEIEAFIDTVDWNSGFVDKV
ERSERQIRDKEYEDRYQIGTDIGFSFTELKAPKGFVQGQTMAKILRTTSD
NIPYLNSFDQLPIPFRAVATDIEKLEPVVLDKGNLAEAMMASMSVPGALP
PAEYDGRLLVDGGVVNNMPVDVVREMGADIVIAVDIGSDYLEADDISSYL
SVMGQLTNFMVKNSTKQQEKLLGDKDILLAPHVGKMETAEFDKMPFAYGK
GYDIAYEKHKALDKLVLSDEKYQEYLKEKEIKASTLLRGEDLYVNKITIK
NDSLYTESMLLDRLNLEEGRSYSADELEEHIRDLYVIDRFERVDYYYQEN
EEGTHDLIVEVKEKSWGPNYLDFRFALEDDFDNQSKYSLGMSINFTDIEL
TGLRDNRSELRTNFELGTDKLVSAELYTPFLVNQLLFTSFKSVYSVEQKK
FSLSGNELGSIDNDFPLEYSDLVFEGAVGLQGHLWSDFRIGGRYTKGKVA
FTSLRDLNASYSREGIFAQYRLDTLDNFTFPTKGFYVKAEYLYSHDNVED
SVVDIEATKDSVIEISLNTRAAWTYSRHTFVGNFEYGVVENKKGDLQLEP
KSLGGFLRLSGTPKDSLTGQNLIFGSLVYRYRLMDNDFGLFQSPIYLGAS
LENGGLWNQDSIKDAPLYTAGSAFIGVDSPIGPIVLAYGRTEQNHESVYL
SIGAVL
>VF0192 UDP-2-acetamido-2,6-dideoxy-beta-L-talose4-dehyd rogenase
MKILVTGANGFIGKNLCFQLEEQGFTDLIKIDRSNSTEELNEALKSADFI
YHLAGVNRPQNDDEFKLGNADLTSHIISKLKELNRTPPILLTSSIQAEQS
NAYGVSKALAEDALNSYAEQSGAKVYIYRLPNVFGKWCRPNYNSVVATFC
HNIVNDLPLTINDPSAKVNLVYIDTVCEHFIHHLSNNEPGGEQSIKLIYP
TTVGDIATALESFKASKTSLVTENVGTGFLRALYSTYISYYSPEQFSYTI
PAYTDPRGSFCELLKTKDAGQFSFFTAHPGITRGGHYHHTKNEKFLVIKG
EAKFRFEHIATGECYELDVTGEDYKVVETVPGWTHDVTNIGESELVVMLW
ANEIFDREKPDTFTKPL
>VF0474 D-alanyl-meso-diaminopimelate endopeptidase
MFFSRYSLIALSLISFSSIADIKETLSSLPSGSRTAITVENLQSNKIEFQ
QKQDELLPPASTLKIATALAARLALGTEFTFTTTLYKADKDVVLTFSGDP
SLSRKQLSELFDDSELKTIQGDLWIDGSIFTGYERAVGWPWDILGVCYSA
PSSALSIDENCVQASITTHEDGSTRVFVPIHQPISFSSYAKSVSREEQKS
TFCDLELTTQGNHYELNGCLVRRNKPLPLKFAVQDTRDFTKRTVSKILAE
HNIKLNGEIHFGAPKSELTNLNVLANHNSKPLMELLDHMLKKSDNHYADN
LTKMLGHLNYQQPGSFTNGTAAIKDILLKQADIDLSNAVLVDGSGLSRNN
RMTANQMKSILQFIHKYDKELGLIELLPTSGIDGTLKYRNSMRKEPIKGS
MKSKSGSLFGSYNMAGFVGLENKEPQLFVQFVADYHPVVAKEGTIPVERP
IDSFEKSFYQELIKLSQE
>VF0468 lipoprotein signal peptidase
MTSDKKTLPLLKESGLRWLWLAGIIFMADISIKLFVMKEMGYGWANRIEV
LPFFNFLYVHNYGAAFSFLSDQAGWQRWFFTGIAISVCGLLVYWMRKAPQ
KDKLNNIAYALIIGGAIGNVFDRLVHGFVVDYLDFYWGNYHWPAFNLADA
AICIGAGLIILDGLRSGKKEQ
>VF0926 sodium-type flagellar protein MotY precursor
MKKIFVTSALLVSFLIATPVLANKNYVAKPEQSKWTMLENSPLECRLSHN
IPNYGSAQFSSYANKKMNLDFELKMNRPMGETRAVNLVSMPARWMPGDGA
ESMLNLKFFKQFDGYVGGPTAWSMLAELESGRFPTFTYADWQSPKQMIEV
ALSPVLFQEQYNVFSMCIANLLPYSFEDISFTILHFDKNSDELNKASKKR
LSQIADFIKYTKDVDLVLVATYTDSSGGKNVNQQVSERRALKLQNYFESI
GLPADRIRVHSYGERRPIADNATPIGKNKNRRVVISLGRTII
>VF0755 apolipoprotein N-acyltransferase
MPLLSHYFIRLLVALLSGASATLAFAPYSLWAFAFIAPLILLLLMHKQTT
KKATWLGFVWGLGYFGAGVSWVHVSIDNFGGMPVAASLFLMIGLISYLSL
YPMLFAFLLQRFFSNHNITKYLLAAPALWIITDWLRGWVFTGFPWLWLGY
SQIDSPLSAWGPILGVEGITVMILLSVGTMAYSFIDKKWGLLLIPAVIFA
TSFAIKPFDWVTPQPDKATKVALIQGNVNQAIKWLPSERWPTIMKYMDLT
RKNWDADVIVWPEAAIPALEIEIPSFLRNLDSAATMNNSTVITGIVGQSP
TGNFYNNIISLGVNGTNGYDYGQQPRYSKHHLLPFGEFVPFENLLRPIAP
IFNLPMSSFSRGDYIQPNMEASGSHLAPALCYEIVYGEQVRENITSQTDY
ILTLSNDAWFGTSIGPLQHMEMAQMRALEIGKPVIRSTNNGVTAITDHKG
QITKQIPQFTTAVLRGEVIPTTGTTPYRYWGSIPLYLLVGLFLLVAWRKR
KDNM
>VF0141 UDP-bacillosamine synthetase
MSKTPLVEFVRNIYQTNDFIPLHAPTFDGNEQKYVLETIQSTFVSSVGKF
VDEFEQKIETYTGTAKAVATVNGTAALHAALYMAGVQHGDFVITQALTFV
ATCNALHHMGAEPIFVDVSPVSLGLCPKAMDEYLTQHAQVTDTGCVHKQT
KRPIRAAVPMHTFGHPVELDELIAVCHKWNITLVEDAAESLGSFYKGKHT
GTLGDFGAVSFNGNKIITTGGGGMVLCKSAELGARTKHVTTTAKVPHPYE
FYHDEAGFNYRMPNLNAALGCAQMEILETYLAQKKALANHYQEFFAESDF
QFVVEPEYAQSNYWLNAVICPSAQARDDLLKQTNESGVMTRPIWQLMHRL
PMFKDAPRGDLTQSEHIEAHLINLPSTPIAL
>VF2195 UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase
MIRQRTLKSIVQMTGVGLHSGRKVTLTLRPAAANTGVIYRRTDLNPPVDF
PADPESVRDTMLCTALVNDEGVRISTVEHLNAALAGMGIDNVVIEVDAPE
IPIMDGSASPFVYLLQSAGIEELNTAKKFIRIKKPVRIEDGDKWAEIRPY
NGFRLDFTIDFNHPAIESDDQKLVFDFSSQSFIKDISRARTFGFMRDIEY
LQSQNLCLGGSFDCAIVLDDYRILNEDGLRFDNEFVTHKVLDAVGDLYMS
GHSILGELRAYKSGHALNNQLLRAVLADQEAWEWTTIEDEQESPVAFMQP
GMVLA
>VFA0045 hypothetical protein
MNRSLYSLLVLTLFILTGCQEENTTEQSKPLYISGFTVNAPVTQQFRSFK
GQVVPAEQTPIAFRVTGEIEEVLVKAGDVVKQGQLVAKLEDSKVKQAVND
AKAQYSLASKQYLRGKELNRRAMISKAELDELFANRELAQATYRAAKNQL
AYTHLVAPFNGKVLDVYKEQFERAAAGEPIMNVYQNDKVYVRIDLSDNVL
AMINPETNRDSYHPTTTFVGLSDSYSMKYLEHTSEPNAQTQTYEMYLSMP
QPNVEILPGTSATVNVDMVEAGITSIDGYQVPVTALQAGQKSGLFYVWII
RDGQATKVPVTIRKISGEGAIVSSGIKQSDVLANSNLRKLRDGKKVMLME
NQH
>VF0289 organic solvent tolerance protein
MSFTSRSLLASFTGCLLYGTPAIADNGSEPVSPENGIVFPLQTDAVNSCE
VPDKKSKEEEDQQPVLIQADSVEASNNSKAVYKGNVHIIKGRQEIKADSI
TLHQQENIAIAEGNVDYSSMEMRTTSDKVTTNLSTEDTTMVNTAYKMSCQ
PIRGQAGRVLKTGQEIYQLEDASFTTCPADDNSWRFKASDIELDQSDEWA
TFYNARFEVLDVPIFYLPYVTVPVGDTRKTGVLIPSIGLDSKNGFELSVP
IYWNIAPNYDATTTINYMERRGTQLETEFRYLTELGKGTVDAEYLNEDDK
FKDKGSRWGVSWDHSGIYQQHWKFDVEYSKVSDIDYFQDLNSSIGTRDEG
QLQQSGEVSYRSQDWDMTMRVRDFQVLVEEQTPYRLMPQIEFNYYAPQFY
SEFDFNLHSHISKFTTDDKAKPSATRVHLEPKLSLPLSGTWWSLIPETSL
LYTYYQQDFDKQPVGPNGSLNLDHEVSRTIPEVRINGAIYLDSTHKFLGE
YLQTLEPKIQYLYVPEVDQSNIYGGTGDGGYDSSKLQLDYYGLFRDRQYS
GVDYIADANQFSVGATSRFYDDAYKERMNISFGQILYLNGSGTEQNNDDK
NSSAWAMESDFNYDDYLFYHGGIQYDSNVSELQVANSTLEYRFSKGYIQA
NYRYVSKNYIESNVNFEDDLSLITQHGIYQAGLLSEYNLGRNWALKGQYF
HDTKEDQMIEALVGVTYLSDCWSFGLTYSDQLIAPESAKTIGTYEPEYES
NLMLSIAIRGLGNNTGITSGSANNALDYGRPFYLNN
>VF2199 cell division protein FtsQ
MIKAVKMNTSFDKEKVRKHLPGAIFLSLVVITSLWLVISTISWMTDEDRL
PLSHMIIQGQLKHITADDIREAIDSMDSIGTFMTQDVNKLQDALLSLPWI
AQVSVRKQWPETIKVFVVEHQPEATWNNRVIVNPEGVVFNAPMSDLREPK
PALFGLKPAVKMYLIFGTNCKAI
>VF0906 outer-membrane lipoproteins carrier protein
MKKFLFSLCLLSSTVLASPQSELTERLNQNAGFEAGFTQKVLSPEGDVLM
QGEGDVKILRPNLFRWHTQTPDENLLVTDGNTLWYYNPFVEQVTLMGLEK
ATTQTPFVLLTRNKASDWDNYSVSQNGDAFTVSPKADSAVKSEFIVRIQE
NGKVTGFSVVEQDGQRSDFDFTKFEAKKPAKDNFTFAIPDGVDIDDQR
>VF1106 hypothetical protein
MLLKLAWRNVWRNKMRTSIMLGAMIFGVVGVILMMGFMSGFIDNMVKNTI
QWQTSHIQIHQKNYALNPDINLVIDEEKEITPLLNDSSDVKAWSSRTLVN
GMIASARSTRGIKINGINLQMEKKITPLSAHIIDGEWLSETGRNPILVSQ
KTAERLKLRVGSKVVLTFSDTTGEVTGAAFRVSGIFKTSSSTFDDANTYV
RKADLQKVGKVFQDHEIAILLNDNTKVEAFRDHLITNINSDNSVQDWLQL
QPILSTMMSSMNAGNQVILVIFIVAMGFGIINILLMSVFERTREFGVLMA
VGMKKDRIRYLIILESGFLGLLGGGIGVLLSILCIAVFNHTGIPLESMAQ
GLNAFGIDSVLYPSISWHQYAVVSIMVFFVSVCAGLYPAHQIIKKNPVQA
MAEKQ
>VF2426 UDP-N-acetylenolpyruvoylglucosamine reductase
MQILLNKTLKPYNSFSVNESADLIIQADSIQDLIDIWSDKKYTDMTKLPL
GRGSNTLFCNHFNGVVVLNRLFGKSVTETDTDYLLKISSGEDWPALVEWC
VDNGFAGIENLAMIPGCAGSAPIQNIGAYGLELKDICESVEYLDLETLQI
KTLKNSECLFGYRESIFKHELKDRCIITAITLRLNKQWQPVLAYGPLSDL
RNSKTTPKNVFDKICEIRSKKLPDPNVIGNAGSFFKNPVISEEHYLALCE
TYPNLPAYDVTEGKKIAAGWLIDNAGLKGFKINGAQVHQEQALVLINTGT
ATSEDILELANHVKNSVLDMYDIELEHEVRFYLNGEESFLSELFDERTH
>VF1954 protective surface antigen
MAMKKLLIASLLFGSVAAHSAETFVIDDIRFEGLQRVALGAALLKTPVRV
GDTMSQQDVAQVIQALFASGNFEDVKVFRDGNALLIKVTERPTIANISFS
GNKAIKEEQMQQNLEASSIRVGEALDRTTLSNIEKGLEDFYYSVGKYNAT
VHAVVTPLPRNRADLKFVFTEGVSAKIQQINFIGNEVFTDEQLLSRFNLN
VDVAWWNFLADEKYQKQVLAGDIEALRSYYLDRGYLKFQVDSTQVSISPD
KKGVYIALTIDEGEPYTVSGVKFQGELIGKEEEFKKLIPFENGEVYNGSA
VTSLEENIKRILGEAGYAYPQVRTMPEFDDENQTVSLIINVEAGNRMYVR
DIRFVGNTSTKDEVLRREMRQMEGAWLNSKSIETGKNRLNRLGFFETVDV
QTVRVPGSDDEVDLVYSVKEANSGSVNFGVGYGTESGISFQVGLQQDNFI
GSGNRVGINAMMNDYQKNISLDYRDPYWNLDGVSLGGKIFYNEFEASDAG
IVDYTNQSYGGSLTWGFPFDELNYFEIGVGYTHNKISNLEGYVQIEQYLQ
SVGDAYDSGDQTLIVSDFDVTLSWTRNNLNKGYFPTAGNYQRASYKITTP
NSDSQFFKAQYEVRQYFPLTKKHEFALLMRGKAGYGNGYGQTDGNDNLYP
FYENFYAGGFTTLRGFGSNSGGPKAVYAQGSNGGIGNNTSYAATDDSVGG
NATALASIELIVPTPFASEETRNQIRTSVFFDMASVWDTEFDYKEPKPGM
DGAQYYYDYSDPSNFRSSYGAAVQWMSPMGPLVFSIAKPVKIYEGDDEEF
FSFTIGRTF
>VFB47 outer membrane protein
MKYSKFLFVGTLAVLVSACSNTPPDIHGREAQINDIQQETINAQSKQIAA
LNYKVQQLVENNFPSPMISVTPRLYQVYYPYNVSKLTVTPELRYSILKDA
KQATRINLLGRTDGVRPTDSDKKVAMARAMFLRDYFVHNGIDPTLIYVNY
ASATDYADNNWSRIGRKNNRRVEIEIYPREED
>VF0663 N-acetylneuraminate lyase
MKKLTGLIAAPHTPFDSSNNVNFEEIDKIAKHLIKDGVKGIYVCGTTGEG
IHCSVEERKAIAERWVSASNNQLDIIVHTGALSIIDTLELTRHADTLDIL
ATSAIGPCFFKPGSVADLVEYCATIAAAAPSKGFYYYHSGMSGVNLNMEE
FLIQADKHIPNLSGLKFNSGDLYEYQRCLRACDGKFDIPFGVDEHLPGAL
AVGAKSAVGSTYNYAAPHFNSIIEAFNRGDQEAVFNKMTNVIELIRVLVD
FGGVAAGKVAMELHDINAGDPRLPLMPLTAEQKVTVATRMRNAGFIQ
>VF0766 outer-membrane lipoprotein LolB
MRLSRMFPRFVRSPFTILIFTLFLNACSTTPLTPQQSTDWDKHQAKLEQI
TQYKVTGKIGYQAPNQRHSLNFQWIQKPEQSQLLLTSFLGQTVMKLTMTE
QMTTIETGDGQKFEGRDPGKLMYSLSGISMPIGYLQDWIKGLPTAADNFQ
LNELNTVEHLSKQIGQTNWHLRYNSYIEKSNLLLPNSMKLTQQDTTIKII
ASNWIISQ
>VF0315 opacity associated proteins OapA
MNKKKKMNVKRPDFSEQLANLKEKCGPLIEKVAPYWQRLPQFHQKALRIL
VPVTFVLILLPSGAEEEVDSIQPTVIPAPEMQRQSVSLNLEGLSEQEASS
NRNQRETRVNREEKVPTQTASIEKETTAVEAKWHDYQIQEGDTLYQVFRK
NNLPLTELNKVVKIEGADKPLSNIKKGQLFRFKLNRQGDLDIVQIERDGQ
AIMYFRMSDGNFGRSK
>VF0178 3-deoxy-manno-octulosonate cytidylyltransferase
MNVKVVIPARYGSSRLPGKPLLTLLDKPVIWHVIERCKEAGIEQNDIFVA
TDDQRIIDALRDESIQVVLTSSEHQSGTDRINEVAQIKGWDEDTIIVNVQ
GDEPMIPYRLIQRIVSFTQLNPSYHITTAVVPLVSQDDFVNPNVVKAIIG
YNGRALYFTRSPSPLNRDNSSDLSLAKRHIGIYAYRASALKQFCSYSEDE
LEQYEKLEQLRALSHGMSIGATIFDGFVPHGIDTIDDYENIKKIMEENIL
>VF0168 dTDP-4-dehydrorhamnose 3,5-epimerase
MDIIKTKLADCIIIKPKVFGDERGFFLETFHSQRYKEVAGIKEQFVQDNR
SQSSKNVLRGLHFQKTKPQGKLVTVISGEVFDVAVDLRPESETFGQYEAV
VLSGDNKLQFYVPPGFAHGFCVLSESADFQYKCTDYYDPDDESGLLWSDP
IINIQWPLKTPLLSEKDKIQPLLSEIEAKIKEGWV
>VF1702 membrane-bound lytic murein transglycosylase B
MKKKLLLGIVSLFLATSASASATPEGDFQDYIVGLKNEAREIGISEPILE
RAFKNVAFKEKAVKSDRNQPEKKLTLDEYIPRAVPKWKIKQANDLYKKHY
KVLNRIGEEYGVQPRFIVALWGVESNFGKLTGGYNVIEALTTLAYDGRRE
AFFKKQTMAALTILQQGHITPENMKGSWAGAMGQCQFMPTSFLSYAVDGN
GDGKKDIWNTHADVFASAANYLKQVGWDDTYTWGRQVQLPESLDAESLKG
LSEEKGKTLAQWQELGVRRLTGKALPDADIKAWLVQPDDKDGRAYLVYNN
YQVLMDWNRSHYFALAVSHLADSIK
>VF2523 periplasmic component of efflux system
MKKWTFFMLLLALLLFGSVIGFNMFKQQKIAEYMANRPEAEFPVTVETVE
PTLWTPTIEAIGFIEPNQGVTLTTEVNGIIDKISFDSGSQVKKGQVLVSL
DSKVEKANLKSTQARLPAAEAKYKRYKGLYKKGSISKEAYDEAEANYLSL
AADIESMKASIDRREIKAPFSGVIGIRNVYLGQYLQPSTDIVRLEDTSVM
RLRFTVPQTDISKINIGQEIDISVDSYPEDTFRGSISAIEPAVNIQSGLI
EVQADIPNNGGKLRSGMFAQAKIILPTLENQVVIPQTAITFTLYGDNVYI
VSEKDGVKRVQQHVVKVGERSKDIAHILEGVKAGDMVVTTGQVRLSNDAK
VRIVESNATTPPAETPML
>VFA1152 acriflavin resistance periplasmic protein
MKSKMLLASIISTALLVGCSDESTAQRAPQAPLVGTYTVEPISYQQGKTY
IGRIEAMEDASISAQVSGYIQSRQFKEGQMVEKGDVLFQIDPSSFEAQVA
NAKAGITQANAALKKAQLDFNRGKNLLPKGNISQAEFDGLTAQLLSAEAQ
VEAAQAQLKLAQVNLSYTTITAPFTGRISDSKASIGDLVSPASGVLTTLV
SLDPQFILVLPSVNVSV
>VFA0444 copper/silver resistance periplasmic protein
MKSFKIAVLSVVIGGVIGAGSMNFYSAHSMNMMPKNQDTPSVSSSNEPLY
WVAPMDANYRRDKPGKSPMGMDLVPVYADDAQGEKAPVGTVTIDPSVVNN
LGVKSAFVEKSILSPNIDTVGYIAFDESKLWQVNVRAAGWVEKLNINAIG
ERVNKGDVLFTLYSPELVKAQEELLNAYRTGRKGLVKGARERLYSLGVDK
VQVNSIVRSGKANKNIEIKASSNGVIASLNIREGGYLSPSQIVITAGPLE
DIWVDAEVFERQAYWLSSGNKAVMTLDAIPGKMWEGEVDYVYPILDPKTR
TMRMRLKFDNQDGALKPNMFANITIQPKTKEEVLTIPRQSVIRSGGMTRV
VLDEGNGKYRSARIVIGREAGNKAEVVKGLKENNKVVTSAQFLLDSESSK
TAELSRINGPENSIWISGDITMLMADFGMVTFEHRAVSQWDWKAGEMNFS
VENNIDLSTFREGEAVQFLVQKDNDEFKLLEIEKEGEAL
>VF1011 hypothetical protein
MKKTLLALAIASISASAFAVDTSSQNSKNEDMFAFDPMHKDQFSVSGSVG
VGGYYDTGSKAFYDDWATGLTLAVNYRNNRIVGYFETDLMLNYTTDNATS
PILKDGSEFATDVDKAWLGFDTGFGIASFGWENDTALDAVDGAGDNTYEF
GASAGDASDAFNVVKFQGSTSGFAYGVSYFETDDTHVDAEKGVNGYVGIE
QEIFNVYAGYELRDEATRTLRKLPNGAKIEAVDADYQVMTVTGNVKLGEV
KLGANFWIEDTSGKNLDKTNTGYYLSAGYAVTEDLTLAAGYAANTDEVTG
MKDLDQSYMNVAAMYTLAKNMDMGIDIKQELDSGYNNVDEETYVFAAGYY
YF
>VF0332 outer membrane protein
MIKKLPLFIIVCLLAISSQALAETELEIEGLEGPLLSNVEAYISGIPEED
YSVSLRFQARLQESITDALKALGYYQSTTTFVVEGDTSDRTLLVNIDAGQ
PVIIYVSDIVISGEAAADEDFINAVDNSGLNLGQVINHGRYESLKSTLQN
LALRKGYFDGDFTTNRLEIAPGRHQAIVRIHYDSGKRYSFGETSIDGSQI
EEKRVRSIIPFQAGDPYLASQVGELNQYLSNTEWFSSVYVEPDIDAVGKT
YQLPMKVHLSPQVRNQLETSIGYATDVGARGKIRWKKPWLNPEGHSLDTA
LSISKPEQEATISYKIPLEQVLKDYYVVKYGLKNVDNNDTDSLESNLAFE
RHWVYDSGWHRTIYTRFLYEEFTQGVQDGTAWLVLPGISFSKSRSRGGTM
PMWGDKKAFTIEATDQALTSDVKLLRLQAQGAIVRSIGENHRGVARADIG
AIYTDDFYKLPPSIRFFAGGDNSIRGYGYEEVSPKDSEGYLTGGQYMATA
SLEYQYRVVGNWWVATFVDYGDAWLDTPDWKMGTGVGIRWASPVGPVRLD
FAWGLDAEPGDEFKIHFTLGPEV
>VF1869 peptidoglycan hydrolase FlgJ
MQSVKMNNSVNMTDVGFIHDVGGLDKLRKSAVSGDQDSQDKALRAAAEQF
ESIFTQMLFKSMRNANDSFKSDMMSSDNQQFFEQMRDDQMATELSKKGSL
GLADMIVAQLGASMNQAAPVQSGNNLEQDARMAMRKAATDETLRLPADYS
YPHASQAKQESQTEAPEIAQIDKMLAARKVQPADKFETPQDFVNTMKPYA
EKAAKALGVDSNLLIAQAALETGWGKKVIKNSVDSSHNLFNIKADRSWQG
DKISKNTLEYHDNIAVTENAAFRSYDNYEESFSDFVRFLNQNPRYERALQ
QTDSSESFIKGIHSAGYATDPNYSNKVMSVMRKVESLLK
>VFA0466 N-acetylglucosaminyltransferase
MVINVDGDTSFDNNMALKMARTFANPNVIACGGALRVRNRESSFWTKMQS
LEYMMSMQSSKTGMATWGLLNNISGAFGGFRRSVLKQVGGWNTHTAEDLD
LTIRLKQYKKRYPGTRLNFSPRAIGHTDVPDTFKGLMSQRLRWDGDLLFV
YLRKHKHGLRPKLYGWGSFGYTLVYGVLQAVLLPVLMTLFNFYIFIFYPT
TVVLAVLSCLYVIYLVFIAMTFLIYLSLISERIQEDREMLLWLLIYPFYA
LFMRFVTAFAMINEIVRRSHEESSMAPWWVLKRGKRF
>VF1632 hypothetical outer membrane protein
MACDYVQSYAVLLILWLYKVVIVSKLISRSVFCLLVLFNSSANAKISQWS
LGAAAAYSPSFYKETPSNATIIPMVGYEGEHLFLRGFSGGYRLKPVGSPQ
NIIFRFVYDPRTFKPNDSNDAAMQKLDERKSTVLGGMSYQMVTHIGIIEL
TGGTDVGRTHNGLYAEAAWRLPIRGRGWAITPSLGYSYNSEKLNNHLYGV
SNEEALRTGVDQFNADWDGQFFIGLSTYFHITPNVRVTGGLRYVNLEGNL
ENSPMIEHTTSSTGSVGIVYVF
>VF2515 glycine betaine transporter
MSRNKDKYSIDNTDYTVGQDNVQKWGFDVHNPVFGISAGLIALFLVAVAV
TDPESAKTVLDGFKWKIINAFDGLFMWSANIFVIFCLALIVSPFGKIRLG
GDKAKPDYSMVSWIAMLFAAGMGIGLMFWGVAEPVAYFTGWFETPLGVEA
NTPEAAKLALGATMFHWGLHPWAIYGVVALSLAFFAYNKGLPLSMRSIFY
PILGDRTWGWPGHVVDILAVLATLFGLATSLGLGAQQAASGFHHVFGMDG
GLGLQVAIIFVVTLLAVVSVMRGIDGGVKVISNINMLIAIVLLAFVALVT
FAISMGTIPTTVMGYVENIIPLSNPHGRVDEAWMHGWTVFYWSWWISWSP
FVGMFIARVSRGRTVREFITAVLIVPTLFTVLWMSIFGGVAIDQVVNNIG
TLGSKGLTDVSLAMFEMFDALPMGNILSMIAVVLVLVFFITSSDSGSLVI
DSITAGGKVDAPMPQRVFWAFMEGAIAVALLWVGGTEAIQALQAGAISTA
LPFTLILLAMCVSLLMGMRTEKYNRS
>VF0180 undecaprenyl-phosphatealpha-N-acetylglucosaminephosphotransferase
MINAYLFVFLVSFISLFIMRKVAKRIGLVDKPNERKHHKGVIPLIGGISI
FTTLCIGLLLFLPVTETLLMYLACAAVLVVLGAFDDYFDVSFKIRLIVQT
GISLVIIFAGGHSLHNLGFLMGSETIMLSSAVSGFITILGVIGAINAFNM
VDGIDGLLGGLASVTFAALATVFYYSGNDYLAHVCGLIVIAMVPYIMLNL
GFPLGRRFKVFMGDAGSMFIGFTVVWMLIRGSQEPAVIAFKPVTALWLIA
IPLMDMATIMIRRVRKGQSPFKPDREHLHHICQRLGLSSYMTLFLICTVA
LICAFFGIWADLNGVSESVMFFSFLALFGVYFMTISYIWRITTFVHKLFG
KRMSVQLQAEISK
>VF0342 UTP--glucose-1-phosphate uridylyltransferase
MIKKCLFPAAGYGTRFLPATKSMPKEMMPVVNKPLIEYGVEEAINAGMDG
MCIVTGRGKHSLMDHFDKNYELEHQISGTNKEELLEDVRELIDSAHFTYI
RQREMKGLGHAILTGRELVGDEPFAVVLADDLCVNEEQGVLAQMVALYKQ
FRCSIVAVEEVPDNETHKYGVISGEMIKDDLYRVDNMVEKPEPGTAPSNL
AIIGRYILTPDIFELIEQTEPGKGGEIQITDALLKQAQSGCVLAYKFKGK
RFDCGSVEGYIEATNHCYENIYLKDKKSSELAKKVTGKK
>VF1939 membrane-bound lytic murein transglycosylase D precursor
MKLKLHWIGLALLAGCQTAPTPENTQPDTNSAITTPSKTEPKAAEVKPVE
KPAPTPQEQEDVWQRIAMQLEMPIPDNESVDYYRNWYIKHPSHLRTVAKR
AKPFLYMITVEIEKRGLPMELVLLPVVESAFDPFAYSHGSAAGLWQFVPG
TADRFKLERNWWYDGRRDVPAATTAALDYMEYFDSRFDGNWQHSIASYNS
GAGRVSRSIKKNQRLGKPTDFFSLDLPKETSGYVPKLLALADVIKNHEKY
GVELPPIPNKPVLEMVDPKQQLDLAIAAEFAGISITELQGYNPAYNQWAT
SPDGPYHLLLPIEHVDQFNANLKKNANKTMKVVRYKVQSGDTISQLAVKH
NTTTKIIEQTNDLNGANIRVGQYLLIPTASKGNKTYALSAPQRLKKTQAK
AKGKYKLTHKVKDGESLWSIARDNSISYRDLAKWNGMAPRDSLRVGQNLV
IWKNSSDGAIIRTVHYQIRQGDNLSSIAQKFSVAVTDIMKWNNIERGSYI
KPGQKLKLYVDVTKVNV
>VF0152 ADP-L-glycero-D-manno-heptose-6-epimerase
MIIVTGGAGMIGSNIVKSLNNKGFNDILVVDNLKDGKKFKNLVDLDITDY
MDKEDFITQIMAGDDFGPIEAIFHEGACSATTEWDGKYIMMNNYEYSKEL
LHFCIEREIPFLYASSAATYGETDTFIEERAYEGALNVYGYSKQQFDNYV
RRLWADAEEHNETLSQITGFRYFNVYGPREQHKGSMASVAFHLNNQMNAG
DNPKLFEGSDEFKRDFVYVGDVAAVNLWFLENGVSGIYNCGTGRAEPFRA
VAEAVIKHHGKGEVETIPFPEHLKGAYQEFTQADLTKLRAAGCDVEFKSV
ADGVAEYMAMINK
>VF1182 acriflavin resistance periplasmic protein
MFKKTAIAAVLGSILLAGCDSKEPSIAEPDSRPAKILTVSVGDHETSRLF
PAKAEAGDKAVLAFRVPGQLNTLNVHAGQSVSKGELLATINPDEYRLIQK
QAQAQYRLIDVQYQRIKKLRKDKVVSEQDYDTAVANRKTAKASLDQASAN
LSYTKLVAPYDGTISLLPTENFEYVNAKQSIMHIQTNDILYVVFQLPDYL
LQRFSFTDVSATVSFDSFPNTTFPLEFEEIDTEADRKTSSYTVKMSMPRP
KDLGVLPGMSGQVKVTIPKGGSEKLPLSAIDQDGDTTYVWRVKEDGIVEK
VAVKLNEKRQVVSGIEDSDQIVSSGITGLEEGMKVRKWVKERGL
>VFA0405 mechanosensitive ion channel
MTRFLDWWNTLLEFKDHDWAQNIIVITLFSAFLWLSWRVIIKRLHHIAAK
TQLPWDDAVITAISAPVTLVIWLWPATASLKILLSTQTHFSSTWLPELQV
FILIWGFIWSALRLTSLIEKQFLTNPKHDETTVLALGKVVRLIFITLGVL
SLMQGVGLSLSGLLTFGGVGGLVVGLAAKDLLSNFFGGMMIYFDRPFKVG
DWIRSPDRSLEGTVERIGWRMTVIRTFDKRPLYVPNSVFSNIVVENPSRM
LNRRIKEDIGIRYDDIHSIERIVDEIKTMLQEHNDIDSNQTLIVNFNGFG
PSSLDLLVYTFTKTVNWIEYHKVKQDVLIKIGDIIAQNNAEIAFPTQTLK
VEQIPSE
>VF0420 membrane-bound lytic murein transglycosylase C precursor
MKKIILIASTCLLLTSCSRESIESTFGVNYDTTNRFAKNLAPLPGQFTKD
IKALDSLISSFNGNIEKRWGKKNLVTAGKRSYVKYTDGYLSRSQVDFTNG
RVTVRNGCWY
>VF0171 hypothetical protein
MEWSDFSDDYDMLFCDSAVAKSIKQDIYVNKLSRIKSIVKVLFLFFRKNK
CIDFKYNGINNLYVLESMTPSNFKTINPIFELDKSSKLIIVTTPVFQRID
NVRYRGNLFNIDDYTFVNIGDFINSLHFCRRFNNKFRFVNIFQLIFLYLR
ASSLNNVLNELFSNVKCNNIILTNDTLGLSNLIVQNSRVFNIKNYVLQHG
LPTKFYFPTSADNYIVWGRRFVSEFKNKGARSKLYSLGSPKVDEVMKYCF
SDAKYNDFLKRYNISNNKKIFTYFSNSHAPELDKKVHEINIKLLNGLISH
KDYHVCIKLHPSESMQFIKEVLQPYDGKYTIIDHEDDVYDLVKFSSYCAS
IYSTLLIESMCLGTYTFQFNATKSHKIPDYSNGGGCVEINSFEQLELSLN
ASNKNKILNQQLKYTENYFSNQGTSSEKILELIHERNCI
>VFA0286 amino-acid abc transporter binding protein
MNLFHKLFFTLLILPINAEALELAPLSNKSYKGDYNEISKKGVIRVLVSM
EVGFYQVSNGKPIGIISEFLSHFERHLAKKNDHTHIRIIPVSDDDLIWSL
KAGFGDIAVGHLAITKARLRHIDFSTPTIKDSEEWLITAKGHAPITELAD
LSGKEIWVKGSSSYFETLQNINEQLTSNNMAPMDVHFLEESLGDNEVLEM
VENKLLPATVIENYRAILWKKIIPNIQYHEEFPLKQDINIAWAVRKNSPQ
LTNVVNQYITKIKKGSFLGNLIYKKYLNDEKWLAKILQTDNIDKLYELSD
LFKHYSSMYNLDWQLTSALAYQESRLDNKAVSHKGAVGIMQVLPSTAKDK
HVQIDNIYTLENNIHAGIKYLSFVHKRYFDKPEISADNQLYFSLAAYNAG
PAKIRRIRKKAQEQGYDPNVWFNNVELMALKYISKEPVHYVSNISRYYVI
YKQIVQLKEQKEQRNALNKATFDFDNI
>VFA1163 type I secretion outer membrane protein
MKWIKLATCSSLLVLSVSSQAQTLEQAISQTLTTNPEVKKAYNSYMSFVE
DSNSVDGNYLPSIDLDAGIGYEQINPASGNDTSLTRKDATLSLTQLIWDG
SNTINDMDRTEAEAESARLQLLSLAENKALDVSQVYLDAVKATEILALSE
SNLAIHKKIYKDIKKRAASGIGSTADVSQVEARIARAHGNLLAAQNNLFD
THTVFTQIVGSPPQALIYPRADANTLPLSLQEGIDRAFKHHPVILTAQSD
IQAAKFQYAQSKSNNYPTFSLEAAQTWRDDAGGIEGNSDEFSAMVRMRYN
LYNGGTDSSLSEKSAYQLNMAKDLRDSAYRNVEQGLRLSWSALDLTLQQK
EFLADHVDAATDTVIAYEKQYRIGKRTLLDLLNTENELFEARKSYLDAHY
AEQFAKYRVLHATGTLLPSLLIDTPQEWDNKNEKEEEK
>VF0748 cell elongation specific D,D-transpeptidase
MIKRKRTQIRDYHAETRLFASRAIISFSGIIVLIGLLLTNLYNIQINEFQ
DYKTRSNDNRIKIVPIAPNRGLIFDRSGNPLAENRPVFNLEVTPDKVSDL
SLLFTELQTILPITQDNIDDFQKERRRTRRFKSVPLLTQLTQEQVAIFSV
NQHKFQGVEIKAYLKRFYPYGKTLTHVLGYVAKINDRDLARLAREEKDAN
YQATRDIGKLGIERFYEDILHGTAGYQEVEVNSRGRVIRTLKYVPPIPGK
DIVLNLDIKLQKFVEKQLDGRRGSAIVLDPKTSAVLAMVSSPSYDPNLFV
HGISSKNYSALLNDPDRPLVNRSTLGIYPPASTVKPFIAVAALKEKIVTT
ETTRDDPGYWRIPNSKTKPFRDWKRWGHGTVNLKQSIEESVDTFFYQIAY
DMGIDRLSTWMMKFGFGDYTGIDIREESKANMPTREWKVARFRTPWYQGD
TIPVGIGQGYWTATPMQLAKATAVLTNHGKVQAPHLLKGIIENNKEVPYE
PEPYPPIEGVKDSYWQLAIDGMILVNNGRKGTARRAFAGTPYVSAGKSGT
SQVFGLKEDEEYNADEIAEHLRDHALFTGFAPAKDPKVIISLVLENGGGG
SSQGGPIARHVFDYVLLPKTEEAAKK
>VF1953 outer membrane protein OmpH
MILKKLVKVAALGAVLVSGSFFANAAEAATKVGYVNMAQIVQQMPQREAI
SEKLRAEFKDRIDELRGLESKIKDKVETIKRDGELLGASGKTKLEREIAS
LQSDYKLKAQALDEDNRRRQGEERQKLIMQVQQTVEKVANKEGYDMVVDA
ATLLWAKPEDNLSEKVIKAIK
>VF0167 Glucose-1-phosphate thymidylyltransferase
MKGIVLAGGSGTRLYPLTRGVSKQLLPIYDKPMVFYPISTLMLAGIKDIL
IITTPEDNAGFKRLLGDGSDFGINLEYAIQPSPDGLAQAFIIGEEFIGDD
SVCLVLGDNIFYGQSFGRTLRKAAARDYGASVFGYHVKDPERFGVVEFDK
DYKALSIEEKPENPKSNWAVTGLYFYDNRVVSFAKKVEPSHRGELEITSI
NQMYLNDGSLNVELLGRGFAWLDTGTHESLHEASSFVQTIENVQGLKVAC
LEEIAWSQGWLSDEKVYEIAKPMLKNDYGKYLVSLLDNETLRSSLQANK
>VFA1035 glycosyltransferase
MKTIIHVVQHLSPGGLESMVLDMLEFTSQEHRIIIVSLDGAYEKTLENWP
RLQRYQDQIICLNKSAGFSFKVIKQLLNLFKTYNATVVHSHHIGPLIYSG
IAAKLNKKINHVHTEHDAWHLNASKHRRLQRFALSLSQPKLVADASFVKK
SLNNIFNSYPIYTIKNGINPYKFSIGDKQKARNKLNIILPVNSIVVGNAG
RLETVKGQLNLIEAFRFLNSKYHLLLAGSGSQKEHLMQLVKRYHLEDRVH
FLGHIDHMPTFYHALDLFCLPSNNEGFPLSTLEAQACGIPCIANDVGGVS
ETLCPKSSILVSNNAAITLAQAIESMTHKTKKFSSRDFILKNNHAQSMVN
AYEELYFEGANL
>VF0166 dTDP-glucose 4,6-dehydratase
MKILVTGGAGFIGSAVVRHIINNTQDSVINLDKLTYAGNLESLSDVDSDE
RYVFEQVDICDGAELDRVFSEHKPDAVMHLAAESHVDRSIDGPAAFIETN
IVGTYTLLEATRSYWNTLSDDKKQAFRFHHISTDEVYGDLEGTDDLFTET
TSYEPSSPYSASKASSDHLVRAWLRTYGLPTIVTNCSNNYGPYHFPEKLI
PLMILNALDGKSLPIYGNGMQIRDWLFVEDHARALYKVVTEGVVGETYNI
GGHNEKANIDVVKTICSLLEELVPNKPEGVAQYLDLITYVTDRPGHDVRY
AIDASKIERELGWKPEETFESGIRKTVEWYLDNKQWWSRVLDGSYAGERL
GVYSESAVIEKEAK
>VF0340 probable transcriptional regulator SyrB
MATLLTQGTLLEAKKIKKPLTKSFLLSLTILFFFCAHFFQPNPGGSGLHL
AFNAASWIPASIAIAIALFHIAKQGILKFSTLSIVLFISVCLLSIPLLYQ
EASPHLATGKFLGLWAGLLFFITLQQFSFSNKQKQWLLWCIIGSVLIETL
FGYIQYLFLETGNSFGYNVIVNRPYGIFQQPNVMASFLVTGLAIASYFLA
RQPIKYRENIIALTLLYATIIFTLPLIVVLASRTGWLSATFSLVLLVPYM
WKYCTKPRFISWLLALVVGFSGSFALLDLSKNDDISNVTLISKKADLESA
REYIFPQALDMFLEKPVTGYGYGNFEAEYILYTAKQHQLSSDYRAGEPSM
DHPHNEILYWGVEGGIVAILGLLLAAGGVLAKIRRSKLDTQFALLALIAP
IFIHSQLEYPFYHSMIHWFTFIILLFWIDQLSCKYKKYRISDISKITLRV
SSLVLPIVTGFYMLSTLHTNWVLTQFETTKPMNPDILSRVTNPVVWEDRF
NWDVLSTQLKIGIINKKPELIKPYIEWSQELIKTKPRPAFYQNLIIAYQA
LGDEKRAEDIRREAIFLFPKSKFESVQLDKKLQMTN
>VFA0592 type I secretion outer membrane protein
MLKMTRVSILITTLLSISVQAKSVDFDSAWKNVLNNHNGIAAERMNVQRQ
ESLASGTSDLNLPSITLSANYTYLDDDVTVSAEQVWNSTNASIPFLLPNL
TSTLSERDIFTSSIRAIWPIFTGGRISAAESAAEGKTAEARSQLLMKQQA
SYEDLAKYYFSTVLAKEVVNTYSEVEQGLAKHRDNAIKLQQQGQIAKVER
LQADASYDKAKVDLRKAQQDYDIANAALVSMLQTTETVTPETQLFINKSL
PQLNAFVDSTLDTYPGLALLDAKELQAESLVKAEKGRYYPDVYLYGNYNL
YEGDSLSAEITPDWLVGVGVNVPLLDNKGRSDKVVAAHSAIQQVKYLKNQ
AKQDLALLVEKTYREALQAIDEYNGLASSLELAKENVQLREKAFKQGLST
SLDVVDAELYLASIKTQRSLASFNYVISLVKLLALSNQTDTFVQYQLQAR
QG
>VF0165 chain length regulator (capsular polysaccharide biosynthesis)
MSQAINSTRDTSTSDEIDLAKLFGQLIDGRWLILSITTLFAIAGIAFALL
STPIYKADALVQVEQKSNGGMSALVGDMGEMFASESSSTTEIEIIKSRMI
LGDTVDALNLTTIASPQYMPIIGKGLSRLMGEEKAIKVSRFDIPRYVDKP
NFTLVLDNAEQGTYTLFDGQERKILTGKVGVLADKNDYRVFVMQLEGNTG
DVFDVSKISRFDAILALQQSLSISEKGKQSGVLQFSLEGENKAQIEAIIN
DVSQNYFLQNIARNSAEAEQSLEFLQAQLPAIKDKLTTSENVLNDFRLER
KSVDLSLEARSALDVLVKLEAQLNELTFKESEISQRFTKDHPAYKSLIDK
RKVLLAEKDRLNGQVQKLPKTQREVLRMQRDVELNQEIYIQLLNKTQELN
IVKAGTVGNVRILDTAQAYTHAVKPKKPLIVVLATLLGGMLSVAIVLLKA
AFHRGVENPDEIEALGIPVYASIPKSNWQEKLDIRYNKKKVKHLETLLAE
SNPADLSIEALRGLRTSMHFAMMEAKNNVVMITGPAPNIGKSFVAVNFAA
VIAKTGQKVLVVDADMRKGYMQRYFGMRWDNGLSDYLSGKLSLEESIQKS
EVPNLDVLTRGQVPPNPSELLMTKRFSDFIDWASANYDLVLIDTPPVLAV
TDPSIVGALAGTTLMVGRFDQTSVKEIDVARHRFEQAGIEVKGFILNAVE
KKASSTYGYGYYNYSYDSDK
>VF0297 acriflavin resistance periplasmic protein
MKINKKYLFFPVVAVGVIVLITITKLRPDAETKPLEDRSKVVNIQLLEPQ
SIAPQAIGYGKIRPKFEWKAIAEVSGKVVYRHPELHKGNILLAGTEVLRI
DPLDYELKLAQAEADLGSSQTQLAKVDLEEKNIRNTLKIEKNRLSISKKE
LSRKINLQKKGLTSQSDLDQQNQSYLAQQKVVQDIQNQILLLPDEKKVAA
AMVKVNQAKLEEAQRSLEKTSIILPTDVRISEVDIEADQVVNLQQTMFIA
HGIKTMEMEAQISIHDMQTLAQSVKAFQLSEQGMPNIDSLPLTANVELSS
GRFDAKWEAKVARISETVDPNQATVGVILEIDQNYRALQPNSLPPLVNGM
FVKARIEGDASEQWVIPESALHGDKIYLLGQDNKLIILPIEIVYRRNNQV
AVAGDIKSHDRLILNDLLPAINGMQLRLAKSHNDEEPVQ
>VF0182 glucose-1-phosphate cytidylyltransferase
MKAVILAGGLGTRLSEETSVKPKPMVEIGGKPILWHIMKLYSAHGINDFI
ICCGYKGYVIKEYFANYFLHMSDVTFDMKENKMEVHHKRAEPWTVTLVDT
GDNSMTGGRLGRVADYLKDEEAFCFTYGDGVSDVDITKTLEFHKAHGKKA
TLTATFPPGRFGALDISAGKVNSFKEKPRGDGAMINGGFFILSPKVLKLI
DGDSCTWEQYPLNKLAEDGELMAYEHHGFWQPMDTLRDKVYLDELWQEGK
APWKIWE
>VFA1036 glycosyltransferase
MNLFLIIITSLSIGIVIYHHALYPILLRWFASRHPIKAIKPTCRNFAESK
KDRTLPSITMIIPAYNESQWIAEKIRNLSCLDYPSSKLKIIIACDGCTDD
TVTIAYNTIQEALCADTHFEILDFEHNRGKVALLNQLIPQYQSSDVIALS
DVSALLSYDALLIAAKHFENKNVGVVNPTYHLLTPSSEGEKKYWEYQTLI
KQQEATLGSSLGSHGAFYLFRSELFIHLESDTINDDFILPMMIVKQGYQA
VYDPSILAVELERVVQEEDFSRRLRISAGNVQQLFRLVTLFNPKYKGTAF
TFFSGKGLRAMMPYFMLIAYIGSACLLSNPLFLIAFIGQTIGYCIGVISL
FLPALFSNKYCQILAYLISGHTANLLGGLNYLLKKPTAPWTRVQK
>VFA0464 Lipoprotein releasing system transmembrane protein LolE
MFSPLSLFIGSRFARAKQRNKMVSFISISSTLGIAIGVAVIIIGLSAMNG
FERELQNRVLSVIPHAELEGVKKPVTDWQSMMIQAKKHPKVTGAAPYVRF
TALLERGSKLKAVEVRGVEPLLENSVSKLPEYIDKAAWNAFEANKQSVIL
GKGVADTLNVKVGDWITAMIPDENADRQLRSPKRQRLQVVGLLSLGGQVD
HGLAIVPLKDAQQYINLGDSVTGVSLQVSSVLNAQDIVREVGGTLSEYVY
LRSWIQKYGYLYRDIQLVRSIMYLVMVLVIGVACFNIVSTLMMAVKDRAG
DIAILRTMGANDGLIKRIFVCQGIFSGVTGSIAGSVLGSVVALNLTPMIK
ALESLIGHQFLSGDIYFVDFLPSQLVWSDVAIVTCTAILLSSIATWYPAR
RASRLQPAAVLSSK
>VF0142 UDP-N-acetylglucosamine 2-epimerase (N-acetylmannosamine-forming)
MSKSLINKKVAVFTGTRAEYGLLFWLLKDIQNDPELQLQLLVSGMHLSPE
FGETYQQIEADGFVINEKIEILLSSDSSVGTAKSMGLGVLGFADSLARLQ
PDVLVILGDRFEALAAAQTAMIMRIPIVHLHGGEITEGAYDDAIRHAITK
LSYLHGTSTEEYRQRVIQLGEDPNRVQNVGAIGLDHLKRATFMTVPELSE
SLGFTLDKPFFLVTYHPVTLGNEVPEESFQALLNALDEYPDHQVILTYPN
ADDGGRRIIPILEEYARNNSARVLAIPSLGQVRYLSSVMHATAVIGNSSS
GIIEVPAFDVPTVNIGSRQKGRLAAKSVLNVEPNQQSISNGIQTAILRTY
KLIDEKVHNPYGQGDTSGQVIEMIKSLQFTPSKAFYDITFNYVE
>VFA0352 UDP-glucose 4-epimerase
MKVLVTGGMGYIGSHTCIQMIEAGIEPIILDNLGNSKVAVLDCIEALTHV
RPVFYQGDIRDEAFLDSIFAEHSISSVIHFAGLKAVGESVAKPLEYYDNN
VNGSLVLARSMRKANVKSIVFSSSATVYGDPAIVPITESSPTGATTNPYG
RSKYMVEECFSDLFDAENDWSITLLRYFNPVGAHPSGTMGEDPQGIPNNL
MPFIAQVAVGRRESLSVFGNDYPTPDGTGVRDYIHVMDLADGHIAALKAV
GEKSGLHIYNLGTGKGSSVLEMVEAFSQASGKSVPYTLCPRRAGDIAECW
ASTEKAEKELGWKATRNVMEMSADTWRWQSNNPEGY
>VF0188 hypothetical protein
MLLTIAIPTFNRAEKLDLQLKNICDQLIELKRDDICILVQDNHSDDQTTE
ISNKYMSKFESIDFVYFRNESNLGFDRNVNLCLTNSKSKYTWILSDDDDL
NSNAILTIISEIDRNVGKFNFAFINYIVRSSEGVCANKCPNIKTKLVNGM
NLLYEIELSHSFISSCIFEVKSWLNKDVSEYFDSLWIHLLVARDIVPNGK
TLLISEPVITMNMPSLEESRDSVIYEDKLEFYTNAHIRISKFCHELDNYG
YSNDLKQYLVNKCRDYDRRQVINYKLTVERNSFKDMVRIAKAYYSVKNNT
WSYFLVLLPLILLPREFFKALKWLKYVLK
>VF0186 dTDP-glucose 4,6-dehydratase
MSNILMINKNDLELISDKVESSFGLFKNKNIFITGGTGFFGKWLLEAILY
LNLKRNLNITVTLLSRDPERFKNNYPHLCSSDNISFIKGDVRDFPFPNEY
FNYIIHAATEASSTLNKENPSLMRSTIMDGAKHICNFANTVKCERLLYTS
SGAAYGPQPPNMKAMSEDFIINPNFNVNDAYSSAKLESEDFFKNNLKCQI
IVARCFAFSGPYLPLDGSYAFGNFIRDALDGKNISLNGDGTAVRSYLYAA
DLVIWLMKALVIGQDRTIYNIGSPDPITTLKLAEKICDASGNNSSVNVLN
KSSDSGNIYIPCTLKSQSDLDVEVYTSIDESILKTLKFYR
>VFA0725 choloylglycine hydrolase family
MMKRSFISTALIGALTLSAIAPAAQACTRILWKTQDHGTFVTRTMDWSEQ
THPHLMNFPAGSSYLAHSEKSNKVTSKYDVTGLTTYGFITDGVNSKGLSG
NVLYDGEMDLAVKSSNKNGSLTYLRNMLSQYQSVNEVVAAINEGAPSIEF
VEGVPIRIALHISFQDTTGDSAIVEWRNGKPQVWHGKQYTVMTNQPGYAQ
HLANVERSKRGWGEKDKQWSQTNLGTGGNTNPEDRFIHATYFSGHLTEPS
SVINGILKLDSTSFKIPHDAPNKMINGKMAGYATEYSVNRHLDSGETVVR
YQWGDAFNQVQYNVKEIQKSGENIAFDISKPGLSGNITQTVINNAR
>VF0419 membrane-bound lytic murein transglycosylase C precursor
MVKNHTQLREYKYADIVRKASLKYDIPEDLIYSIIRTESSFNPYAVSWAN
AYGLMQVVPKTAGRDVFKLVKNKSGDPTPEYLFNPYNNIDTGTAYFHILK
TRYLKDIRHPTSKQYSMISAYNGGAGGVFNTFSSSRSRAINDINSLQPNQ
VYWALTKSTKMQRPDAT
>VFA0044 acriflavin resistance periplasmic protein
MRKQNIKRTFLGAVIALSLSGMLTGCEKAVSETTDQTIKPVKLLSVKDLA
MADSDAFLARIDATYRAQLSFQVGGEVSDIKVKMGQAVTKGELLASLDPN
DLQLALDAADAQFSLAKTQWNRAKSLYSKKLISTNDYDQRETQYQAALAN
YEQAKTDLSYTEIHAPFSGIISYTYVKPHQIVGEKQEILNLIDNSTLDVS
VTLPITYVDSISIPALISSDMWVTMDNEPNNEIKGRFKEISTQPNLDTNS
YEAIVTMTLPQGRNLLTGMTGQVHIPKQKSSDYLQLPQSAWVNKGLNQGQ
VWLMNQETKTVTKTTLPLNEQGLVISGLHANDYIVIAGVDSLVEGQTVKA
WQREEGI
>VF1394 glycine betaine transporter
MSTNSKQTSDKLVPTLTIGFILLFLLAAFVDLSAFTATIQSLFMSVSTMF
GYWWQWLMIITFVLAFIIAMSSYGKIKMGSESKPTIGTFRWVAMIMCTLL
AGGGVFWSAAEPIFHFITPSPSFSDVKGGTLAAVAPALSQSFLHWGFLAW
AVLGTLSTIVLMYAHYNCGVKLRPRALLYPILGDKLENHWIGSVIDACSI
IAVAAGTIGPIGFLATQLSYSLTVLTGLESSLMSQIIILTVIVSIYSVSA
FSGMDKGLQWLSRMNVIGAVALLVAILVLGPTGFIFKEFGMAFGTYIQHL
PEMSLSTADPSWNSWWTWFFWGWFIGFAPMMAIFIARISQGRSIRELIIT
VAIIAPIATNFWFSSLGGTGIFLELQTPGSISQPLQEAGLPAVLLASLAQ
LPFSFLLIPAFLVLTTTFVATTGDSMAYSIAMAVEGTDTPSRYQRLFWAV
MMGVVAGVLLIAGDGGLNALQSFIVITAVPVSFLVGVTFITGPIAVLRMK
SAELESKSSVDCTKSVTV
>VF0122 Lipid A biosynthesis lauroyl acyltransferase
MSKYPAPKFSSALLHPKYWGVWFGFGFLFAIVTLLPYKVTYKLGRSLGLL
GLKLGKSRAHVARRNLELAFPEMESSEREAIIVENFKNSGLAIFETAMAW
VWPDWRVEKHFSYENKQHILDLAEEGRGVLVVCVHALNLELTARAFTSFA
PGYGVYRPHNNPAYDFIQHWGRTNNGNQMIDRKDVKGMLRVLRKGERLWY
MPDHDYNRNKSVFVPFFAVPDACTTVGSDILISASKCAVVTASGFRTYNN
YHLQIDNDISDQFPKKDPVGVATVMNKAVERVILRCIPQWMWLHKRFKTM
EDPNVKKGIRYD
>VF2234 D-glycero-D-manno-heptose-7-phosphate 1-kinase
MKPTLPNYDQSSVLIVGDVMLDRYWGGPTSRISPEAPVPVVKVEKIEERP
GGAANVAMNIAALGGDAHLVGLVGEDEPAQALTTTLESLKVHCDFVALPE
FPTITKLRVMSRGQQLIRLDFEDSFHDVAAEPIISRMQQALSSVKAVVLS
DYAKGALEHVQLMIQEARKVNVPVFIDPKGADFERYRGATLLTPNMLEFE
TVVGKVKDEDDLVAKGQQIIEEFDFEALLVTRSEHGMTLLRRNMEPLHLP
TQAREVFDVTGAGDTVISVLAASVSTGKPLDEACALANAAAGVVVGKLGT
STLSTIELAEAIHGSQDSGFGIIGEEQLISAVKQARARGEKVVMTNGCFD
ILHAGHVSYLNHAAELGDRLIVAVNTNESVQRLKGPGRPINPTDRRMAVL
AGLGAVDWVVPFSEDTPQRLISQVLPSLLVKGGDYAIEDIAGGAEVIAAG
GEVKVLNFEDGCSTTGIIEAIKGGRG
>VF1329 soluble lytic murein transglycosylase
MRLMKKGFVGLILGCVSNSAFAISELWLDRYAYDAIQQGFNKKDISVYHK
KRGDLDNYPLSGYADYRAFLFDLENKTPEEVNQFSKKFADYPFSVSIRAD
YLNALIATKNWPYLIAYQTELPRDQDYQCWYYTAFYHENELDTAFDGAKL
LWLDGESVSSACNSLFSYWDKAGERTDNMILERALYAVDAKNPRLITYLR
KLASTVDSKDTLTEMLRLYRQPEKFTVVFETKEDTQFNRNYAQTALKHLA
KHNINSAYEKVDFVQSHFSFEVNELQATLEFLAVRLLDTKDPEIIQWRDD
VFERSNDSVVLEQRIRLAIRKTEWNEIIFWINKLTSEEQASYRWQYWLAR
SEMKLGDTESGETRLKRIAGNRHFYSIAASIALKREPRFPIARVECNKEQ
LEPYQDDIDRVEELLALGKTYPARKHWRHVVAKENQAKSAVLACYAKKKH
WHLFTHEATIRGELWDYIYLRFPVRYWKEFTRYGTKYNVDPVTLLALSRQ
ESGLELTTKSPVGARGLMQVLPSTAAFMAQKYNLNYRHSSDLFDLDKNVA
VGSRYLSHLLARYKNNRAYAFSAYNAGPTMVMVWRRAASKEIDIFGYIES
ISFKETRVYVKNIFMFEMYYREILKLEGDFLRPSELTNSI
>VFA1022 transporter
MRIIQVLLIIVMLSPFSVSQANEKKDVVRVGDIISIMLPGEDSLNKGFQV
DKQGRLILPEIGPISVVGKTEAQMVSTVTLNLKTILQNLTNLQVFISKRQ
LIVNIQGYVKQPGEYTLSDGDSVQLALYAAGGLRSGAQLNRLQLRRSNKV
TTFNYKAFLDSGDQALLPTLQSLDTLFIPASPMVGNIEQEFDPAKLSQAG
DAADGKKAIKVFGEVNSPGTFSYKDGSNLVDVLMRAGGVTRYAGVEQIRV
ISKNQPALFNLKRYLDTGDSSLLPPLEVGSTIFVPKQEEEIKSGSNMVYV
MGEVAKPGAFEGKKGATFMDILANAGGPTRFAESRQIRVIKANGAVINFD
LSGYTEGTNYQRPPAIAAGDAIFVPEKTDMNEKSWLKIAPSRAVRVLGEV
QHPGRIEWSDEMSFLDLLAHVGGPTLRGDTTRIEIVTPDASGKNHVYTFN
LDSFISKGKPDSALPTIRAGATIRVHDLPQDPSDNKSQWVRQSSDSSIYV
FGQVNAAGRYRFTNDMHFLDILSAADGPTMDADIHNIRITHRDKSYARVS
KLNLALYFETGDESLLPKVKTGDTIYIPEKNRIWVDESKETTIRVLGAIN
KPGRYRFNDSMTLLDLLAEAGGPSDVAYLEKISVVNHSLNEGQARTFDLV
EFSRTADFRSIPVLRAGDTVYIPNKDESTMEQVRVVMKDVFQVVATIALI
GAL
>VFA1075 possible heptosyltransferase
MIKLKNILRNFDRYRRTKMAVLEPLLYRLLNNTHGQLSYLLDKDDIQHIL
IIRNNRRIGNMYFLIPFIRQMRRSYPDAHITLMLNQPWQRDVFRYIGVDE
FVFSYFSIREFGKFARIMKGQRKKEYDVIILPYSSVEDTLITAMLRAKNK
ISGDNARRNVAFTHTFKKDDDRLHAAFSCLYLLSALGNRLPSSISHHLVF
SQKELNDGVSAKKHLYQGEQLCLAYFRGARGDKRLPDSTWLTLINKFENK
FPQPIQWVEILSPDITTPLREGTVTFKTTDMRHLACVLKEMDAFICCDTG
PLHLADAAGVSCIGLYNKTNPEVFGVVGNNSINTTDISNINIDSIFTVLM
DDRNRSLIS
>VFA0378 glycine betaine transporter
MSTTDKYSIDSTDYEVGQDNIQKWGFDIHNQVFGISAGSIILFLTVLLVM
DPTEAKSLLDGVKWQIINNFDGLFMWSSNIFLIFCLALIISPFGKIRIGG
DKAKPEHSTISWMAMLFAAGMGIGLMFYGVAEPLAYFTDWYGTPLDVEPF
TEEAKKLALGGTMYHWGIHPWAIYGLVALSLAFFTFNKGLPLSMRSVFYP
ILGDRTWGWFGHIIDILTVLATLFGLATSLGLGAQQAAGGINHVFGTDGG
VNMQIGVIIFVTMLAMISVIRGIDGGVKLLSNVNMLVAVALLFFIIFIGF
SDVMSALPLTVTGYIENIIPLSNPHGREDEGWMHGWTVFYWAWWISWSPF
VGMFIARVSKGRTVRQFLISVMIIPTLATALWMSAFGGIAIEQVVNKVGE
LGENGLQDITMALFNMYDAIPMSTALSVISIVLIMVFFVTSSDSGSLVID
SITAGGKVDAPVPQRIFWATVQGSIAAVLLWVGGTEAMQALQAGTVSTAL
PFTFILLMMCVSLIKGFSTEKFGTTPNMGKAKA
>VF2108 mechanosensitive ion channel
MADQGAVTDLATTGVANLEHWLTDNTELFITYGVNIISALAILFIGNIIV
KKVANSVSNVLKKKKMDKAVVDFVHTLVRYLLFIIVLIAALGKVGVQTAS
VVAVIGAAGLAVGLALQGSLSNFAAGVLIVAFRPFKSGDYVEIGGVAGSV
DSIQIFQTILTTPDNKMVVVPNGGVIGSPITNYSRHATRRVDHVIGVSYS
ADLKKTKEVITKVLESDPRVLKTPAPTVGVVALADSSVNFVVRPWCKTAE
YWDVYFDTLQAIKEGLDNEGIEIPFPQMDVHLNKVD
>VF0735 alanine racemase
MKFTKCALALSLALPSIANSAPLLSLDTLTNQEKIQQTNAWLEIDTQAFQ
NNIDTLRASLEQDTKVCAIMKADAYGNGIEGLMASVIERNVECIGITSNE
EARIVRAKGFVGELMRVRAASPNEIESGLQYKIEELIGSSEQANIIAKLA
KQNNTIIPVHLALNAGGMGRNGLDLSQPQGKKEALNIAFNGHVNIVGIMT
HFPNESVDEIRTKLNLFKQESQWLIDEAQLNRDDITLHVANSYTTINLPE
AHLDMVRPGGLLYGDMPNNPEYKRIVQFKTSVASLNYLPKGSTIGYSSTY
VLGRDSILANLPLGYSDGYVRSIGNNGYVLINGQKANVVGVTSMNTTMVD
ITDIKNVQPGDEVVLFGKQNEFTIEAKEMEAFSSRSMPELYVIWGSTNPK
IYK
>VF1455 mechanosensitive ion channel
MRHFIWILLFFSSLSFASEAQDLSHLEKINAEIARLKTESNSFSGSELAI
IRVQQVEKNNELRSVLSQLIQEHDKTTKELLISEVNNQIGYAERSFAYLD
KELKSKQAQLDKADIEHKLALQNTLKETRDYYYLSLSDQLENYQWLADLG
ESNEAQIDAFKLLIDQKIKFLSASLSFDASREQRLSDQLQHSSESEKSSL
TLDHLFFERKVFNSTSGLEKLISIADQLDINTTDYKRQLFSTTGNLTEDI
LKFPVIAAILSNWISSGSNWLLKHAPDQLLKFLVFILILFATRLIARLTS
RVVLKAVVQPHLRMSKLMQDFFVSMSSKLIYFIGILIAFSKIGLDLAPVL
TGFGVAGIIIGFALQDTLSNFASGMMLLIYRPFDVGDLVEAGSVSGKVSH
MSLVNTTIKTFDNQIIILPNSMIWGDVIKNVTHERVRRVDMVFGIGYEDS
IEHAEKILAEIVDAHPAALKKPEPNIRVHTLGASSVDFIVRPWVKTDDYW
DVYWDITREVKLRFDKEGISIPFAQQDVHVHFAKKDKKPKKPNPITEKIG
NVIDSVRSKDS
>VF2204 phospho-N-acetylmuramoyl-pentapeptide-transferase
MIIWLSNFLEQYFPFFRLFEYLSFRAILSIITALTISLWMGPKLIAWLQN
LQIGQVVRDDGPESHFSKRGTPTMGGIMILTAITVTVFLWADLTNPYVWA
VMFVLLGYGAVGFVDDYRKVVRKNTDGLIARWKYFWQSSIALVVAFALYA
YGKDTAATQLVVPFFKEVMPQLGLAYILLTYFVIVGTSNAVNLTDGLDGL
AIMPTVFVAAGFAFIAWATGNVQFANYLHIPHIPLASELVVVCAAIVGAG
FGFLWFNTYPAQVFMGDVGSLALGGALGTIAVLVRQEFLLVIMGGVFVVE
TLSVILQVGSYKLRGQRIFRMAPIHHHYELKGWPEPRVIVRFWIISMLLV
LIALATLKVR
>VF2201 UDP-N-acetylglucosamine--N-acetylmuramyl- (pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase
MKNKNKRLLVMAGGTGGHVFPGLAVAKQLQSEGWEIRWLGTADRMEADLV
PKHGIEIDFIKVKGLRGQGLKKLIAAPFQILGAISQAKKHIKAWQPDVVL
GMGGYVSGPGGIAAWLSGIPVVLHEQNAVAGLTNQWLSKIAKRVFQAFPG
AFPNAEVVGNPVREDVCQLPHPKERFAQRTGPIRLLVMGGSQGARILNTT
LPEALPQLSHEIEIWHQAGKGSQETVEQAYRDNGIADAKVTEFIDNVAEA
YAWADLLVCRSGALTVSEVSAAGVGSIFIPFMHKDRQQALNADHLVQCGA
AQMIEQQDLTVQGLVDTLNGLERKQLLEMACNARDAAIIDADVRVANAIK
SLAK
>VF0135 ADP-heptose--LPS heptosyltransferase III
MPLFTSAPHSLCILRLSAIGDVCHAIAAVQTIQTTWPSTKITWIVGKVEA
QLIHDLPGITVIPFDKKLGLAGMRTIWHQLKDQQFDALVHMQLALRASLL
TVGIKAKYKVGFNRKRAKEGQWLFTNRKIEDTASAHVLDSFYAFIEYLGV
PKREPSWNIPLSEVDLAFIDTHVSSEKPYVVISPAASKDERNWLTERYAQ
LADWLNEQGYQVVLCGSPSEREKQLGAAIESLAQSPLINIIGLTSLKQLT
AVLKKATVVIAPDSGPAHIATTQHTPVIGLYGHSNPKRTGPYNSLPYVVS
VYEHHVTQQQNKPIEDLKWSTRVKGDHIMQDITLDMVKEAFLRLRHQ
>VF0344 glycosyltransferase
MTEKITVIGTRGIPNVLGGVETHCQHLYPEIHRQFDNDICVIARSPYVDY
KISSFQGVQTKAVWAPKKKSLEAIIHSTLASLTTLFDGSKVIHVHAIGPG
LVVPLLRLLGKKVVFTHHGPDYDRQKWGGFAKRILKLGEKLAATYANEII
VISEVINDIIKEKYNRYDAHLIYNGVKLPTQLPQEKIDSTLSKFALTAGN
YFVAVGRFVEEKGFHDLIDAYQQANLNIPLVIMGDTDHPTPYSEKLKQQA
KNVDGVILTGFLKGEELQAIFSQAKTFVMPSYHEGLPIALLEAMSYSLPA
IVSNIPANLEVKLTPDTYFSIGNTEELTLQLAQHAKNEYSSINYASYLEY
YDWEKIATQTMAVYQRALTKKVLSGQS
>VF0346 hypothetical protein
MTKLPFISVIIKTYNEEAGIEKTISSIKKNMGVYPHKIIVADSLSTDNTQ
DIATKMDVTVVSLTEPEDRCCGVGHQLGYLYSEGDFLLLLDGDMELESGF
IEQGVSFLLENPQYAGVAGSVEMDDVDSYEFKSRKQRLHQIYPIGDCSHL
GGGGLYRKTAIDEIDYLTNRNLHAYEESELGMRLTHAGYKLHRLDVPYFF
HTSYTMSSLALMKHRWKGGYLFAPGELVKGAFGTPLFSHALKTIKNEAIF
AVYLFILFASLLSFNPILIGATSLPLFAFIGLKTIKNRSIRDALQSVLNL
SVFAAGLIKGLFIPLKDPKTPPPHTVINEGKK
>VFA1107 mechanosensitive ion channel
MIKKYFAALLLMMSMMAPAYAQSIDSMVTLQQELKERLVQLSTADPADKL
FFEDVLRRKNDKIRADIELQLQDNPSVKGLDEVVRSEMTLMGNLLKLSHQ
DLVELTKAVRKAKGEEKDDLEFAAQKRLGIMDVYYEEAFKTLSWGETLNI
DFTKEKTAILKELTNRADLLSNIIHYLESQKSDIAKRMQYASAEKKDLLT
QNATSLTERISLMIASLEVTTALMEQNNIDITEYKQLIFSVTGDINSDVL
DISVAYGLTEEWVTRFKDWAVENAPSIIVKLIIFAVILWITNFLSRLAKS
AIKRSVSHSKMKFSKLMQEFFVSMGSKFVMMIGILIALSQIGINLGPLLT
GFGVAGVVIGFALKDTLSNFASGMMILIYRPFDVGDLVDIGGIVGKVNRM
NLVSTTIKTVDNQNLIFPNNKIWGDVIKNVTIETERRVDMVFGIGYQDDI
EKAKAIFTDILESHPAVLKTPEPMVKLHTLNESSVDFIVRPWVKTDDYWD
VYWEVTETVKKRLDAEGVSIPFPQRDLHIYKHEA
>VF1481 penicillin binding protein transpeptidase
MSKQKTPFRNHQFETSLFNQRVIVAFLFMLVAIGGLVFNLYHLQVRNHDR
YQVRSNRNRIKIIPVAPNRGLIYDRNGVVLAQNIPVSTLELTPAKIDDIN
ATLTSLQKLLNLSDHDIAKFKKLMHRTRSTKPITLIEQMSEVQIAKFSVN
QFHYNGTNINAYLERYYPYGESLTHVLGYVGKINDRDIRTLKKDNRYTNY
EGTHAIGKLGIELYYESTLHGKSGYQKVEINSHGRIVRTLDYVAPIPGKD
IKLNIDLGLQLYAYNQLKIKKENPITHKMEDYHRRGSIVVLDPRDDSVLA
MVSSPSYDPNLFVHGISSKHYNALLNNPDLPLLNRTTLGIYPPGSTVKPQ
IAVAALSEKVITPNTTTNFPGWWRIPHSKSRKFRDDIRWGHGEVNVVKAI
EKSVDTFFYQVAYDMGIDRLSTWMNKFGYGKPSGIDIREESPANMPTRDW
KHSNYHQAWYKGDTIPVGIGQGYWTATPMQIAKATAVIADEGIVHRPHLL
KSVMEDGKFKPIIFKDFPKVNHTKKQYWNLAKEGMHRVIVSGTARKLFQN
LAYKAGGKTGTSQVFGLDKGEEYNSEDVAEHLRDHALFTSFAPLDKPKVL
VAAVLENAGWGKYAAPIGRNIMDYVLINPKISLDHT
>VFA1028 glycosyltransferase
MSKSKKTTLLFVHYGDNWIRGSEVCLINLIKSINHQKYRCILWCNQQCLA
DEVNKQVEAAYVTPFTLLLGWDSPRFSLSNWFQFYQQGKQIIKSHNIDLI
HCNSAAPCQWMNLVARHTQIPLVTHLHTQYPLRDRLSLGIHLSPKLVTVS
DAISQNVLTDGYKKEQLTTIPNGINTTKLNTQHKIDLRAQLGIDKDAYVL
ATSGSLIHRKGVDLLIDSLVLVDAVTLNIHLVIIGEGEERANLEAQVRRL
KLTNNVHFLGEQSNVVGLLKSDINAYISGARDEAFGLALIEASLAQLPVI
APMVGGIPEVITHYETGFLTQPNDSESFAKAIMVFIQNPHLASRLGKKGK
ETVYRYFTLSQYAQQFENIYEEQLINNQSHTQPLWAAIKPIFNNLTYISK
LFVRNHIASHFRSNDDLSKEAHHE
>VF0349 chain length regulator
MALSIIENGKKLESTIDFSNFLKEFKKYRLRVLLVVLAITLAAFPLINGM
TPQYTATATIVLKAKTDNSTPIDQVEDFDATQAEYYPTQAELLQSKTVIE
AAAKKLDLINSPIFEDEDKDENIPQSEEEHLYSIVKAIKKKLSISPVRFS
QLVHVSYESKDSDMSALVANAVVESYIEQQEQRKIEKTQQAQQWNNTRMS
ELKEKIKQQKADIDKFLSDNGLLTYQGVDGFETEQLALVNDRLATAKEKR
ITAKANYNTISEALGYPLEDVATLPSISNHAQLQDLRIALIQAKRTLFDL
QKMYGPKNRQILEANAQIKAIELQTTALLKELKTGLYKEYQAAIERENKY
RALLAEQKKDFTALAAKKDTYNTMKADLDKTQELYEKIFLRSKEQELTVL
YREPVARLLDAATPPHKPSKPNKALLLIMVCAMTIIFSLLFIIIKSALNK
SINNLTQVNTRLGLQGIGELISLNYIDELALFTKNFFKNSYSAETVHAIR
TTILLDDKPWPIIGLTSTESTESNELNSYLLAYSFSQDRSTLLIDLDYRK
EISLTEAILMQKENEIDAKKAENSDDFETVPTSTVMGVAEALEQKHPIND
CLIKIENNLTFLPRGTLTETPLITLASEELGRQLKELSKQFEQVIVNLPA
MTESKDAQLIARHLSGVIYTVQAGELSANHILANIEKVKQVQTPIMGVIL
TDVQNDELETEEAKQQLIHQNDDILG
>VFA0588 hypothetical protein
MKKQLLGIIISASLLMGCQSTSDDEMADIAETPTVASFVDYHNEQLQQFV
TEDIGSVAQTNEEIIILLNGDKSFDSGSIEIKNESKLVLSQLAKLLNDKP
ESEVFIAGHTDSRGSKKFNMSLSNQRADSVLALLEENGVDGNRINTYGFG
ESEPIATNINAEGRKKNRRIEIRITPITELFDEE
>VF1799 lipid A biosynthesis (KDO) 2-(lauroyl)-lipid IVA acyltransferase
MTEKIDKNVYNPTFQWAFLHPKYWPTWLGIGFAIILAFIPFRLRDKLAAK
IVKLVLKKPSGGIKRAKLNIATCFPEKSEQEQQKLLEDTYITGAQVMLGF
SELLVRSRKHNEKRGIFVGGENLFPLLEQKENIIILAPHAWAIDFPAILL
ASRGYHVTTMMKPQKNPITDWLMHVQRMQYGGKIYARSAGIKPLIKAIKE
GYLAYYLPDEDHGPQNSVFVPFFATQKATLKGFGKLARLSKAKVVPMLPS
YNSETGQFEIITLPAIADFPSGDEETDARAMNIAIEQLVTERPEQYMWVL
NLLRSRPGGSRLY
>VF0555 TagE-like gene
MPDKIRISVSHNKGTRLFAISQRRKKLVILSLVLGVSSFALSGFGLHYFY
QQQESAKVAIAELQNKNNVLNQLIVDNNNSNHELTQQLEAKENELLVISQ
RVDDVESVLGLQEISEEDSSLAEKTLEQRLDVAAIDSAVRATMFRLIPND
TPLHYTRESSSFGRRTNPISGKRQRHLGVDLTCKRGTEIYAPADGVVELA
RASNKGYGNLLKVQHSFGFMTMYAHLQKFKVRSGQFVKKGELIATCGNSG
NSTGPHLHYEVRFLGRVLNPRSFMDWTPEKFDSLFEKERSVKWTPLVDVI
NNVVKLQLKLTQKPTVEQVEAINTAKAENESSQQLTQ
>VFA0736 ABC transporter permease protein
MRKLISLLPYSLRLAWLNLLRNGRRSALSILIITITVFALTSAGGFGLYT
YDSLKESTARDTGHLTLSQPGYFESDEEMPLSNGLSDTSELIRTMMKYDE
VRGVQPRIDFTGLISNGVKSTIFMGTGVNDREFDMKGPFLDMRSGKTLTD
ITSSRYDVMEPEIMLGVDLARNLNVSVGDWVTILATTSEGALNAFDFKVH
GTYSTGVPELDKRQLYIHIDSAQELLLSEKVSTLSVFLFDTEKTAELHQR
LAQELETMPLDYDVEITPWQERAFFYNKVKDLYDLIFGVMGFVMGLVVFV
ALFNTMTMSVTERTREIGTLSALGSYPNEIIHSFLREAGLLAVIGVVLGA
VMTALTTILLLVVDVQMPPPPGRTDGYPLNIYFSFELVAYAGVGVVCICL
LAAYLSAKKGVKKPITEALIYV
>VF1917 lipoprotein-34 precursor
MKVKTRFVVGSLMIAVLSACSSSPTERRQAKQDFKYLETPPLVEWQEPAD
AKPEFYPQYDIPKGEFTGGIGKEVDIRPPQQVLELIPGARIEEQNGEVTV
WLVKQEDVDKLWQTVLTLMKKKDIGIVKEEPSEIETDWLKWSSEDEDHEF
GARYKISKLNQNNRVGFQILLIDWQVDGNQAEVTPANKARYNILMTNLVT
SAYDEQLREEARIRAEELVKRIPISMGQDRSGLPVIIARAPYNIFWERLG
ELLPMMGLAIEDRNRSQGTIEVKYKEPDDEFWEEIGTKPLSFDGRTYNLL
LGDLGNRTSINVTDAGGKPVDEDTLDSLVPVLAAMIEKSNNAPKTEQDEE
>VF0138 3-deoxy-D-manno-octulosonic-acid transferase
MIRLIYSLFLALLSPLLLYSLYKKKDGKPAFGRRWKEHFGCTPSLNTTQA
PVWIHAVSVGEAIAAAPIIKTLKKQTPEQPILVTTTTSTGAEQIEKLGDL
VEHRYMPIDFCFAVRGFLKATKPEKMLIMETELWPNTLHTVAKFGIPISV
LNARLSEKSFLGYKKVQPIFNLLGKHLTHVCCQYKDDADRFVALGIQPEK
VHVTGSVKFDIEITEQIQASGGILRKQLGEDRPIWIATSTHKGEDEQVLA
AHRSLLHKIPNALLILVPRHPERFNSVFELCQSADFKTVKRTSNQTLTPN
CQIYLGDTMGEMLTLIGASDICFMGGSLLGNKVGGHNLLEPAALAKPSIT
GPSYYNFLEIAETLIKEDATKVIISAEELANLLEQLMTQPEYAEKMGKNA
QSFISKNSGAVIKTLNIV
>VFA0425 tetraacyldisaccharide 4'-kinase
MIEKIWFDNHFLGKLLWPLLWPLSYLFKWIATKRKSDYQSGKKQSYRSSV
PVVVVGNITAGGNGKTPVVVWLVEQLQSKGYKVGVASRGYGGKAPHYPYL
LTETTTPDISGDEPVLIKQRTKAEVAVAPVRSEAVKMLEQQGVDFIITDD
GLQHYALQRDIEFIVIDGKRRFGNQHYIPLGPLREGVERLSSVDFLICNG
GESQENEVSMRLQPSEAINLVTGERRSVSSLSNLVAFAGIGHPPRFFETL
NQLKANVVHTQGFEDHKAFEPTEIEQLMQYGEQLIMTEKDAVKCQSFAQS
SWWYLPVDATFPKEKAQQILNKIIEVKE
>VFA1027 glycosyltransferase
MKNRNDEIWLLLDSRNFGGIESHVLQLAKGIKSFQRSVRVIFLCRYPTTH
PLVALLNEANVSYRFLEGSFSSLLTYTRHHSPKVIHSHGYKAALYSRLLR
ISQYTSQQKIRYINTYHAGEISRGKLAIYDLIDRWSAPLSHCNFAVSELI
KKRIPSKTTVLNNFINTENLIQSKGTQIAFVGRLSHEKAPDRFLELANQL
SKVQFHFYGSGPMEKNLQNYSPSNLHFHGHQNSMDSIWPHIGLLVICSRY
EGLPMVALEAMGRGIPVVSTPVGNMPTLICNNENGWIVTPDALPTAIKNW
VNLPSSQAKNIQKNAQQTIQETFSSQAIIPSLLSAYQI
>VF0173 hypothetical protein
MIKKKKRILLVIPKFFNYEKNIKKHFELMGYDVDLIIDETPFRTILCNYI
PYMKLFFGFYVENKIKKLITKNDYTSCLVIKGSSLSLKALTIIESHIKNR
YLYQWDSLSNYPYQTMLLYFNHVLTFDISDSKHLNLEYYPLFSMIENDRK
ELSRNIDILFIGSFHSDRYKVLKEILCQYKDLNIYFYLYIPFLSYIKRIF
KGEKILLSDIRFFKIKPEKLSCFYNNSKCVLDIEAYHQTGFTMRTLEALY
CGCKLITTNDNIYTADFFDKKIISVIDRNDVLLDKSFIFNDENVEDNKIL
QVKNLKEWVVRFADD
>VF0963 peptidoglycan-associated lipoprotein
MQLNKLLKSLLIALPVVALSACSSSDSATDSTAGQESTNAAETQTTNGAE
GQTDTAVLSSIEADEAMNEAEVRAQAEQELRKVQTVYFAFDNSTISSEYE
DMLAAHAAFLSADPSIKVTVEGHADERGTPEYNIALGERRAKAVSKYLQA
LGVSADQISIVSYGEEKPLVLGQTAEDYAKNRRAVLVY
>VF0772 2-dehydro-3-deoxyphosphooctonate aldolase
MQNQKTVKIGNIDVANDKPFTLFAGMNVLESRDLAMQICEKYVEVTDRLG
IPYVFKASFDKANRSSVHSYRGPGMEEGLKIFQELKDTFGVKIITDIHTE
AQAQPVADVVDVIQLPAFLARQTDLVEAMAKTGAVINVKKPQFMSPDQVG
NIIDKFSECGNENIILCERGSCMGYDNLVVDMLGFGVMKKASNGSPIIFD
VTHSLQNRDPSGKASGGRRSQTVELAKAGLATGIAGLFIEAHPNPDKALC
DGPSALPLDQLEPFLKQMKSLDDLIKGFEHIDIK
>VFA0193 TolQ protein
MTIKPLILAVSLLGLSINTATANTELLKETKQASHVQKQHDAQRESGFKQ
TEQSLKAQRNALIAERKKLQKESDQLSATFSKNEKTLATLEQQLHLETGS
LGELFGVVRQTAKDVNAELKNSMSGSENNKYNQLIADIVAAKSLPSMTQL
TGLWQTMAQQVNASSELELTTVTMINGSGHRQSINAYRLGNMALVGEGGF
LQWDNKKQVATYYAQQPKLTPTTTILSEMPSEQVIMMASDPSRGIMLEQL
ANTPTMKERLQAGGVVGKIIIGLLLIGLIISLFNGVRLFVIRQQIRKQLK
QPQELGQNPLGRVLAVYDAEKQRSVEALELRLLETIVDEQQGLEKGLSML
KLLAALAPMLGLLGTVTGMIETFQVITLFGNGDPKVMAGGISMALVTTVL
GLVAAMPLLLTHNILSSQAESIRTILEKQGLGLVAEQAEKVVQPNAMDMA
A
>VF0187 hypothetical protein
MVIMKNNITVCIPTFNRCESLKKTLGHLLSSKSISFSVVVSDNASEDDTW
EYLNSLDDTRLIISRNETNIGFTGNILKVLELSPTDFILFMSDEDFVILE
NIEEIIRTNIDDDVGVFYGGVLHENNSTYYYKYNKKTWKKKEALNKVVLS
HSYMSGMIFNKKYLDLNKFNTSIADEDVVLYPHEIMVYMILCNGGKLVTD
SLPIAKQGEAVESEAIIKYKYYEYNERLKLFKQYCRVVSNLDYGLIESRI
FFKKMAIIASCVFVDEVLIKKIKPKQYLSEIFSLNCGWLFKLQFVTYSSA
VFLMRKLKN
>VFA0358 acriflavin resistance periplasmic protein
MRSTTSTLMLIKKTAIAVSLAVGSMVISGCDTNEVAKEISQPTIRPALTE
IVSPSANAQLRFNGVVRSAQRADLAFRMSSRVISVLVDEGQQVKKGQLLA
QLDPRDAQTALESARVEYKNSKAEYTRGKAIYEKSQAIAKSDLDTLTTRY
QLAKNRLDEAQRQLEYTQLHAPFDGVIGKKMIDNHVQIQANSPVLTVHNV
DDLEVLINIPDSVMLGDLKGSKALAQISALRNETFPLVLSTYGTQADPIT
QTYPVVLTFEDLRGFNVLPGMTVKVVPVYSDEQDQASLLITVPLTAVVPD
NQGGQFVWVVTQENKVQKRIISAGTLVSNRIVINDGLQTGERIITAGASS
LKEGMEVRPYTDTLSSQVEK